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Summary  
 
Socioeconomic deprivation (SED) is inversely associated with mortality. The most 
deprived are at a higher risk of all cause mortality and cardiovascular mortality. However, 
only limited study of the relationship between SED and non-fatal cardiovascular disease 
has been previously undertaken. In those studies that have examined the relationship 
between SED and non-fatal cardiovascular disease, analyses have been limited to one form 
of cardiovascular disease (CVD), such as myocardial infarction or stroke and often 
prevalent disease. Furthermore, these studies have often failed to examine the association 
between SED and CVD whilst adjusting analyses for cardiovascular risk factors which are 
more prevalent in the most deprived. The aim of this work was to examine the association 
between SED and a number of cardiovascular outcomes after adjusting for the traditional 
cardiovascular risk factors of age, sex, smoking, blood pressure, diabetes mellitus and 
cholesterol. To determine is SED is in fact a risk factor for CVD after adjustment for these 
other risk factors, the relationship between SED and a number of fatal and non-fatal 
cardiovascular outcomes was examined. A number of forms of CVD were examined, 
including all coronary heart disease, myocardial infarction, stroke and heart failure 
A cohort of over 15,000 men and women who participated in the Renfrew Paisley cohort 
study was examined. These individuals were enrolled between 1974 and 1976 and 
underwent comprehensive screening for cardiorespiratory risk factors. They have since 
been followed for hospitalisations and deaths for 28 years. SED was measured using the 
Registrar General’s social class system and the Carstairs Morris index of deprivation. 
Rates of fatal and non-fatal outcomes were calculated, as were a number of composite 
outcomes. Adjusted analyses using multivariable regression were conducted to account for 
the risk factors of age, sex, smoking, blood pressure, diabetes and cholesterol. Further 
adjustment for the risk factors of lung function as measured by forced expiratory volume in 
1 second, cardiomegaly on chest x-ray, body mass index, and a history of bronchitis was 
also made. The association between SED and the risk of recurrent cardiovascular 
hospitalisations, the burden of cardiovascular disease, as well as mortality and premature 
mortality was assessed for SED.  
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I found that SED was associated with higher rates of hospitalisation for CVD disease in 
men and women irrespective of the measure of SED, either social class or the area based 
score of the Carstairs Morris index. This association persisted after adjustment for the 
traditional cardiovascular risk factors of age, sex, smoking, systolic blood pressure and 
diabetes and cholesterol. Further adjustment for lung function, the presence of bronchitis, 
body mass index and cardiomegaly on a chest x-ray did not explain the relationship 
between SED and each outcome. This risk was long lasting and persisted to the end of 
follow up. The strength of association of SED with coronary heart disease, myocardial 
infarction and stroke and all cause mortality was similar.  
The risk of a recurrent CVD hospitalisation was not higher in the most deprived after 
adjustment for CVD risk factors. However, I observed that SED was associated with 
higher mortality following an admission to hospital with CVD, before and after adjustment 
for cardiovascular risk factors of age, sex, smoking, systolic blood pressure, cholesterol 
and diabetes and after adjusting for the year of first developing cardiovascular disease.  
All cause mortality and cardiovascular mortality was highest in the most deprived. Again 
this association persisted after adjustment for cardiovascular risk factors. The most 
deprived also experienced longer hospital stays than the least deprived for a number of 
cardiovascular diseases including myocardial infarction and stroke. As a result the costs 
associated with cardiovascular disease admissions to hospital were highest in the most 
deprived despite their higher risk of dying during follow up. The cost differential was also 
explained by the finding that the most deprived experienced a higher number of admissions 
per person. Finally, the population attributable risk associated with SED is comparable to 
that of other traditional cardiovascular risk factors.  
In conclusion, I have found that the risk of CVD in the most deprived is higher even after 
adjustment for a number of cardiovascular risk factors. The numbers of hospitalisations, 
costs and mortality are also highest in the most deprived. Efforts are required to redress 
this imbalance. This can be achieved at the level of the individual through health care 
interventions to reduce the absolute burden of cardiovascular risk factors and to treat 
disease. However, societal level interventions are also required to tackle this problem as 
SED exerts complex effects on health that seem to also be independent of risk factors.  
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Introduction 
This thesis will examine the relationship between socioeconomic deprivation and 
cardiovascular disease. It will review the published literature surrounding this topic and 
will report the results of a number of studies examining the relationship between 
socioeconomic deprivation (SED) and cardiovascular disease (CVD) occurring in a cohort 
of men and women in the west of Scotland followed for over 25 years.  
In the first section I will review the principles behind the measurement of socioeconomic 
deprivation before moving on to describe the literature relating SED to health and well-
being in Scotland, and the UK. The next section will describe the literature that has 
examined the association between SED and cardiovascular outcomes, highlighting the 
deficiencies in the literature that underlie the need for these analyses. Following from this I 
will state the aims and objectives of this thesis. I will then describe in detail the cohort 
studied in these analyses and some of the general statistical methods used to analyse the 
data. The subsequent chapters will present the results of the analyses performed which 
have examined the association between SED and CVD. I will present the results of 
analyses that have examined the association with a first non-fatal CVD hospitalisation and 
a number of composite outcomes, the impact of SED on recurrent hospitalisations and 
subsequent cardiovascular and all cause mortality and finally the burden of disease, 
including the numbers of CVD admissions, length of stay and health care costs. In each of 
the analyses a number of the major forms of CVD will be examined including all coronary 
heart disease, myocardial infarction, stroke and heart failure. 
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Socioeconomic Deprivation 
Measurement and definition of socioeconomic 
deprivation 
The literature surrounding the concept of socioeconomic status or deprivation is almost 
immeasurable and many concepts and terms are still open to debate and outside the scope 
of this thesis.1 For example, multiple terms are used to describe the concept of social status 
from “social class”, “social inequality”, “socioeconomic position” and “socioeconomic 
deprivation” with each having theoretical advantages. For consistency I will refer to 
socioeconomic deprivation (SED) throughout this thesis. This can be measured by a 
number of different methods. It is often defined on an individual level using measures such 
as income, education and occupation. Each measure has its own advantages and 
disadvantages; however, comparing measures between different countries and cultures is 
often difficult as levels or scores are country or culturally specific. In addition, individual 
measures of SED may not account for the other contextual effects that poverty and the 
environment impart on an individual. As these are much harder to quantify than individual 
measures such as income, a number of different scoring systems have been developed. I 
will discuss below the theory and use of two measures of SED that I will utilise in the 
studies that I have conducted and note some of the other measures commonly encountered 
in the literature surrounding SED and CVD.  
Theoretical background to the measurement of 
socioeconomic deprivation 
Before discussing the methods by which SED can be measured in the literature it is 
important to assess the broad concepts underlying the measurement of SED. Societies are 
complex systems and social stratification is an important mechanism by which societal 
resources and goods are distributed and accumulated over time by different members of a 
population. Different measures of SED capture different aspects of social stratification. 
Each measure may be more or less related to different health outcomes and may also be 
related to health at different stages of life. For example, social class as defined by parental 
occupation is more likely to reflect social circumstances in childhood than late adulthood. 
Most indicators are correlated with each other to some degree because they all measure 
some aspect of a population’s underlying socioeconomic stratification.  
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The full theoretical and historical background of social theory is too large to summarise 
here but has been reviewed by other authors.2 Two social theorists have informed much of 
the thinking around social stratification and the concepts which have led to different 
measures of SED.3 The first is Karl Marx. Marxist theory defines social position as a 
structural relation between groups in a society based upon the production and ownership of 
material goods. This is based on how the owning classes exploit the non-owning classes in 
a society. The theory is underpinned by the inherent conflict in a society between the 
exploited workers and the exploiting capitalists. Therefore, in this view of SED the 
relationship is not a feature of the individual per se but of the inherent social system of the 
few exploiting the many.  
Max Weber is credited with the other major theory of SED. Weber suggested that a society 
is stratified through many dimensions. This creates groups of individuals who share a 
common position within a society and therefore share the same “life chances”. Their life 
chances are created by a common ability to beneficially use or trade their education, skills 
and attributes in the marketplace of their society. Thus, Weberian theory leads to the use of 
education, occupation and income as measures of these aspects. Weber, in contrast to 
Marx, therefore places more emphasis on the individual’s ability to change life 
circumstances as opposed to the inherent flaws in a society that Marx proposed, over 
which an individual had little influence.  
Occupation based measures 
Occupation based indicators of SED are widely used and are perhaps the most commonly 
understood method of assessing SED.3,4 Occupation can represent SED by reflecting a 
person’s place in society in relation to their social standing, income and intellect. It can 
also characterise working relations between employers and employees. Most studies use 
the current or longest held occupation of a person to assign an individual’s SED. 
Occupational measures based on one individual are often used to define the social position 
of those around them. For example, the occupation of the ‘‘head of the household’’ can be 
used as an indicator of the SED of dependants (the most common situation is that of the 
husband’s occupation being used to define the social position of his wife and children) or 
the household as an entirety. A number of general mechanisms may explain the relation 
between occupation and health outcomes. Occupation is strongly related to income, and 
therefore, the association with health may be one of a direct relation between material 
resources and health. Alternatively, occupation may reflect social standing and be related 
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to outcomes because of the privileges that it brings, for example better access to health 
care, access to education, and so on. Occupation may also reflect social networks, stress at 
work, level of control, and autonomy and thereby affect health outcomes through a 
psychosocial process. Finally, occupation may reflect specific toxic environmental or work 
related exposures, for example, environmental smoke. 
A particular strength of this measure of SED is its availability in routine data sources, such 
as the census and death certificates. A limitation of occupational indicators is that they 
cannot be readily assigned to people who are not currently employed such as housewives. 
As a result, if used as the only source of information on SED, socioeconomic differentials 
may be underestimated through the exclusion of some of the population.4  
In the UK, social class was measured according to industry as early as 1851. In 1911 the 
Registrar’s General’s annual report differentiated occupation and industry with a summary 
of occupations representing ‘‘social grades’’.5 This scale is based on the prestige or social 
standing that a particular occupation has in our society. In 1990 it was revised to take into 
account more explicitly the skills needed to perform a particular occupation.  
In the Registrar General’s social class scheme, occupations are divided into six classes 
(Table 1), ranked from highest, to lowest, on the basis of prestige.6 The table is also 
divided into two broad categories, manual and non-manual occupations. The seventh 
category of all people in the armed forces (irrespective of their rank), is generally excluded 
in health studies.  
Table 1 Registrar General’s Social Class scheme 
Grade  Example Occupations  
I Professional Doctor, Lawyer, Executive 
II Intermediate Sales Manager, Teacher 
III-N Skilled non-
manual 
Shop Assistant, Clerk 
Non-Manual 
III-M Skilled manual Machinist, Brick layer 
IV Partly skilled Postman,  
V Unskilled Labourer, Porters 
Manual 
VI Armed forces   
 
The strength of this measure is its past official status in the UK and hence its widespread 
use in central statistics, as well as a number of censuses and surveys. It has been adapted 
and used in other countries, making comparability between studies easier. However, its 
subjective basis is a limitation. Furthermore, it does not account for recent changes in the 
occupational structure of society. There has been an increase in service jobs and a decrease 
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in unskilled and semi-skilled manual occupations. To redress these difficulties, since 2000, 
the Office for National Statistics in the UK has used the new UK National Statistics 
socioeconomic classification as its official occupation classification. Despite these issues 
the Registrar General’s social class system has been, and continues to be, widely used.  
Other occupation based measures are available. For example the Erikson and Goldthorpe 
Class Schema was devised to allow international comparisons to be more easily made. It 
has been used in some studies.7 However, it does not have an implicit hierarchical rank and 
therefore may not capture gradients in risk across its groups. A Marxist view of occupation 
underlies the classification system of Wright, which has also been adapted.8 It explains 
differences in outcomes across groups in terms of exploitation and conflict between the 
classes (capitalists, petty bourgeoisie and self-employed). This is an underused scheme 
though has been applied in the UK.9 Other scores or measures of occupation include the 
Duncan socioeconomic index, and, the Cambridge social interaction and stratification 
scale.4 Again, these scores are relatively underutilised in the health care literature 
especially with respect to CVD.  
Area level measures and indices of socioeconomic 
deprivation 
Area level indicators are also used as measures of SED. These are commonly aggregated 
from individual level or small area data, usually from census or other data sources.4 They 
can be used to define areas as deprived, or affluent, and consequently are used as a marker 
of SED for the people living in those areas. A number of area level measures of SED, also 
often referred to as indices of deprivation, have been developed. I will discuss the index 
utilised in these analyses, but also highlight some of the other commonly used scoring 
systems. 
The Carstairs Morris deprivation index  
The Carstairs-Morris deprivation index is an area based risk score.10 This index, based on 
official Scottish-wide census data, is used to rank postcodes of residence into seven 
deprivation categories. The geographical areas are based on postcode sectors – that is areas 
with identical postcodes except from the last two characters (e.g. ‘G84 9_ _’ omitting the 
last two letters of the postcode). There are almost 1,000 postcode sectors in Scotland, with 
an average population of around 5,000. The index was originally developed in the 1980s 
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using 1981 census data. It is composed of four indicators which were judged to represent 
disadvantage in the population. The four indicators are combined to create a composite 
score. The deprivation score is divided into seven separate categories, ranging from the 
most deprived (category 7) to the least deprived (category 1). The seven categories were 
designed so as to retain the discriminatory features of the distribution of the deprivation 
score, rather than to ensure equality of numbers between each deprivation category.11 
Some very small postcode sectors were excluded and do not have a score. The index was 
designed with the expectation that it would be mirrored by direct measurement of 
household income if that were possible.10 
The four variables measured were: 
1. The degree of overcrowding:  
This was defined as the number of persons in private households living at a 
density of more than one person per room as a proportion of all persons in 
private households  
2. Level of Male unemployment 
This is the proportion of economically active males who are seeking work in 
that postcode sector. 
3. Proportion in Social class IV or V 
This is the proportion of all persons in private households where the head of 
household was deemed to be in social class IV or V according to the Registrar 
General’s social class scheme outlined previously. 
4. Ownership of a car 
The proportion of all persons in private households with no car  
All the proportions are calculated using the households in a given postcode sector.  
As suggested by the above, area based indicators account for the socioeconomic conditions 
of an area, and therefore can have an independent influence on health. Recently, the 
concept that over and above individual characteristics, the place where a person lives can 
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affect their health, has received more attention. The place where a person lives can be 
defined as a neighbourhood, a city, region, or country. Studies that have investigated ‘‘area 
effects’’ tend to find smaller associations relative to the size of individual SED effects. It is 
unclear if the association between area level measures of socioeconomic circumstances, 
and health outcomes, are related to the socioeconomic characteristics of where people live 
independently of the (lifetime) characteristics of the people living in these areas.4 One 
difficulty in disentangling this question is that area based measures are often based on 
individual level data. One disadvantage of area measures is that they are often used as 
proxies for individual level indicators when these are not available. In such a situation, 
given the misclassification of individual socioeconomic circumstances when measured by 
area characteristics, the association with a disease is likely to be underestimated. The larger 
the areas the greater the misclassification will be. In my analyses I will utilise both the 
Carstairs Morris index and occupational social class to minimise this misclassification. 
Before discussing other measures of SED it is worth noting that the Carstairs Morris index  
is not the only area based measure available. The Townsend deprivation index12, Jarman or 
Underprivileged area score13 are conceptually similar to the Carstairs score. They are area 
based scores constructed from census variables that are similar to the Carstairs score. For 
example, the Townsend index uses four variables, the proportion of unemployment 
amongst the ages of 16-64, proportion of non-owner occupied households, car ownership 
and overcrowding. The Breadline Britain Index is slightly different in that it includes 
variables such as proportion of individuals with long term illness and lone parent 
households.14 These other area based measures have been used in the literature surrounding 
SED and CVD. In particular, the Townsend deprivation index is commonly used in studies 
based in England. However, despite their differences, all of these area based scores share 
the same limitations as the Carstairs Morris index with respect to misclassification and 
potential difficulties in extrapolating results to the level of the individual.  
Other measures of socioeconomic deprivation  
Other measures of SED are used by researchers, particularly in the field of cardiovascular 
disease. The most common of these are income and level of education. As these will not be 
utilised in the analyses conducted during this thesis they are discussed here in brief, 
however, they are worthy of note due to their widespread use in the cardiovascular 
literature. They have been used in multiple prior studies of the relationship between SED 
and cardiovascular disease particularly in North America.  
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Income enables an individual to purchase goods and services, such as education and health 
care, which may impact on health. Income also allows individuals to purchase items such 
as better food and shelter. It may also be beneficial through the purchase of material goods 
relevant to participation in a society, thus fostering higher self esteem in an individual, an 
example would be membership of a social group such as a sports club.4 Income has 
limitations as a measure. Poor health may lead to an inability to work and lower income 
which may lead to reverse causality in epidemiological studies. However, the measurement 
of income is complex as individual or family income can be measured. Income may be 
adjusted for family size. Income can also come from other sources. For example, income 
can contribute to wealth over and above the primary wage in the house, through non-
monetary income such as benefits, and, an account of tax relief measures enjoyed by an 
individual may need to be included to fully determine income. One final limitation of 
income as a measure of SED is the high rates of non-response in relation to income related 
questions, which is reported at approximately 10%. Income is particularly favoured as a 
measure of SED in North America as the health care system is not a universal access for all 
system such as the National Health Service (NHS) in the UK, therefore, the treatment an 
individual receives may be directly related to their ability to pay for access to health care 
services.  
Education is a widely used measure of SED in epidemiological studies.4 Questions on 
educational attainment have very low rates of non-response in comparison to those on 
income and questions are rarely complex. Education may also reflect future employment 
and income. As level of education is fixed after young adulthood it is not influenced by 
poor health in adulthood, as income may be, and therefore, is not likely to lead to reverse 
causality. However, poor health in childhood may lead to lower educational attainment. 
This is not the only limitation of education. There are differences between birth cohorts in 
level of education, so that the resulting social and behavioural correlates of education may 
vary according to age.  
Whilst there are many measures of SED, no one measure can adequately measure or 
capture the entire multidimensional construct behind the term socioeconomic status. In a 
recent study of SED in health research Braveman et al 15 concluded that socioeconomic 
deprivation should be measured by as many relevant measures as possible, and, include 
individual and area based measures. Whilst it is acknowledged that no one measure is 
perfect, by examining health effects using multiple measures, the unmeasured 
socioeconomic effects are lessened. 
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Socioeconomic deprivation and health in the UK 
Before moving on to examine the relationship between SED and CVD, it is worth 
recounting the relationship between SED and general health and well being, and, the 
political agenda in the UK. This has set the scene for the current interest in health 
inequalities and government policy is one of the key drivers to reduce such inequities.  
The NHS was launched in the UK on 5 July 1948 with a guiding principle that health care 
should be available to all irrespective of wealth. Thus, one of its aims was to redress health 
inequalities through the provision of a universal health care system. However, subsequent 
Government reports noted that the NHS appeared to be failing in its aim of reducing 
inequalities in health when evidence of widening health inequalities began to emerge.16  
The current interest in social inequalities is driven by recent reports in the UK. In the 
1980s the existence of health inequalities was famously ignored by the then  Conservative 
government who labelled such inequalities ‘variations’, explained by statistical artefacts or 
the fault of those who suffered as a result of them. Furthermore, the magnitude and 
underlying meaning of the difference was ignored. This is best exemplified by the 
persistent refusal to acknowledge the findings of the ‘Black Report’17, and by attempts to 
bury it by publishing it on the August bank holiday in 1980 and producing only 260 copies. 
The report, by Sir Douglas Black, was not received well as noted by the foreword by the 
then Secretary of State, Patrick Jenkin. In his foreword he noted that:  
“they (Sir Douglas’ group) make clear, the influences at work in explaining the relative 
health experience of different parts of our society are many and interrelated.......It will 
come as a disappointment to many that over long periods since the inception of the NHS 
there is generally little sign of health inequalities in Britain actually diminishing and in 
some cases, they may be increasing. It will be seen that the Group has reached the view 
that the causes of health inequalities are so deep rooted that only a major and wide-
ranging programme of public expenditure is capable of altering the pattern. I must make it 
clear that additional expenditure on the scale which could result from the report's 
recommendations - the amount involved could be upwards of £2 billion a year - is quite 
unrealistic in present or any foreseeable economic circumstances....... I cannot, therefore, 
endorse the Group's recommendations. I am making the report available for discussion, 
but without any commitment by the Government to its proposals”.  
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The inequalities in death rates according to SED that were described in the Black report 
were therefore to be left un-tackled. A major issue with the Black report was the inability 
of the authors to disentangle why these inequalities were present. One explanation was that 
they were due to artefact and it is on this explanation that the Government of the day 
seized.  
However, the Black report was not the only report that documented the inequalities in 
health in UK society. Following a change of government in 1997 to that of Labour health 
inequalities became an important issue. The Independent Inquiry into Inequalities in Health 
– ‘The Acheson Report’18 chaired by Sir Donald Acheson, reviewed the evidence of the 
most effective action to reduce health inequalities. This report also reinforced the findings 
of the Black report that health inequalities were still widening and were evident across all 
aspects of health. More reports on the health inequalities in the UK have followed 19and in 
Scotland similar reports of health inequalities also exist 20-22.  
Socioeconomic deprivation and Scotland   
On the 6th of May 1999 Scotland underwent devolution from Westminster. Devolved 
powers included: health, education, local government, social work, housing, planning, the 
environment, sport, arts, agriculture, forestry, and fishing. Some aspects of law, home 
affairs and transport were also devolved. Health inequalities in Scotland had been well 
documented.20 It has been documented that of the “worst off million” people in the UK in 
terms of health, 52% of these individuals were living in Scotland. Mortality rates in 
Scotland’s local authority areas with the worst health were twice as high as the UK 
average. Inequalities in health also existed within Scotland. The rate of coronary heart 
disease mortality was two and a half times higher in the most deprived versus the least 
deprived. In 1998, a comprehensive report looked at health and health services in Scotland 
through from a health inequalities point of view 23. Using NHS data, it highlighted 
substantial inequalities both in the distribution and access to health care for all the major 
health issues (mental health, coronary heart disease, stroke, and cancer). As expected the 
most deprived communities experienced the worst health and least access to care, re-
affirming the inverse care law of Tudor-Hart, that the availability of good medical care 
tends to vary inversely with the need of the population served.24 
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Summary 
Socioeconomic deprivation is a complex construct which not only refers to poverty. The 
theoretical basis of SED is founded on two philosophical schools of thought that have 
guided the development of measures of SED. The Registrar General’s social class scheme, 
an individual measure of SED, and the Carstairs Morris index, an area based measure of 
SED will be used in this thesis. The relationship between SED and health has been the 
subject of much interest in the last few decades and differences in health, between the most 
deprived and least deprived members of society, have been documented in Scotland and 
throughout the UK.  
The relationship between cardiovascular disease in particular and socioeconomic 
deprivation has also been studied. Prior studies have reported that in those with 
cardiovascular disease, the prevalence of socioeconomic deprivation is higher.25 The 
distribution of SED in relation to prevalent disease is perhaps the best studied aspect of the 
association between SED and cardiovascular disease. Survival and case fatality in those 
with cardiovascular disease has also been studied widely. However, much less is known 
about the association between SED and incident cardiovascular disease. In the next chapter 
I will review the literature surrounding the relationship between SED and cardiovascular 
disease. I will focus on studies of incidence and subsequent mortality as well as 
cardiovascular mortality. I will review the literature surround the relationship between 
SED and recurrent cardiovascular events before examining the impact of SED on the 
burden and cost of cardiovascular disease. 
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Socioeconomic Deprivation and Cardiovascular 
Disease 
This chapter will examine the literature surrounding the relationship between SED and 
cardiovascular disease. The literature surrounding the prevalence of cardiovascular disease 
runs to hundreds of manuscripts and has been extensively reviewed in a seminal American 
Heart Association (AHA) Medical/Scientific Statement by Kaplan and Keil in 1998.26 
Rather than replicate that study of the literature I will instead concentrate on the areas of 
the relationship between SED and CVD that are less well studied. It is these understudied 
areas that the present thesis aims to address. I will also focus on more recent studies, 
published after 1998 and where possible cite studies from Scotland or the UK.  
MEDLINE, CINAHL and EMBASE were searched for articles published between January 
1998 and January 2009. A generic search strategy (Appendix 1) was written in MEDLINE 
with appropriate synonyms used to search CINHAL and EMBASE. The grey literature was 
searched using the terms ‘Socioeconomic Deprivation’ or ‘Health Inequalities’ and 
‘cardiovascular disease’. Reference lists of selected articles were reviewed and citation 
checks carried out to identify further potentially relevant studies. A number of exclusions 
were applied. Studies employing a life course approach were not examined as the aim of 
the present studies was not to examine the relationship between CVD and SED over a 
lifetime but rather adult SED and CVD.  Some studies also included “softer” event types 
such as coronary artery spasm in their composite outcomes and were therefore excluded.27 
Finally, studies that examined the relationship between SED and cardiovascular disease in 
developing countries or countries currently undergoing the epidemiologic transition were 
excluded. In these countries a positive association between SED and CVD is observed i.e. 
the most socioeconomically deprived exhibit the lowest risk of disease.28 In the UK, this 
association was present until the middle of the last century for CVD.29 However, the 
association has now reversed and the most deprived are at higher risk. In light of this, the 
findings of studies in developing countries are unlikely to be generalisable to the UK 
population. 
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Socioeconomic deprivation and coronary heart disease 
Coronary heart disease mortality 
All cause mortality has been related to SED since the 19th century 30 and these inequalities 
persist.31 Cardiovascular mortality is also inversely related to SED.32 Higher mortality rates 
are consistently found in the most deprived individuals.33,34 Importantly coronary heart  
disease is one of the main contributors to the excess mortality in the most 
socioeconomically deprived groups.35 
Coronary heart disease mortality is consistently higher in the most deprived, an 
observation that was reported in the middle of the last century.29,36 Studies from 
Sweden35,37, Finland38,Denamrk39, Norway40, UK25 and Scotland41 and a number of other 
European countries ( Belgium, Italy, Spain, Switzerland, 32) have all reported this 
association. Studies from other developed countries around the world such as the USA42-44, 
Japan45, Australia46 and New Zealand47 also exist and confirm the association. These 
studies are broadly similar in that the most deprived are at higher risk of CHD death over 
follow up regardless of the measure of SED used. However, such studies have been based 
on population level data, thus, are unable to fully correct for cardiovascular risk 
factors,40,43,44 or, have been limited to men44 or women43. 
A few studies are however, worthy of more scrutiny.  No review of the literature on the 
relationship between SED and coronary mortality could be complete without referring to 
the seminal Whitehall study. In this study 17,530 civil servants, between the age of 40 and 
64, were screened for the prevalence of coronary heart disease. The prevalence of angina 
was nearly 53% higher in the most deprived individuals (those on the lowest employment 
grade) as compared to the least deprived (the highest employment grade). After follow up 
for 10 years the mortality rate from coronary heart disease was 3.6 times higher in the most 
versus least deprived.48 Since this study multiple studies (outlined above) have reported 
similar findings and a repeat sample of civil servants, the Whitehall II study25, reported that 
these inequalities persist. The finding has also been replicated in women. The gradient of 
risk seen in women may be weaker than that in men.49 Some authors suggest that up to a 
quarter of coronary deaths in the UK are attributable to higher levels of socioeconomic 
deprivation.50  Recently in a large study of European coronary death rates, Avendano and 
colleagues 32 demonstrated a clear excess of coronary deaths amongst the most deprived 
members of each society. In contrast to lung cancer where the gradient followed smoking 
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trends, the trends in coronary mortality did not. In keeping with other studies the strongest 
trends were seen in women. Interestingly, they observed that socioeconomic disparities in 
coronary mortality were higher in northern European countries as compared to southern 
countries.  
A number of studies have examined the relationship between SED and CHD mortality in 
Scotland.41,51,52 However, as with studies from other countries they are all limited by the 
inability of the authors to adjust for cardiovascular risk factors as the studies have all used 
administrative data sources, which do not hold information on patient risk factor profiles. 
Finally, and perhaps most worryingly, data from Sweden suggests that difference in CHD 
mortality by SED, as measured by neighbourhood, is in fact widening.53 This finding has 
now been observed in Scotland.41  
Coronary heart disease incidence 
Whilst much has been written on the relationship between SED and CHD mortality, very 
little has been published in relation to non-fatal CHD. Studies are consistent in that they all 
report that the most deprived individuals display higher rates of coronary heart disease, 
though exceptions in the literature do exist37. Whether SED is measured by individual 
measures such as education or social class or whether area based measures are examined, 
consistent results are obtained (Table 2).  
Studies have tended to included non-fatal CHD as part of a composite outcome with fatal 
events. This makes disentangling the relationship between SED and non-fatal CHD 
difficult. However, as can be seen from Table 2, fairly consistent results are obtained 
regardless of the measure of SED utilised. Adjustment for cardiovascular risk factors is not 
comparable between studies, though it is consistently reported that adjustment attenuates, 
but does not remove, the association between SED and CHD.  
The study by Sundquist et al54 merits further exploration. It has a number of strengths. 
Firstly the size of the sample is large, the entire Swedish population between the ages of 40 
-64 years amounting to 2.6 million people. They were followed using an administrative 
hospital discharge database which is highly accurate. It included both men and women and 
it used two measures of SED, and individual one, income, and, an area based measure. 
They reported that after accounting for individual income, the odds of developing CHD 
was 1.87 (95% CI 1.72 - 2.03) in women and 1.42 (95%CI 1.35 - 1.49) in men. However, 
as this was an administrative database only age and sex were adjusted for in the analyses.  
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Two other studies55,56 have overcome this limitation and adjusted for the risk factors that 
are classically associated with cardiovascular risk, age, sex, smoking, diabetes, blood 
pressure and cholesterol. They both reported that education was not associated with a 
higher risk of fatal or non-fatal CHD, especially after adjustment, however, Thurston et 
al55 found that income was associated with a higher risk after adjustment for the traditional 
cardiovascular risk factors in both men and women. 
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Table 2 Summary of the literature on socioeconomic deprivation and the association with fatal and non-fatal coronary heart disease 
Study Design Outcome Measure of SED Unadjusted Adjusted Adjustment 
Winkleby57 
Sweden 
Prospective cohort Fatal / non-fatal CHD Neighbourhood  Men 1.7(1.53-1.88) 
Women 1.56(1.23-
1.74) 
 
1.36 (1.22-1.52) 
1.33 (1.08-1.65) 
 
Age, marital status, 
family income, 
education, immigration 
status, mobility, 
urban/rural area 
Sundquist58 
Sweden 
Prospective cohort Fatal / non- fatal CHD Neighbourhood 
education 
 
Neighbourhood 
income 
 1.38 (1.13-1.69) 
 
 
1.36 (1.11-1.66) 
Age, sex 
Rosengren37 
Sweden 
Prospective cohort 
(Men) 
Fatal/ non-fatal CHD Social Class P=not significant   
Emberson50 
UK 
Prospective cohort 
(Men) 
Fatal CHD/ non fatal 
MI 
Social Class 1.41 (1.21-1.64) 1.23 (1.05-1.44) Smoking, systolic blood 
pressure, cholesterol, 
BMI, physical activity, 
alcohol, FEV1 
Picciotto59 
Italy 
Prospective cohort Incidence of fatal/ non-
fatal CHD 
 
 
Neighbourhood 
 
 
 
 Men 
1.4 (1.3-1.5) 
Women 
1.78 (1.60-1.98)  
Age 
 
 
 
Sundquist54 
Sweden 
Administrative 
database 
Non- fatal CHD Income  
 
Neighbourhood  
1.75 (1.65-1.85) 
 
2.02 (1.86-2.20) 
1.70 (1.60-1.79) 
 
1.87 (1.72-2.03) 
Age, income and 
neighbourhood 
deprivation. 
Thurston55 
USA 
Prospective cohort Fatal/ non-fatal CHD Education  
 
 
 
 
Income  
Men 
1.58 (1.18-2.12) 
Women 
2.15 (1.46-3.17) 
 
Men 
1.40 (1.11-1.76) 
Women 
1.64 (1.31-2.05) 
Men 
1.29 (0.90-1.74) 
Women 
1.61 (1.08-2.39) 
 
Men 
1.35 (1.06-1.71) 
Women 
1.40 (1.10-1.79) 
Systolic and diastolic 
blood pressure, 
hypertension, cholesterol, 
BMI, diabetes, smoking, 
alcohol, activity, marital 
status, ethnicity  
Yarnell56 
Ireland and France 
Prospective cohort Fatal/ non-fatal CHD Education (most vs. 
least) 
0.72 (0.73-0.98) 0.9 (0.65-1.24) Age, smoking, diastolic 
blood pressure, diabetes, 
BMI, cholesterol, 
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fibrinogen, study site 
Morris60  
UK 
Prospective cohort 
(Men) 
Fatal/non-fatal CHD Neighbourhood 1.55(1.19-2.00) 1.22(0.93-1.59) Marital status, Housing, 
car ownership, social 
networks, social class 
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Socioeconomic deprivation and myocardial infarction 
Myocardial infarction incidence 
It is perhaps unsurprising that most research on the relationship between SED and 
cardiovascular disease has focussed on myocardial infarction (MI). Socioeconomic 
deprivation is associated with an increased risk of myocardial infarction (Table 3). This 
association again has been demonstrated in a number of countries through a number of 
years (see Table 3). The association was examined in a number of the MONICA 
(Multinational Monitoring of Trends and Determinants of Cardiovascular Disease) cohorts. 
For example, in Glasgow, Scotland, the age adjusted relative rate of myocardial infarction 
was 1.74 (95%CI 1.58-1.91) in the most versus least deprived men with the least deprived 
being less likely to survive to reach hospital alive (age adjusted odds most versus least 
deprived 0.93 (0.87-0.99)).61 As noted above the same pattern was seen in women but the 
gradient was steeper (age adjusted relative rate most versus least deprived 2.34(1.98-
2.76)), and again the most deprived were less likely to reach hospital alive (age adjusted 
odds 0.94(0.85-1.05)). In the Finnish MONICA study similar patterns were observed when 
education and income were used as measures of SED in contrast to the area-based measure 
of SED used in the Scottish study.62,63 However, both studies, being registry based, failed 
to adjust for the traditional cardiovascular risk factors such as smoking, blood pressure, 
diabetes and cholesterol, a major limitation of these otherwise informative studies. As can 
be seen from Table 3 many studies have failed to adequately adjust for all cardiovascular 
risk factors or have examined the incidence of MI in conjunction with all cause mortality 
or in other composite outcomes.  
A number of studies, including that of Morrison et al61 have been conducted in Scotland. 
Each study has utilised a hospital discharge database (the Scottish Morbidity Record 
Scheme [SMR]) which records all discharges from NHS hospitals in Scotland. Each have 
employed slightly different methods, and examined different outcomes. In one study the 
likelihood of reaching hospital alive was lower in the most deprived versus the least 
deprived as measured by Carstairs Morris index (16% less in deprived men and 3% in 
deprived women).64 In another study of all fatal MIs occurring in Scotland between 1986-
1995 the risk was highest in the deprived and the gradient appears steeper in younger 
women.65 A recent study examining all discharges where MI appeared in any of the 
diagnoses at discharge and all coronary heart disease deaths, confirmed this finding, 
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however, the use of such broad inclusion criteria make extrapolation of these results 
difficult.66  
More recently, the INTERHEART study 67 confirmed that a number of risk factors, 
psychosocial factors (stress, stressful life events, perceived locus of control and 
depression), apolipoprotein B/apolipoprotein A1 ratio, hypertension, diabetes, smoking, 
exercise, vegetables and fruits, alcohol consumption and abdominal obesity) were 
responsible for the majority of cases of myocardial infarction. In a study that added 
education into the collection of explanatory variables, SED as measured by education was 
a significant risk factor.68 
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Table 3 Summary of the literature on socioeconomic deprivation and incidence of MI (including studies where MI was part of a composite outcome) 
Study Design Outcome Measure of SED Unadjusted Adjusted Adjustment 
Stjarne69 
Sweden 
Prospective cohort Non-fatal MI Social class index of 
area  
Age 
Men 1.50 (1.12-2.00) 
Women 1.94 (1.22-
3.09) 
 
Men 1.19 (0.88-1.62) 
Women 1.60 (0.96-
2.66) 
Age, individual level 
socioeconomic status, 
education, employment 
status, marital status, 
ethnicity 
Hallqvist70 
Sweden 
Prospective cohort Fatal / non-fatal MI Social class  Men 1.99 (1.58-2.53) 
Women 2.34 (1.52-
3.61) 
Age 
Emberson50 
UK 
Prospective cohort 
(Men) 
Fatal CHD/ non fatal 
MI 
Social Class 1.41 (1.21-1.64) 1.23 (1.05-1.44) Smoking, systolic blood 
pressure, cholesterol, 
BMI, physical activity, 
alcohol, FEV1 
Albert71 
USA 
Prospective cohort 
(Women) 
Cardiovascular death 
or Non-fatal MI/stroke 
or revascularisation 
 
Education (most vs. 
least) 
Income (most vs. 
least) 
Age and race 
0.5 (0.3-0.7) 
 
0.4 (0.3-0.7) 
 
0.8 (0.5-1.2) 
 
0.8 (0.5-1.2) 
Age, race, BMI, 
smoking, hypertension, 
diabetes, LDL and HDL 
cholesterol, triglycerides, 
hormone use, family 
history of CHD, alcohol, 
activity, CRP, ICAM, 
fibrinogen, homocysteine 
Diex-Roux72 
USA 
Prospective cohort Fatal CHD/ non-fatal 
MI 
Neighbourhood Age and study site 
White  
2.1 (1.6-2.8) 
Black 
1.7 (1.2-2.3) 
 
White  
1.6 (1.1-2.2) 
Black 
1.5 (1.0-2.3) 
Smoking, activity, 
hypertension, diabetes, 
LDL and HDL 
cholesterol, BMI 
Morrison11 
Scotland 
Registry Fatal/ non-fatal MI Neighbourhood 
(Carstairs) 
Men 1.74 (1.58-1.91) 
Women 1.28 (1.22-
1.24) 
  
Salomaa63† 
Finland  
Registry Incident MI 
 
 
 
 
 
Income  
 
 
Education 
 
 
 Men 1.67 (1.57-1.78) 
Women 1.52 (1.38-
1.68) 
Men 1.48 (1.40-1.55) 
Women 1.65 (1.48-
1.83) 
Study area, urban/rural 
residence 
Rose73  Prospective cohort Non fatal MI Neighbourhood Black men    
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USA 1.63(1.20-2.06) 
Black women 
2.14(1.69-2.58) 
White men 
1.24(1.07-1.41) 
White women 
1.79(1.58-2.00) 
 
Davies66 
Scotland 
Administrative  
database 
Fatal CHD/Non fatal 
MI 
Neighbourhood 1990-92 
2000-02 
1.74(1.58-1.92) 
1.94(1.76-2.15) 
 
Rosengren68 
Multinational* 
Multiple case control 
cohorts 
Non fatal MI Education  1.95(1.71-2.21) Age, sex , psychosocial 
factors (stress, stressful 
life events, perceived 
locus of control and 
depression), 
apolipoprotein 
B/apolipoprotein A1 
ratio, hypertension, 
diabetes, smoking, 
exercise, vegetables and 
fruits, alcohol 
consumption, 
abdominal obesity, and 
region 
Macintyre 65 
Scotland 
Administrative 
database 
Fatal MI Neighbourhood 
(Carstairs) 
Men‡ 
<65 years RR 1.93 
65-74 RR 1.39 
>75 RR 1.08 
Women‡ 
<65 years RR 2.58 
65-74 RR 1.50 
>75 RR 1.12 
  
† Duplicate study 62 not included, * Results from high income countries only included, ‡Estimated from figures given 
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Myocardial infarction and case fatality 
Similarly survival following a myocardial infarction varied according to SED in the 
MONICA studies.61-63 In the Glasgow MONICA cohort the rate of CHD death in hospital 
was not different according to SED, though CHD mortality following discharge was.61 It is 
in the setting of post infarction survival that most studies are concentrated (Table 4). As 
noted previously, the most deprived have higher rates of adverse risk factors.74 Most of 
these studies have used well characterised members of registries and therefore are able to 
adjust for cardiovascular risk factors. However, despite this many studies have found that 
after adjustment the relationship is attenuated to such and extent that it becomes non-
significant.75-77 Multiple studies have tried to explain this association. Some studies would 
suggest that the most deprived receive the least aggressive pharmacotherapy78, the least 
follow up79,80 and lower rates of revascularisation.62,79  
 42 
Table 4 Summary of the literature on socioeconomic deprivation and case fatality following a myocardial infarction 
Study Design Outcome Measure of SED Unadjusted Adjusted Adjustment 
Gerber 81 
Israel 
Prospective cohort Mortality following MI 
 
 
IHD mortality 
following MI 
Income  2.64 (1.92-3.63) 
 
 
 
2.68 (1.79-4.01) 
1.58 (1.13-2.21) 
 
 
 
1.52 (1.02-2.31) 
Age, sex, smoking, 
hypertension, diabetes, 
physical activity, MI 
severity, ejection 
fraction, killip class, 
anterior MI, admission to 
intensive care, 
comorbidity index, 
coronary  angiography, 
angioplasty, 
thrombolysis, aspirin, 
beta blockers, race, 
employment status 
Gerward82 
Sweden 
Registry 28 day survival  
following MI  
Neighbourhood  
 
1.25 (1.03-1.52) Age and sex 
Engstrom83 
Sweden 
Prospective cohort  3 year survival 
following MI 
Neighbourhood *Men R=0.6, p<0.01 
*Women R=0.37, 
p=0.35 
  
Pilote76 
Canada 
Administrative 
database 
MI mortality 
 
 
 
 
 
 
 
 
 
 
 
 
Neighbourhood  
 
 
 
 
 
 
Income or 
employment rate or 
education or 
population size, 
average rent 
 Quebec, Ontario, 30 
day – NS, 1 year - 
NS 
British Columbia 30 
day – NS, 1 year 
1.18(1.09-1.28) 
 
All areas, 30 day and 
1 year – NS 
 
 
 
 
Age, sex, comorbidities, 
hospital 
Stjarne69 
Sweden 
Case Control Case fatality at 28 days Neighbourhood 
(Carstairs) 
Age adjusted 
Men 0.98 (0.90-1.07) 
Women 1.01 (0.89-
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1.16) 
Alter84 
USA 
Prospective cohort 2 year post MI 
mortality 
Income (high vs. 
low) 
0.45 (0.35-0.57) 0.62 (0.48-0.74) 
 
0.77 (0.54-1.10) 
Age, sex, ethnicity, 
psychosocial factors and 
pre-existing 
cardiovascular diseases 
Alter85 
USA 
Registry 1 year MI mortality Neighbourhood 
income (high vs. 
low) 
 0.90 (0.86-0.94) Age, sex, specialty of 
admitting physician, 
hospital 
Gerber75 
USA 
Prospective cohort Post MI mortality Neighbourhood 
income 
 
Education 
2.10 (1.42-3.12) 
 
 
2.21 (1.47-3.32) 
1.62 (1.08-2.45) 
 
 
1.01 (0.65-1.58) 
Age, sex, race, 
comorbidities, ejection 
fraction, hypertension, 
hypercholesterolaemia, 
smoking, BMI, beta 
blocker, aspirin, statin, 
angioplasty, bypass 
surgery, ST elevation 
Rao 
USA 
Retrospective cohort 30 day case fatality 
following MI 
 
 
1 year mortality 
following MI 
Income of area 
 
 Low vs. middle 
1.09 (1.04-1.13) 
High vs. middle 
0.89 (0.85-0.94) 
Low vs. middle 
1.05 (1.0-1.10) 
High vs. middle 
0.92(0.88-0.97) 
Age, sex, ethnicity, 
smoker, diabetes, 
mobility, past history of 
MI or CABG, 
hypertension, stroke, 
COPD, dementia, 
hospital, treatment and 
revascularisation. 
Rosvall86 
Sweden 
Registry 5 year mortality post 
MI 
Income  Men 
1.63 (1.51-1.77) 
Women 
1.44 (1.27-1.63) 
Age 
Chang87 
Canada 
Retrospective cohort 1 year mortality post 
MI 
Neighbourhood 
median income (per 
$10,000 increase) 
0.87 (0.83-0.90) 0.94(0.91-0.98) Age, sex, diabetes, 
hypertension, 
hypercholesterolaemia, 
cancer, peripheral 
vascular disease, past MI. 
Cesana88 
Italy 
Registry 28 day post MI 
mortality 
Social Class 2.46 (1.52-3.99)   
Rasmussen89 
Denmark 
Registry 30 day case fatality 
 
 
 
Income  
Education 
 
 
 
1.54 (1.36-1.79) 
1.24 (1.03-1.50) 
Age, sex, year, civil 
status, comorbidity, 
education or income.  
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>31 days 
 
Income 
Education 
1.65 (1.45-1.85) 
1.33 (1.11-1.59) 
Bernheim77 
USA 
Cohort 1 year mortality 
 
Income 2.80 (1.37-5.72) 
 
 
1.19 (0.54-2.62) 
 
 
 
Age, sex, ethnicity, 
health insurance, 
smoking, diabetes, 
hypertension, 
hypercholesterolemia, 
COAD, HF, ejection 
fraction <40% 
Picciotto59 
Italy 
Prospective cohort 28 day case fatality 
post MI 
 
 
1 year case fatality 
post MI 
 
 
 
28 day case fatality 
post MI 
 
 
1 year case fatality 
post MI 
 
 
 
Neighbourhood 
 
 
 
 
 
 
 
 
Education 
 Men 
0.91 (0.69-1.19) 
Women 
1.35 (0.94-1.94)  
Men 
1.23 (0.86-1.75) 
Women 
1.36 (0.85-2.17) 
 
Men 
1.22 (0.95-1.56) 
Women 
1.31 (0.91-1.88)  
Men 
1.02 (0.75-1.38) 
Women 
1.02 (0.64-1.62)  
 
Age 
 
 
 
Age, co morbidities, 
angioplasty 
 
 
 
Salomaa63† 
Finland  
Registry 28 day case fatality 
following MI 
 
 
 
 
1 year case fatality 
following MI 
Income  
 
 
Education 
 
 
Income  
 
 
Education 
 Men 3.18 (2.82-3.58) 
Women 2.17 (1.76-
2.68) 
Men 1.92 (1.74-2.11) 
Women 2.43 (1.91-
3.09) 
Men 3.18 (2.84-3.55) 
Women 2.15 (1.77-
2.62) 
Men 1.87 (1.71-2.05) 
Women 2.34 (1.88-
Study area, urban/rural 
residence 
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2.92) 
Morrison11 
Scotland 
Registry 28 day CHD case 
fatality 
Neighbourhood 
(Carstairs) 
 Men 0.98 (0.90-1.07) 
Women 1.01 (0.89-
1.16) 
Age 
MacIntyre 65 
Scotland 
Administrative 
database 
30 day case fatality Neighbourhood 
(Carstairs) 
Men‡ 
<65 years RR 1.96 
65-74 RR 1.29 
>75 RR 1.02 
Women‡ 
<65 years RR 2.62 
65-74 RR 1.40 
>75 RR 1.23 
  
Chaix53 
Sweden 
Prospective cohort Post MI IHD case 
fatality 
Neighbourhood 1.40 (0.71-2.85)   
Tonne90 
USA 
Prospective cohort MI case fatality Neighbourhood Age and sex 
1.55 (1.24-1.93) 
 
1.38 (1.14-1.67) 
Age, sex, hospital, AF, 
heart failure, shock, 
angina, Q-waves, 
hypertension, diabetes, 
stroke, past MI and age-
sex interaction 
Manderbacka91 
Finland 
Administrative 
database 
Post MI 2 year CHD 
case fatality 
 
 
 
28 day case fatality 
Income Age 
Men 1.39(1.18-1.63) 
Women 1.26(1.02-
1.55) 
 
Men 1.94(1.81-2.08) 
Women 1.49(1.34-
1.67) 
 
 
Men 1.35(1.15-1.59) 
Women 1.17(0.95-
1.43)  
 
Men 1.93(1.80-2.07) 
Women 1.44(1.29-
1.61) 
 
Age, heart failure, 
arrhythmia, hypertension, 
diabetes, asthma and 
chronic obstructive 
pulmonary disease, 
severe mental disorders, 
thyroid insufficiency, 
multiple sclerosis, 
Parkinson’s disease, 
epilepsy, malignant 
tumours, sarcoidosis, 
rheumatoid arthritis, 
ulcerative colitis, 
Crohn’s disease, and 
gouty arthritis 
** Correlation coefficient  ‡Estimated from figures given 
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Recurrence of myocardial infarction 
Following from this, despite there being a large body of literature on the epidemiology of 
recurrent myocardial infarction, there are very little data on the association between SED 
and recurrent infarction (Table 5). One study did examine recurrent ischaemic events 
(Death, MI or unstable angina) following a non-fatal MI according to SED.92 Interestingly 
the authors reported that after adjustment for age, sex, diabetes, race, treatment with aspirin 
and thrombolysis and left ventricular failure the adjusted risk of an event in the most 
versus the least deprived was 1.59 (95% CI 1.03-2.44). After further adjustment for the use 
of secondary prevention (aspirin and beta-blockers) at discharge the association became 
non-significant 1.78 (0.80 -3.99). This would support the hypothesis of others that the 
differential survival post MI by SED is explained by differential treatment following the 
event.79,93 However, as noted above not all authors have found this in relation to case 
fatality.81 
In another study by Scheffler et al94 of the Kaiser Permanente Health Insurance Database 
in California USA, the rate of recurrent fatal or non-fatal MI was lower with increasing 
income (HR 0.94 95%CI 0.91-0.97) after adjustment for sex, race, age, measures of 
income inequality of an area, societal capital and race mix of an area. After further 
adjustment for past medical history and pharmacotherapy including revascularisation 
therapy the association persisted (HR 0.97 95%CI 0.95-1.00). 
As can bee seen from Table 5, inconsistent results have been reported when the risk of 
recurrent coronary events associated with SED has been examined. This may be related to 
the different populations, different outcomes (many of which are composite outcomes) and 
different methods of adjustment in the multivariable models.  
 
 47 
Table 5 Summary of the literature on socioeconomic deprivation and recurrent myocardial infarction and coronary heart disease 
Study Design Outcome Measure of SED Unadjusted Adjusted Adjustment 
Pilote76 
Canada 
Administrative 
database 
Readmission for 
MI/HF/Angina 
Neighbourhood or 
income or 
employment rate or 
education or 
population size, 
average rent 
 All areas, 30 day and 
1 year - NS 
Age, sex, comorbidities, 
hospital 
Scheffler94 
USA 
Administrative 
database 
Recurrent acute 
coronary syndrome  
Income 0.94(0.91-0.97) 0.97(0.95-1.00) Age, sex, race, social 
capital indices, medical 
therapy, hypertension, 
diabetes, depression, 
stroke, heart failure, 
peripheral vascular 
disease, revascularisation  
Barakat92 
UK 
Prospective cohort Readmission 
Angina/MI/Death  
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
Neighbourhood 
(Carstairs) 
 
 
1.54(1.02-2.32) 
 
1.02(0.66-1.60) 
 
 
1.56(1.01-2.39) 
 
1.05(0.66-1.67) 
 
1.60(1.04-2.48) 
 
1.08(0.68-1.71)  
 
1.59(1.03-2.44) 
 
1.07(0.68-1.70) 
 
1.78(0.80-3.99) 
 
1.00(0.63-1.59) 
 
 
Age, sex, race 
 
 
 
Age, sex, race 
 diabetes, aspirin and 
thrombolysis  use 
 
Age, sex, race 
 LVF 
 
 
Age, sex, race 
discharge aspirin and 
betablockers 
Rao95 
USA 
Trial registry Death or recurrent MI  Income  30 days 
1.3(0.8-2.1) 
6 month 
1.4 (0.9-2.1) 
Age, weight, height, 
smoking, systolic blood 
pressure, heart rate, 
presence of rales, time to 
treatment 
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Bernheim77 
USA 
Prospective cohort Post MI all cause 
rehospitalisation at 1 
year 
Income 1.55 (1.17-2.05) 1.36 (1.01-1.89) Age, sex, ethnicity, 
health insurance, 
smoking, diabetes, 
hypertension, 
hypercholesterolaemia, 
COAD, CHF, ejection 
fraction <40% 
Picciotto59 
Italy 
Prospective cohort 1 year MI 
rehospitalisation 
 
 
1 year other CVD 
rehospitalisation 
 
 
 
1 year MI 
rehospitalisation 
 
 
1 year other CVD 
rehospitalisation 
Neighbourhood 
 
 
 
 
 
 
 
 
Education 
 Men 
1.06 (0.63-1.78) 
Women 
0.94 (0.44-1.98) 
Men 
0.93 (0.74-1.17) 
Women 
0.99 (0.68-1.42) 
 
Men 
0.83 (0.56-1.25) 
Women 
1.39 (0.61-3.18) 
Men 
0.98 (0.81-1.19) 
Women 
1.03 (0.73-1.47) 
Age, comorbidities, 
angioplasty 
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Socioeconomic deprivation and stroke 
 
The relationship between stroke and SED has been well studied in relation to mortality and 
case fatality or survival. The incidence of stroke and its relation to SED has also been 
studied. As with coronary heart disease, the relationship between SED and stroke is inverse 
i.e. the most deprived suffer from higher rates of stroke, higher case fatality and higher 
stroke mortality.  
 
Stroke mortality 
Stroke mortality is higher in the most deprived members of a number of societies including 
Europe96, USA33 and Japan45. In a study of 22 European countries the mortality rates from 
stroke was consistently higher in the most versus the least deprived members (as measured 
by social class and education) of each society.31 In another international comparison by 
Avendano and colleagues97, the association between SED (measured by educational level 
and occupational class) and stroke mortality, appeared to be stronger than that for SED and 
coronary mortality in six European societies. More worryingly, in their study, they also 
examined trends over time (comparing the period 1981-1985 to 1991-1995), and found that 
not only had inequalities persisted, but may have in fact widened in some societies.  
Finally, Kunst et al7 reported in a further study on behalf of the European Union Working 
Group on Socioeconomic Inequalities in Health, that the rate of stroke mortality was 
consistently higher in the most deprived versus the least deprived in 12 European 
countries.   
 
Stroke incidence 
The association between SED and stroke incidence has been examined in a number of 
studies (Table 6). Irrespective of the measure of SED the most deprived are at higher risk 
of experiencing an incident stroke. Many studies have examined both fatal and non-fatal 
first strokes together. 98-104 Most have used income as a measure of SED a large proportion 
have incompletely adjusted for known risk factors for stroke.  
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Stroke case fatality  
It is not only the relationship between socioeconomic status and the development of stroke 
that is understudied and thus unclear. The relationship between stroke case fatality and 
socioeconomic status has only been examined in the short term, at 30 days, or, 1 year at 
most, though consistent results have been reported (Table 7). As with studies of stroke 
incidence, whilst results have been consistent irrespective of the measure of SED used, 
most studies have failed to adjust for the major cardiovascular risk factors.  
 
 51 
Table 6 Summary of the literature on socioeconomic deprivation and stroke incidence 
Study Design (all stroke 
types unless stated) 
Outcome  Measure of SED Unadjusted Adjusted Adjustment 
Li105 
Sweden 
Prospective cohort Non fatal incidence Men: Income 
Social Class  
Women: Income 
Social Class 
**1.37(1.06-1.58) 
1.62(1.16-2.28) 
1.72(1.34-2.20) 
3.14(1.61-6.11) 
1.29(1.06-1.58) 
1.43(1.21-1.68) 
1.75(1.36-2.25) 
2.84(1.45-5.56) 
Age, marital status, 
country of birth, housing 
Avendano98  
USA 
Prospective cohort Fatal/Non-fatal 
incidence 
Age 65-74  
Education 
Income 
Age >75  
Education 
Income 
Age and sex 
2.07(1.04-4.13) 
2.08(1.01-4.27) 
 
0.42(0.22-0.79) 
0.43(0.22-0.86) 
 
 
1.10(0.52-2.31) 
 
 
0.50(0.24-1.08) 
 
Age, sex, race, 
hypertension, smoking, 
diabetes, alcohol, BMI, 
activity, psychosocial 
factors and functioning 
level 
Thrift106 
Australia 
Prospective cohort Fatal incidence 
Non-fatal incidence 
Index of relative 
socioeconomic 
disadvantage (area 
based) 
†1.56 
†1.91 
 
  
Kuper104 
Sweden 
Prospective cohort Fatal/Non-fatal 
incidence 
Education Age adjusted 
All stroke 
2.1(1.4-2.9) 
Ischaemic stroke 
2.9(1.8-4.7) 
Haemorrhagic stroke 
1.4(0.7-2.7) 
 
All stroke 
1.5(1.0-2.2) 
Ischaemic stroke 
2.2(1.3-3.7) 
Haemorrhagic stroke 
1.1(0.5-2.4) 
 
Age, smoking, BMI, 
alcohol, hypertension, 
diabetes, exercise 
Kleindorfer107 
USA 
Prospective cohort  
Fatal/Non-fatal 
incidence 
 
Non-fatal incidence 
Area based measure  
All stroke 
 
 
Hospitalised stroke 
 
†White1.49 
Black1.49 
 
White 1.79 
Blacks 1.78 
 Age and sex 
Jakovljevic108  
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
Fatal/Non-fatal 
incidence 
 
Income Age 25-59 
†Men 3.22 
Women 3.37 
Age 60-74 
Men1.37 
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Women 0.84 
Jakovljevic99  
Finland 
Prospective cohort 
(ischaemic stroke) 
Fatal/Non-fatal 
incidence 
 
Income‡ 
 
 
 
 
 
Age 25-59 
†Men 2.05 
Women 1.96 
Age 60-74 
Men1.51 
Women 1.63 
  
Jakovljevic109  
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
Fatal/Non-fatal 
incidence 
 
Income † Age 25-44 
Men3.37 
Women3.71 
Age45-59 
Men 1.92 
Women1.36 
Age 60-74 
Men 1.24 
Women1.18 
  
Wolfe110 
England 
Prospective cohort Fatal/Non-fatal 
incidence 
Social class 1.65(1.21-2.23)   
van Rossum111 
Holland 
Prospective cohort Fatal/Non-fatal 
incidence 
 
Education (most vs. 
least) 
Social class (High vs. 
low) 
Age adjusted 
0.18(0.02-1.28) 
 
0.60(0.38-0.96) 
 
0.19(0.03-1.36) 
 
0.57(0.26-1.24) 
Age, blood pressure, 
hypertension, 
antihypertensive use, 
smoking, CHD, AF, 
diabetes BMI, alcohol, 
fibrinogen, left 
ventricular hypertrophy 
Hart101 
Scotland 
Prospective cohort Non-fatal incidence  
Social class 
Carstairs Morris 
Index 
Age adjusted 
1.37(1.13-1.66) 
1.17(0.96-1.42) 
 
1.07(0.87-1.31) 
0.96(0.79-1.18) 
Age, smoking, FEV1, 
diastolic and systolic 
blood pressure, height, 
alcohol, history of CHD 
Hart100 
Scotland 
Prospective cohort Fatal/Non-fatal 
incidence 
 
Social class 
 
 
 
Carstairs Morris 
Index 
Age adjusted 
Men 1.80(1.05-3.06) 
Women 1.62(0.90-
2.89) Men 2.09(1.24-
3.54) 
Women 2.27(1.42-
3.62) 
 
Men 1.31 (0.76-2.26) 
Women 1.24(0.69-
2.24) Men 1.58(0.93-
2.69) 
Women 1.72(1.07-
2.77) 
Age, smoking, FEV1, 
diastolic and systolic 
blood pressure, height, 
BMI, diabetes, history of 
CHD 
Gillum102 
USA 
Prospective cohort Fatal/Non-fatal 
incidence 
 
Education (most vs. 
Age adjusted 
White 
Age adjusted 
White 
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least) 
 
 
 
 
 
 
Poverty index(most 
vs. least poor) 
Men 0.86(0.61-1.20) 
Women 0.60(0.42-
0.86) 
Black 
0.59(0.42-0.85) 
 
White 
Men 0.64(0.46-0.88) 
Women 0.65(0.46-
0.91) 
Black 
0.62(0.41-0.95) 
Men 1.03(0.72-1.46) 
Women 0.72(0.50-
1.03) 
 
 
 
White 
Men 0.80(0.57-1.12) 
Women 0.74(0.52-
1.05) 
Black 
0.70(0.46-1.08) 
Smits112 
Netherlands 
Prospective cohort Non-fatal incidence Area based measure 1.27(1.08-1.51)   
*multiple other measures all non significant (antiplatelet agents, thrombolysis, blood glucose measurement, temperature measurement, physiotherapy, 
occupational therapy and speech therapy) 
**Age adjusted 
†confidence interval not calculable from data presented 
‡only income shown due to wide confidence intervals for education 
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Table 7 Summary of the literature on socioeconomic deprivation and stroke case fatality 
Study Design(all stroke 
types unless stated) 
Outcome Measure of SED Unadjusted Adjusted Adjustment 
Saposnik113 
Canada 
Retrospective cohort 7 Day in hospital 
fatality 
Fatality at discharge 
Income and hospital 
volume 
 1.26(1.07-1.49) 
1.27(1.11-1.45) 
Age, sex, hospital of 
admission, Charleson 
score, hospital location 
Arrich114 
Austria 
Retrospective cohort Case fatality Education (most vs. 
least) 
Occupation 
Income 
0.71(0.44-1.14) 
 
2.25(0.84-6.06) 
0.96(0.38-2.39) 
0.77(0.40-1.48) 
 
1.17(0.39-3.49) 
1.44(0.51-4.08) 
Age, sex, stroke severity,  
Li105 
Sweden 
Prospective cohort Case fatality 
28 day 
 
1 year 
 
Men income 
Women income  
Men income 
Women income 
  
3.13(1.35-7.24) 
1.68(0.69-4.08) 
2.17(1.18-4.00) 
1.29(0.67-2.45) 
 
Weir115 
Scotland  
Prospective cohort 6 month case fatality 
6 month case fatality + 
institutional care 
6 month case fatality 
+dependency 
Carstairs Morris 
index 
Non-significant  
Non-significant 
 
2.43(1.51-3.91) 
 
 
 
1.89(1.09-3.30) 
Age, sex, history of 
CHD, diabetes, stroke 
type, onset in hospital, 
function at admission, 
systolic blood pressure, 
neuroimaging 
Casper116 
USA 
Retrospective cohort Case fatality  Social class †White 2.3 
†Black 2.8 
  
Aslanyan117 
Scotland 
Retrospective cohort Case fatality Womersley score 
Murray score 
1.01(0.98-1.04) 
1.03(0.94-1.13) 
1.03(1.00-1.06) 
1.09(0.99-1.19) 
Age, sex, stroke severity, 
blood pressure, subtype 
and past medical history 
Kapral118 
Canada 
Retrospective cohort 30 day case fatality 
1 year case fatality 
Income  0.91(0.87-0.96) 
0.95(0.92-0.99) 
Age, sex, comorbidity, 
physician and hospital of 
admission 
Jakovljevic108 
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
28 day case fatality 
 
Income Age 25-59 
Men 2.10(1.00-4.42) 
Women 2.68(0.88-
8.19) 
Age 60-74 
Men 2.29(0.98-5.34) 
Women 1.40(0.63-
3.13) 
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Jakovljevic108 
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
1 year case fatality Income Age 25-59 
Men 2.12(1.02-4.40) 
Women 2.43(0.80-
7.40) 
Age 60-74 
Men 2.40(1.04-5.55) 
Women 1.15(0.52-
2.57) 
  
Jakovljevic99 
Finland 
Prospective cohort 
(ischaemic stroke) 
28 day case fatality Income ‡ 
 
 
 
 
 
Age 25-59 
Men 2.61(1.46-4.68) 
Women 1.53 (0.65-
3.60) 
Age 60-74 
Men1.62(1.03-2.54) 
Women 1.53(0.89-
2.63) 
  
Jakovljevic99 
Finland 
Prospective cohort 
(ischaemic stroke) 
1 year case fatality Income ‡ 
 
Age 25-59 
Men 2.41(1.48-3.93) 
Women 1.81 (0.86-
3.80) 
Age 60-74 
Men1.48(1.06-2.07) 
Women 1.58(1.03-
2.44) 
  
Jakovljevic109 
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
28 day case fatality Income  Age 25-44 
Men 3.88(1.87-8.05) 
Women 1.09(0.41-
2.89) 
Age 45-74 
Men 1.05(0.67-1.64) 
Women 1.68(1.00-
2.81) 
Age, study area, urban/ 
rural residence 
Jakovljevic109 
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
1 year case fatality Income  Age 25-44 
Men 4.25(2.05-8.78) 
Women 1.14(0.43-
3.01) 
Age 45-74 
Men 1.07(0.67-1.70) 
Age, study area, urban/ 
rural residence 
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Women 1.86(1.12-
3.10) 
*multiple other measures all non significant (antiplatelet agents, thrombolysis, blood glucose measurement, temperature measurement, physiotherapy, 
occupational therapy and speech therapy) 
**Age adjusted 
†confidence not calculable from data presented 
‡only income shown due to wide confidence intervals for education 
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Recurrent stroke  
The burden of recurrent stroke according to SED has not been well studied (Table 8). The 
risk of readmission following a stroke according to SED has only been examined in a small 
number of studies. In a study by Li et al 105,of men and women in Malmo, Sweden, despite 
finding a relationship between SED and incident stroke and case fatality, after adjustment 
for covariates (age, marital status, country of birth, and housing condition) they only found 
that low income in women was associated with higher rates of readmission for stroke. 
Some, but not all authors, have reported that stroke severity varies by SED, as does access 
to therapies such as physiotherapy, occupational therapy and carotid surgery118,119. 
However, length of stay does not seem to be related to SED. Functional recovery may be 
related to SED following a stroke115 and therefore, the burden of stroke is likely to be 
higher in the most deprived.  
 
Table 8 Summary of the literature on socioeconomic deprivation and stroke recurrence 
Study Design Outcome Measure of 
SED 
Unadjusted Adjusted Adjustment 
Aslanyan117 
Scotland 
Retrospective 
cohort 
Readmission 
any CVD 
Womersley 
score 
Murray score 
1.05(1.01-
1.09) 
1.21(1.08-
1.35) 
1.06(1.02-
1.10) 
1.23(1.10-
1.38) 
Age, sex, 
stroke 
severity, 
blood 
pressure, 
subtype 
and past 
medical 
history 
Li 105 
Sweden 
Prospective 
cohort 
Recurrent 
stroke 
Men: Income 
Social Class  
 
Women: 
Income 
Social Class 
 1.15(0.72-
1.82) 
1.00(0.46-
2.20) 
2.04(1.03-
4.01) 
2.78(0.70-
10.98) 
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Socioeconomic deprivation and heart failure 
The relationship between SED and heart failure is similarly understudied (Table 9). Given 
that coronary heart disease is a major risk factor for developing heart failure and the 
multiple studies outlined above relating SED to coronary heart disease it is surprising that 
few studies have examined the relationship between heart failure and SED. A systematic 
review by Blair et al120 published in 2001 identified only 8 relevant studies (two of which 
were published only in abstract form). Since that report only a handful of other studies 
have addressed this relationship (Table 9). 
The prevalence of heart failure clearly varies with socioeconomic status. In cross sectional 
study from Scotland the prevalence of heart failure in primary care practices was higher in 
the most deprived.121 In the most affluent the rate was 6.4 per 1000 population rising to 7.2 
in the most deprived, a 13% increase.  
The incidence of heart failure is consistently higher in the most socioeconomically 
deprived. In the same study of primary care practices in Scotland the incidence of heart 
failure was 44% higher in the most deprived versus the least deprived intervals.121 A study 
from Goteborg, Sweden reported that in 6999 men followed for 28 years a hospitalisation 
for heart failure were 72% more likely in the most as compared to the least deprived men 
as measured by social class after adjustment for age, height, BMI, smoking, activity levels, 
systolic BP, diabetes, alcohol problems and cholesterol.122 In a further study of 2841 men 
from Uppsala, Sweden, after follow up for a median of 29.6 years the rate of incident heart 
failure hospitalisation was twice as high in those with only an elementary education versus 
a college education.123 Furthermore, when occupational class was examined as a marker of 
SED the risk was approximately 50% higher in those with a low occupational as opposed 
to high occupational class. I have reported that in Scotland rates of first hospitalisation for 
heart failure in Scotland were 56% higher in the most deprived compared to the least 
deprived.124 Finally, we have reported in an analysis of 15703 participants in the Renfrew 
Paisley cohort, that the risk of heart failure as measured by a hospitalisation for heart 
failure was 40% higher in the most deprived versus the least deprived.125 This association 
was evident after adjustment for age, sex, history of angina, stroke, blood pressure, FEV1, 
smoking status, atrial fibrillation, abnormal ECG, cardiomegaly on a chest x-ray and BMI.  
Survival in those with heart failure is poorer amongst the most deprived. In a study of all 
hospitalisations for heart failure in Scotland we reported that the risk of death at 30 days 
was 18% higher in the most deprived versus the least deprived men after adjustment for 
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age, year of admission and previous admissions for multiple causes.124 In women the 
excess risk was 3% and not significant. At 1 year the excess risk was 11% and 14% at 5 
years in men. In women the respective figures were 3% (non-significant) at 1year and 4% 
at 5 years which was a significant difference.  
It is not only first hospitalisation rates for heart failure that very by SED, the burden of 
heart failure is highest in the most deprived. Readmission rates for heart failure are 
inversely related to SED. In a study of admissions in New York, USA, after adjustment for 
a risk score (comprising of ethnicity, comorbidities, type of discharging facility and 
procedures performed and finally health insurance type) the risk of readmission for heart 
failure was 18% higher in those in the lowest income group compared to the highest 
income group.126 Similar results were reported from a study of hospitalisations amongst the 
elderly in Rome, Italy, where rates of hospitalisations for heart failure were inversely 
related to deciles of income.127 Hospital admissions for cardiac causes in those with heart 
failure are also inversely related to SED. Using the Carstairs Morris Index, Struthers et al 
128
 reported that the rate of cardiac hospitalisations was 26% in the least deprived versus 
40% in the most deprived, irrespective of disease severity, diuretic dose and adherence and 
age and sex. One explanation for this finding may be that the most deprived individuals 
with heart failure are in contact with their primary care physician less than their affluent 
counterparts.  
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Table 9 Summary of the literature on socioeconomic deprivation and heart failure 
Study  Design Outcome Measure of SED Unadjusted Adjusted Adjustment 
Antonelli Incalzi127 
Italy 
Retrospective 
cohort 
Readmission 
rates  
Income  
Men  
Women 
 
2.32(2.04-2.63) 
3.28(2.95-3.65) 
  
Auerbach129USA Prospective 
cohort 
Care by 
cardiologist 
Income (low vs. 
high) 
Education (College 
vs. high school) 
 0.65(0.45-0.93)  
 
1.89(1.02-3.51) 
Acute Physiology Score, site of enrolment, 
history of dementia admitted to an intensive 
care unit 
Coughlin130  
USA 
Case control Cardiac 
transplantation 
listing 
Income (low)  
No private health 
insurance 
P<0.05   
Compos Lopes131  
Brazil 
Prospective 
cohort 
Cardiac death Public vs. private 
health care 
 OR 3.46(1.91-6.27) Aetiology of HF, Digoxin use, No of past MI, 
history of hypertension 
Gottinder132  
USA 
Retrospective 
cohort 
Incidence  Income P=0.0002 
(women) 
P<0.0001(men) 
  
Jhund124 
Scotland 
Retrospective 
cohort 
Case fatality  
30 day (men) 
(women) 
1 year 
 
5 years 
Carstairs Morris 
Index 
Most vs. least 
deprived 
  
1.18 (1.10–1.28)  
1.03 (0.96–1.10)  
1.11 (1.07–1.16)  
1.03 (0.99–1.07)  
1.14 (1.11–1.18)  
1.04 (1.01–1.08) 
Age, prior admissions (MI, Stroke, AF, CHD, 
renal failure, diabetes, hypertension, 
peripheral arterial disease, respiratory disease, 
cancer) 
Ingelsson123 
Sweden 
Prospective 
cohort 
Incidence Social Class 
Education 
Marital status 
1.82(1.20-2.74) 
2.47(1.34-4.55) 
0.90(0.50-1.61) 
1.46(0.97-2.21) 
1.94(1.04-3.59) 
0.83(0.46-1.48) 
Hypertension, diabetes, Left ventricular 
hypertrophy, smoking, BMI, cholesterol 
Latour Perez133 
Spain 
Retrospective 
cohort 
HF on 
admission with 
MI 
Social Class  2.4(1.1-5.2) Age, diabetes, marital status, sex 
McAlister121 
Scotland 
Retrospective 
cohort 
Incidence  
Prevalence 
Health care 
usage 
Prescribing of 
ACE inhibitors  
Survival 
Carstairs Morris 
Index Most vs. least 
deprived 
 1.44 
1.13 
0.84 
 
 
NS* 
0.88 
Age, sex 
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Philbin126  
USA 
Prospective 
cohort 
Readmissions 
with HF 
Income (High vs. 
low) 
 1.18(1.10-1.26) Risk score comprising of race, insurance, 
aetiology of HF diabetes, renal disease, 
chronic lung disease, history of prior cardiac 
surgery, referral to 
home health services upon hospital discharge, 
telemetry monitoring during the index 
admission, admission to rural hospital, 
discharge to a nursing facility 
echocardiography, cardiac catheterisation.  
Rathore134 
USA 
Retrospective 
cohort 
**Case fatality 
30 day 
1 year 
Readmission at 
1 year  
Area based score  
0.90(0.75-1.08) 
0.93(0.86-0.99) 
1.11(1.07-1.15) 
 
1.13(0.92-1.38) 
1.10(1.02-1.19) 
1.08(1.03-1.12 
 
Age, race, Left ventricular function, medical 
history and mortality prediction score 
Romm135 
USA 
Prospective 
cohort 
Activity score 
Symptoms 
Social class R= -0.181 
R= -0.185 
  
Schaufelberger 122 
Sweden 
Retrospective 
cohort 
Incidence Social Class 2.00(1.42-2.82) 
(age adjusted) 
1.72(1.34-2.20) Age, height, BMI, smoking, activity, systolic 
blood pressure, diabetes, alcohol, cholesterol 
Stewart125  
Scotland 
Prospective 
cohort 
Incidence  Carstairs Morris 
Index 
1.39 (1.04 to 
2.01) 
 Age (per year),Sex, History of angina,  
Stroke, smoking, atrial fibrillation,  
LBBB and ischaemia  
Systolic and diastolic blood pressure  
FEV1, Cardiomegaly Blood sugar  
Body mass index 
Struthers 128 
Scotland 
 
Prospective 
cohort 
Readmission: 
Cardiac  
All 
Carstairs Morris 
Index 
 
1.11(1.004-
1.225) 
1.007(0.933-
1.008) 
 
1.11(1.002-1.224) 
1.013(0.937-1.096) 
 
Age, sex 
*measure of effect not stated 
**also multiple measures of quality of care  
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Socioeconomic deprivation and the health care costs of 
cardiovascular disease 
The health care costs associated with various cardiovascular diseases have been 
documented in multiple health care systems.136,137 However, in a search of the literature 
only one study directly examined the costs of cardiovascular health care according to 
socioeconomic status. In a report from the Women’s Ischaemia Symptoms Evaluation 
study, the cost associated with a 5 year follow up of 819 women referred for clinically 
indicated coronary angiography was higher in the most versus the least deprived as 
measured by household income.138 The total hospital costs over five years in the most 
deprived was $40,477 compared to $23,132 in the least deprived (p<0.001). Of course this 
study did not include men limiting its utility. More importantly, the costs in this study were 
determined over a five year period only. As SED confers a higher risk of all cause and 
cardiovascular mortality, would this translate in less opportunity to accrue health care costs 
over time given that the most deprived die earlier? This question remains unanswered as 
does the precise calculation of the costs of cardiovascular hospitalisations according to 
SED.  
 
Socioeconomic deprivation and the health care burden of 
cardiovascular disease 
The literature surrounding SED and CVD may be abundant with studies on the association 
with mortality and case fatality (albeit with great deficiencies). However, with regards to 
the burden of CVD the only information in the literature stems from studies of the cross 
sectional prevalence of disease in various communities according to levels of SED. 
However, a greater burden of prevalent disease according to SED does not necessarily 
equate to greater health care usage. No studies have explicitly examined the relationship 
between SED and the health care system burden of CVD. A few studies of some forms of 
CVD, such as heart failure have presented data on the primary care burden of disease by 
SED 121.  
In a study of the primary care burden of angina in Scotland, the most deprived individuals 
in 55 general practices, attended their general practitioner less than the least deprived 
individuals (Odds ratio (OR) most versus least deprived 0.67  95% CI 0.57-0.79).139 In the 
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same setting another report from the same authors found that the most deprived individuals 
with heart failure were also less likely to visit their general practitioner than the least 
deprived individuals with heart failure (OR 0.77, 95% CI not stated, p<0.001). From this it 
can be inferred that the most deprived individuals utilise the health services less than the 
least deprived members of society, however, extrapolating these trends outside of the 
setting of primary care is difficult. A study of patients with heart failure demonstrated that 
the most deprived were less likely to receive specialist care OR 0.65(0.45-0.93). It is not 
known if these trends translate into fewer hospitalisations for CVD in the most deprived 
for certain conditions such as heart failure. The observations above in the primary care 
setting may simply relate to a different health behaviour and health seeking behaviour on 
the part of the most deprived.  
Relationship between socioeconomic deprivation and 
cardiovascular risk factors 
Numerous risk factors for cardiovascular disease have been proposed. What is consistent is 
the finding that some risk factors are undoubtedly the most important. This has been 
demonstrated in multiple studies throughout the 20th and 21st centuries.67,140 Moreover, 
the importance of these modifiable risk factors has been underlined by the finding that 
reducing exposure to these risk factors through avoidance or drug therapy reduces the rates 
of cardiovascular disease. The main modifiable risk factors for cardiovascular disease are 
smoking, the presence of diabetes mellitus, hypertension, hypercholesterolaemia.140 
Inevitably as interest in SED and CVD has grown it has been hypothesised that differences 
in the distribution of these risk factors explains the gradient in CVD rates by 
SED.38,40,71,98,100,141-143 SED has been associated with higher levels of all of these risk 
factors.25,142,144-148, including in those with and  without cardiovascular disease.149 In the 
following section I will present the literature surrounding the association between SED and 
these risk factors. In the Renfrew Paisley cohort a number of other variables were 
measured that are also associated with cardiovascular risk. These are body mass index 
(BMI), adjusted forced expiratory volume in 1 second (FEV1), bronchitis measured by the 
Medical Research Council questionnaire and cardiomegaly on chest x-ray. In further 
analyses, these variables were examined in a multivariable model to determine if they 
explained any of the potential gradients in disease risk according to SED. Therefore, the 
association between SED and these additional risk factors will also be discussed here.  
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Smoking 
Smoking is undeniably an important cardiovascular risk factor.67 A large number of studies 
have examined the relationship between smoking and SED. Smoking is consistently related 
to SED25,147,150,151 and this is seen in a number of countries152, but is related to cultural and 
other factors also.152,153 Whilst in this thesis it would be impossible to summarise all the 
literature surrounding smoking and the relationship with SED there are a number of 
important aspects to the relationship that are worthy of highlighting here. The most 
obvious perhaps is that the deprived consistently display higher rates of smoking at around 
20%.145 This association is seen in all ages and in both sexes.146 The relationship is found 
irrespective of the method of measuring SED whether an individual25 or area based 
measure154. The relationship is seen in all developed countries.147,155 Overall, whilst 
smoking rates are falling, in the most deprived the rate of smoking is falling more slowly 
than in the least deprived in the UK.146 This is not an isolated finding, and has been 
reported in the USA151 and Denmark74. Consequently, as a major risk factor for 
cardiovascular disease, this gives rise to the concern that this trend could increase 
inequalities in CVD in the future.  
Hypertension  
Hypertension is another of the major cardiovascular risk factors that is modifiable through 
lifestyle and pharmacological interventions. An inverse relationship with SED has been 
described widely in the developed world and has been comprehensively reviewed 
elsewhere.156,157 Again, irrespective of the measure of SED used, and whether examining 
systolic or diastolic blood pressure, the most deprived display higher rates of elevated 
blood pressure.144,147,151,158,159 The relationship persists after adjustment for factors such as 
salt intake and obesity.160 Furthermore, treatment rates do not affect this relationship.155 
Whilst overall blood pressure has been falling in the community as a result of primary 
prevention, SED gradients remain.146,151  
The relationship between blood pressure and SED is one where progress has been made in 
elucidating the determinants of the association. Awareness of the risks of hypertension 
may be lower in the most deprived.161 The foetal programming hypothesis of Barker has 
been applied to this area in an attempt to explain this association.162 Factors related to 
foetal under nutrition were associated with the development of hypertension, indicating 
that more deprived life circumstances in-utero, predispose to greater deprivation in later 
life and the development of hypertension. Genetic influences on the relationship between 
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SED and hypertension have been reported. A polymorphism of the alpha 2 beta-adrenergic 
receptor has been shown to interact with job strain (jobs with high demands and low 
decision making responsibility i.e. manual class jobs) to lead to raised blood pressure.163 
Therefore, while the association between SED and hypertension is clear, it is in this area 
where some of the greatest strides are being made to disentangle the pathways by which 
SED leads to higher blood pressure. 
Cholesterol 
Whilst hypercholesterolaemia is a major cardiovascular risk factor the relationship with 
SED is less clear. Many studies have reported that cholesterol increases as the level of SED 
increases.25,144,147,150,151,164 In a study of over 37,000 women and 33,000 men undergoing 
risk factor screening serum cholesterol was significantly higher in the most deprived as 
compared to the least deprived (as measured by Townsend score).150 However, the 
magnitude of the difference was reported to be only 0.02mmol/l though this was 
statistically significant (95%CI 0.01 - 0.03). Similar differences in serum total cholesterol 
and HDL cholesterol were recorded in the EUROASPIRE II study.155 The magnitude of 
difference being similar to the study by Layratzopoulos et al at 0.07mmol/l. However, 
despite these differences the rates of prescribing of appropriate lipid lowering therapy is 
lower in the most deprived.155,165 Finally, it is not only total cholesterol that is related to 
SED, subclasses of lipids are also related to SED. The most deprived have higher levels of 
triglycerides and  low density lipoprotein cholesterol and lower levels of HDL  
cholesterol.71,166,167  
Diabetes 
As with cholesterol and blood pressure the presence of non-insulin dependant (Type II) 
diabetes varies according to SED.147,148,151,155,167 The relationship between the presence of 
diabetes and SED is independent of body habitus. In addition to this the most deprived in 
one study displayed higher levels of insulin, greater blood glucose, greater insulin 
resistance and higher levels of glycosolated haemoglobin A1c168. These associations 
persisted after correction for body habitus as measured by BMI.168 In the Whitehall studies, 
the fasting glucose levels of individuals did not seem to differ according to SED.169 
However, one large epidemiological study reported that there was no relationship between 
SED and diabetes in men.164 These conflicting studies used only one measure of SED 
highlighting the sentiments of Braveman et al170 that multiple measures of SED should be 
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used to explore relationships with health outcomes. However, as with smoking, there are 
reports that the disparities in diabetes prevalence by SED may be increasing.151 
Obesity 
Obesity is consistently associated with a higher risk of cardiovascular disease. This is 
perhaps the best studied risk factor in relation to SED. A recent systematic review of the 
relationship between SED and obesity reported that 144 relevant studies were published 
between 1960 and the mid 1980s and from 1998 to 2004 a further 344 studies were 
identified.171 Again, many of the studies that have been referenced above in relation to 
other risk factors have reported an inverse relationship between SED and 
obesity.74,146,147,151 Multiple measures of obesity have been used, BMI, waist hip ratio, as 
have multiple measures of SED.171 Overall, McLaren et al171 concluded from their 
comprehensive review that in developed countries socioeconomic deprivation is associated 
with higher rates of obesity in women though in men the association is less clear with 
many studies reporting non-significant associations. In the UK, however, there have been 
reports that this disparity is widening.146  
Lung function 
Lung function is an understudied risk factor for cardiovascular disease. In a study of the 
Renfrew Paisley cohort, FEV1 was strongly associated with all cause mortality.172 Multiple 
studies have reported that reduction in a number of measures of lung capacity such as 
forced vital capacity and FEV1 are associated with higher cardiovascular risk.173-177 The 
risk of coronary heart disease, myocardial infarction and stroke are all higher in those with 
reduced lung function. The Framingham investigators have also reported that reduced lung 
function predicts the development of heart failure.178 Poorer lung function is associated 
with socioeconomic deprivation.179,180 Vital capacity, FEV1 and the ratio of the two 
measures are all reduced in the most deprived.  FEV1 may be reduced by up to 300ml in 
men and 200ml in women in the most deprived when compared to the least deprived 
individuals.179  
Whilst lung function is related to SED, it has been noted above that smoking is related to 
SED and may confound this relationship. However, in one of the largest studies to examine 
the relationship between SED (in this case determined by occupation) and lung function, 
FEV1 in 32,905 people was 2.7% lower in the most deprived compared to the least 
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deprived.181 This difference was present after correction for height, age, smoking status 
and respiratory illnesses. Amongst non-smokers the association also exists.182  
Cardiomegaly 
Enlargement of the heart is a well studied cardiovascular risk factor.183 Increased left 
ventricular mass or chamber size as measured by echocardiography is associated with 
greater cardiovascular risk.184 Cardiomegaly on a chest x-ray (defined as a cardiac to 
thoracic ratio of greater than 50%) is a simpler measure of cardiac enlargement. The 
presence of cardiomegaly on a chest x-ray increases the risk of developing heart failure 
(over and above the finding of left ventricular hypertrophy on an ECG) in the Framingham 
studies140 and is also a marker of poor outcome in those with heart failure.185 A report from 
the Whitehall II study found that cardiomegaly is also associated with an approximately 
doubling of the risk of cardiovascular and coronary heart disease mortality over 25 years of 
follow up independently of cardiovascular risk factors such as age, systolic BP, diastolic 
BP, heart rate, total cholesterol, smoking, history of angina and ECG abnormalities.186  
Socioeconomic status is related to cardiomegaly. In the Renfrew paisley cohort, a greater 
proportion of the most deprived had cardiomegaly on their chest x-ray154 and was a 
predictor of future heart failure125. Whilst chest radiography may be a crude method to 
assess cardiac size, echocardiography allows more accurate quantification of cardiac mass 
and chamber size. In an echocardiographic study, SED as measured by education, was 
inversely related to cardiac mass.184 
Other cardiovascular risk factors and socioeconomic deprivation 
A number of other novel cardiovascular risk factors have been examined in relation to 
SED. These include other biochemical and haematological risk factors such as 
fibrinogen71,166,187, c-reactive protein71,166,188,189, interleukin-671,166,189,190, von Willebrand 
factor166,intercellular adhesion molecule 171,189, homocysteine71,191, serum amyloid A188 
and monocyte chemoattractant protein-1189. With the exception possibly of c-reactive 
protein 192 none of these markers have found their way into everyday clinical use. 
Other physiological risk factors for CVD have been associated with SED. These include 
heart rate variability193, blood pressure reactivity194, functional capacity and heart rate 
recovery195. Whilst these have been studied in an effort to explain the differential outcomes 
observed according to SED, no definitive proof of their role is forthcoming.  
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Finally, one hypothesis that has linked the relationship between SED and CVD is that of 
infection as a cause of CVD. Studies have linked pathogen burden to the risk of  CHD.196 It 
was hypothesised that greater SED and hence poorer living conditions would expose and 
individual to more pathogens and hence a higher risk of CVD. In a study of the Whitehall 
II cohort, seropositivity for Chlamydia pneumoniae, cytomegalovirus and herpes simplex 
virus 1 did not explain the risk of CHD associated with SED.180 
Summary 
It is clear from the literature above that SED is related to a number of cardiovascular 
diseases. However, as has been demonstrated most studies have focussed on fatal outcomes 
hence less is known about non-fatal outcomes. Similarly, the majority of prior studies have  
focussed on either coronary heart disease or stroke, hence little is known about the effect 
of, and comparative relationship between, socioeconomic deprivation on the incidence of 
(and outcomes from) other types of CVD such as heart failure. As a consequence of 
relatively small cohort sizes, and, short follow-up, almost all studies have focused on first 
events and have been unable to describe the relationship between SED and recurrent 
cardiovascular events i.e. the complete burden of the disease on secondary care services. 
Another limitation of past studies is the extent of baseline characterisation of the subjects 
and consequent ability to perform comprehensive multivariate analysis in order to 
determine whether socioeconomic deprivation is truly an independent predictor of 
outcome. This is especially important as each of the classical cardiovascular risk factors 
and a number of other risk factors vary by SED. In this thesis I will seek to fill these gaps 
in our knowledge of SED and cardiovascular disease. To do this I will utilise the Renfrew 
Paisley study which is a prospective cohort study of 7,048 men and 8,354 women on 
whom comprehensive cardiorespiratory measurements are available and who have been 
followed for over 25 years. This will be achieved through the aims and objectives outlined 
in the next chapter.  
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Aims and Objectives 
 
Aims 
As a result of the literature review the following aim of this thesis was developed 
• To describe the association between SED and a number of cardiovascular outcomes 
in an entire cohort of men and women adjusting for cardiovascular risk factors. 
The above aim was translated in to the following objectives 
Objectives 
• To describe the baseline characteristics and cardiovascular risk factors according to 
SED.  
• To examine the independent effect of socioeconomic deprivation on the risk of 
admission to hospital with a specific cardiovascular diagnosis.  
• To compare the absolute and relative strength of association between 
socioeconomic deprivation and cardiovascular morbidity. 
• To examine the effect of socioeconomic deprivation on the risk of recurrent 
cardiovascular events as well as on first events and the effect on subsequent 
mortality from specific cardiovascular diseases and a number of other composite 
end points. 
• To examine the impact of socioeconomic deprivation on hospital sector costs. 
• To estimate the impact of socioeconomic deprivation on the population burden of 
cardiovascular disease, premature mortality, any cardiovascular mortality and all 
cause mortality. 
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Methods 
Data Source 
The Midspan studies are four separate occupational and general population cohort studies 
based in Scotland197. The original three studies were conducted between 1964 and 1976. 
The Main and Tiree study, 1964-68, was a study of an industrial group of 3,931 individuals 
from 13 factories in the central belt of Scotland. The Collaborative study, 1970-1973, was 
an occupational cohort study of 7,028 individuals from 27 workplaces in the central belt of 
Scotland. The Renfrew/Paisley study, conducted between 1972-1976, was a general 
population cohort from the two towns of Renfrew and Paisley in the outskirts of Glasgow 
(Figure 1).  
Figure 1 Map of Scotland showing the position of Glasgow and Paisley (Red box outlines 
area of detail in Figure 2) 
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Figure 2 Area of detail showing the location of Renfrew and Paisley in relation to Glasgow 
 
 
A fourth study, the Family study, was conducted in 1993-1994 and is a cohort study of the 
offspring of 1,477 families who took part in the original Renfrew/Paisley cohort. The 
Midspan studies originated from a post war drive to control pulmonary tuberculosis using 
mass miniature radiography. In addition to improving the detection and control of 
tuberculosis, the Midspan studies utilised this effective screening method to examine 
cardiovascular and respiratory risk and disease. For this thesis data from the 
Renfrew/Paisley study were used and will be discussed in more detail. 
Population Sample  
The Renfrew/Paisley study is a general population cohort study consisting of 7,048 men 
and 8,354 women who lived in the industrialised towns of Renfrew and Paisley, to the west 
of Glasgow in the west of Scotland. The Renfrew/Paisley study was funded by the by the 
Renfrewshire King Edward Memorial Trust. Eligibility for the Renfrew/Paisley study was 
established by a door-to-door census of all households in the two towns in 1972. Between 
1972 and 1976, all persons aged 45-64 years who met residency criteria were invited to 
complete a questionnaire and attend for a screening examination at one of twelve nearby 
temporary screening centres. Participation rates at baseline were 78.8% of the target 
population in Renfrew and 77.9% in Paisley. Approximately 60% of participants re-
attended for repeat screening between 1977 and 1979.  
Baseline Data 
Each subject’s demographic profile and cardiorespiratory health status was documented 
during their screening visit. Figure 3 shows a floor plan of the accommodation, 
examination stations and route that participants took through a typical temporary 
examination centre as used in the Renfrew/Paisley study. A mobile X-ray unit was 
positioned outside the entrance to perform the chest radiographs.  Approximately ten 
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participants arrived every 10 minutes during each session. Individual questionnaires were 
checked and standardised. Investigations lasting approximately 20 minutes were 
undertaken as participants moved through the examination stations. A further visit six 
weeks later was arranged for participants whose clinical measurements required 
confirmation or clarification. 
Figure 3 Layout of the screening station used in the Renfrew/Paisley cohort study 
 
 
The questionnaire used in the Renfrew/Paisley study was very similar in appearance to that 
used in the Collaborative study but some new questions were included and others (e.g. 
questions on diet and early life) omitted. The data were coded and entered onto computer, 
anonymously. The original questionnaires are currently stored at the University of 
Glasgow archive. The data gathered from the questionnaire are detailed in Table 10. 
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Table 10 Questionnaire data collected at screening 
Questionnaire data 
Sex 
Marital status 
Date of birth 
Occupation 
Exercise 
Medical Research Council bronchitis questionnaire 
Chest wheeze 
Effect of weather on breathing 
Smoking habit 
Rose angina questionnaire 
Severe chest pain 
Diabetes 
Past history of hospital admissions 
Stroke symptoms 
Treatment for blood pressure 
Asthma / hay fever 
Years in present home (Paisley only) 
 
The standard Rose angina classification was used to define the presence of angina.3,4 The 
validity of the Rose angina questionnaire has been tested in studies comparing it to a 
clinical diagnosis of angina, electrocardiogram abnormality, thallium scanning and as a 
predictor of coronary artery disease mortality.5,6,7,8 In the classification, Grade I angina is 
defined as pain or discomfort when walking uphill or hurrying. Grade II angina is when the 
subject also reports chest pain or discomfort when walking at an ordinary pace on the level. 
Angina is further classified as “definite” if, in addition, the pain is sited in the sternum or 
the left chest and arm, causes the subject to stop or slow down and resolves within 10 
minutes of the subject stopping or slowing down. If these additional criteria are not 
satisfied, angina is classified as “possible”. For the purpose of this study, “angina” was 
defined as Rose grade I and II “definite” angina and was not confirmed by investigation or 
evaluation. Possible MI (identified by a separate question on Rose questionnaire as having 
ever experienced a severe pain across the front of chest lasting for half an hour or more) 
was noted.9 The diagnosis of chronic bronchitis was determined by the Medical Research 
Council’s chronic bronchitis questionnaire.10  A smoking history was recorded including 
average number of cigarettes smoked per day (never smoked, 1-14, 15-24, 25-34, 35 or 
more), ex-smoker (less than 5 years or 5 years or more) or pipe or cigar smoker. A history 
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of diabetes was obtained from the patient and was positive if they reported having been 
told they had diabetes by a doctor.  
A number of clinical variables were also measured at screening (Table 11). Blood pressure 
was recorded as the mean of two measurements taken in the seated position and diastolic 
pressure was recorded at the disappearance of the fifth Korotkoff sound. Height and weight 
were measured and used to calculate body mass index in kg/m2 (weight in kg divided by 
height in meters squared). Forced expiratory volume in 1 second (FEV1) was measured. 
An adjusted FEV1 was calculated as a percentage of the “expected” FEV1 (derived from a 
linear regression equation of age and height for men and women separately from a healthy 
subset of the sample who were non-smokers and had no respiratory symptoms) and the 
actual FEV1. These equations were: 
Men:   FEV1 = -185.92-2.86 x age + 3.69 x height  
Women: FEV1 = -22.47-2.89 x age + 2.37 x height 
The cardiothoracic ratio was based on a chest radiograph and cardiomegaly was defined as 
a cardiothoracic ratio <= 0.55. Plasma cholesterol and glucose concentrations were 
measured in a 10ml non-fasting blood sample. Glucose concentration was not measured 
during the whole screening period.  A six-lead electrocardiogram (ECG) was also obtained 
(leads I, II, III, aVR, aVL and aVF) and coded using the Minnesota coding system.  
Table 11 Clinical measurements made at screening 
Clinical measurements 
Blood pressure 
Chest X-ray 
Tine test 
Sputum sample 
Cholesterol (plasma, non-fasting) 
Blood glucose* 
Cardiothoracic ratio  
Height 
Weight 
ECG (Minnesota code) 
Respiratory function, FEV1, FVC 
Biochemical tests*: Sodium (Renfrew only), potassium, Oxygen, Haemoglobin, 
carboxyhaemoglobin 
* only available on some subjects 
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Measures of socioeconomic deprivation 
Measures of SED have been discussed earlier. Two measures of SED were obtained in the 
Renfrew/Paisley study. The first was social class as determined by the participant’s 
occupation recorded on the questionnaire. This was coded according to the Registrar 
General’s classification. For housewives and retired women the occupation of their 
husband or father was used. The classification is outlined in Table 12. Class I is the most 
affluent class and class V the most deprived. Class VI, which denotes service in the armed 
forces, was not used in the cohort.  
Table 12 Registrar General’s Social Class Scheme 
Grade  Example Occupations  
I Professional Doctor, Lawyer, Executive 
II Intermediate Sales Manager, Teacher 
III-N Skilled non-
manual 
Shop Assistant, Clerk 
Non-Manual 
III-M Skilled manual Machinist, Brick layer 
IV Partly skilled Postman,  
V Unskilled Labourer, Porters 
Manual 
VI Armed forces   
 
The second measure was determined from a participant’s postcode of residence. Postcode 
sectors were used to assign a Carstairs-Morris index category.10 The index was originally 
developed in the 1980s using 1981 census data. It is composed of four indicators which 
were judged to represent disadvantage in the population (Table 13). The four indicators are 
combined to create a composite score. The deprivation score is divided into seven separate 
categories, ranging from the most deprived (category 7) to the least deprived (category 1). 
The seven categories were designed so as to retain the discriminatory features of the 
distribution of the deprivation score, rather than to ensure equality of numbers between 
each deprivation category. Some very small postcode sectors were excluded and do not 
have a score. The index was designed with the expectation that it would be mirrored by 
direct measurement of household income if that were possible. Whilst the cohort was 
recruited between 1972-1976, the Carstairs Morris index applied was derived from the 
1981 census. Therefore, the index may not accurately reflect the socioeconomic conditions 
of the cohort at recruitment. However, previous analyses of the cohort 100,101,125,172,198 and 
their congruency with the published literature would suggest that this potential bias has 
little meaningful effect on the results of the study. 
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There are 1010 postcode sectors in Scotland, identified by a combination of the first five 
characters of the postcode (representing 937 areas) and the Council Area. The average 
population is 5012 (range 51 people to 20,512). A total of 15,370 participants (99.8% of 
the total cohort) had a documented postcode of residence that was used to determine SED 
based on the Carstairs–Morris Deprivation category. It should be noted that none of the 
postcode sectors of the participants in the Renfrew/Paisley study mapped to deprivation 
category 2. 
Table 13 Constituent variables in the Carstairs Morris Index 
Variable  Definition 
Degree of Overcrowding  Persons in private households living at a density of 
more than one person per room as a proportion* of 
all persons in private households 
Level of Male unemployment  Proportion of economically active males who are 
seeking work 
Proportion in Social class 4 or 
5 
Proportion of all persons in private households with 
head of household in social class 4 or 5 
Ownership of a car Proportion of all persons in private households with 
no car 
 
Ethical approval and Follow-up  
Written consent was given at the time of enrolment into the study for hospital records to be 
subsequently monitored. Latterly ethical permission was obtained from Argyll and Clyde 
local and regional ethics committee for linkage with the Scottish Morbidity Record (SMR) 
system. Electronic linkage to hospital and death records is possible for all residents of 
Scotland through the SMR.  
Scottish Morbidity Record (SMR) 
Healthcare data for individual patients in Scotland is collected as a series of Scottish 
Morbidity Records.199 The record type denotes the general type of healthcare received 
during an episode. The hospital activity SMRs are outpatient attendances (SMR00), all 
discharges from acute hospitals (SMR01), maternity units (SMR02), psychiatric units 
(SMR04), neonatal units (SMR11) and geriatric long stay inpatients (SMR50). Analysis of 
SMR01 data were used for this study. An SMR01 record is an episode-based patient record 
relating to all inpatient or day case discharges from non-obstetric and non-psychiatric 
specialties. Elective and emergency admissions are included. A SMR01 record is generated 
when a patient is discharged home from hospital, transferred to another clinician (either at 
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the same or a different hospital), changes specialty (either under the same or a different 
clinician), or dies. Data collected include patient identifiable and demographic information 
as well as episode management details (such as length of stay) and general clinical 
information. Each patient is given a principal diagnosis and up to five secondary diagnoses 
and up to four operative procedures. These secondary diagnoses are recorded if they affect 
the management of the patient or are associated with the main condition or are chronic 
conditions. Diagnosis at discharge is coded using the World Health Organisation (WHO) 
International Classification of Diseases (ICD) system. Diseases are coded initially using 
the eighth revision (ICD-8, a small number of initial episodes), the ninth revision (ICD-9) 
up to March 31st 1996 and the tenth revision (ICD-10) thereafter. The data are abstracted 
from case notes and then transcribed onto an SMR01 form. The Information and Statistics 
Division (ISD) of the NHS Scotland collates the data at National level. The General 
Register Office for Scotland records the causes of death for all Scottish residents. The 
codes used to classify deaths are allocated using the WHO International Classification of 
Diseases.  ICD9 was used between 1979 and 1999 and ICD10 has been used since 1st 
January 2000. Classification of the cause of death is based on information collected on the 
medical certificate of cause of death which contains information on the underlying cause of 
death and up to three other causes considered to have contributed to death.    
Since the 1970’s these datasets, SMR and death registration records, belonging to the same 
patient in Scotland have been linked together in the Scottish Record Linkage System.199 
Therefore, the linked data set holds hospital discharge records for non-psychiatric, non-
obstetric specialties (SMR01) together with Registrar General’s death records from 1981 
until the present day.  Ad hoc linkages can also be carried out dating back to 1968. Records 
from individual hospital episodes from different SMR schemes and records from the 
Registrar General are linked using probability matching record linkage to provide profiles 
for each patient. Over the last thirty years, methods of probability matching have been 
developed and refined in Oxford, Scotland and Canada and are used by the Record 
Linkage System to allow for inaccuracies in the identifying information.199 When records 
are linked, two records are compared using identifying items such as surname, first initial, 
sex, year, month and day of birth and postcode and a decision is made as to whether they 
belong to the same individual. Surnames are changed to coded format in order to avoid the 
effects of differences in spelling. A computer algorithm calculates a score for each pair of 
records that is proportional to the likelihood that they belong to the same person.  The huge 
volume of data would mean it is be impossible to carry out probability matching on all 
pairs of records involved in the linkage and blocking is used to cut down the number of 
comparisons required. Only those records that have a minimum level of agreement in 
 78 
identifying items are compared. Probability matching then allows mathematically precise 
assessment of the implications of the levels of agreement and disagreement between 
records. 
Quality of the data 
The self-completed health questionnaire at baseline screening was checked by experienced 
interviewers at the screening examination.  
The linkage process is largely automatic as a threshold score based on probability 
matching dictates the decision as to whether the records belong together. Clerical checking 
has shown that the accuracy of probability matching is 98%. The accuracy of follow up 
using this method has been validated against standard follow up using a clinical trial. In 
comparison to the standard method of follow up, linkage of records to SMR compared 
favourably.144  
The Quality Assessment and Accreditation Unit of Information and Statistics Division of 
NHS Scotland monitors the quality of SMR data, by assessing accuracy, completeness, 
consistency and fitness for purpose. It carries out routine validation of a sample of SMR01 
records where data held on the sampled records are compared with information contained 
in the medical case notes. An assessment of the accuracy of SMR01 data, carried out 
between 2000 and 2002, on a 2% sample of SMR01 data found the accuracy for recording 
of clinical data at the three-digit level was 88% for the main diagnosis falling to 81% at the 
four-digit level.200 The accuracy of the main diagnosis was 89% from the 1997/98 audit. 
The accuracy for main procedure/ operation was 91% accurate and other procedures/ 
operations 92% accurate. The accuracy for non-clinical data items was 97%. 
Cardiovascular diagnoses were 91% accurate overall.  
Organisation and extraction of the data 
The Renfrew/Paisley study is co-ordinated from the Department of Public Health and 
Health Policy in the University of Glasgow. Data pertaining to the initial and follow-up 
screening visits are held in SPSS file format. The cohort is updated for mortality on a three 
monthly basis including full checks on the status (dead/alive) of the oldest participants. At 
the time of commencing these studies subsequent hospital admission data for the cohort 
were available to the date of 31st of March 2004. In collaboration with Midspan staff, Dr 
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Carole Hart and Mrs Pauline McKinnon, a data extraction specification was written which 
detailed the nature of the baseline and follow-up data required for the studies in this thesis. 
Ethical approval and data extracted for present studies 
The Midspan Steering Committee approved the studies. Permission was given by the 
Privacy Advisory Committee of the Information and Statistics Division to use the linked 
data. All studies were approved by the University of Glasgow ethics committee.  
Each patient record contained all information available from the baseline questionnaire. 
Date of death and cause of death until 31st March 2004 were also included. In addition the 
date of all hospitalisations and cause of all hospitalisations was also available up until this 
date. Date of censorship was from the date of each individual’s initial screening visit to 
death, end of follow up or in a few cases date of emigration. Loss to follow up occurred in 
less than 1% of the cohort. 
Statistical analysis 
All analyses were undertaken using Stata (Version 10, Stata Corporation, College Station, 
Texas, USA). All tests of statistical significance were two tailed. Statistical significance 
was taken at the conventional level of 5% (P<0.05). The use and limitations of, p values 
has been widely discussed in the scientific literature.201,202 The p value dichotomises the 
results of statistical analyses into “significant” or “non-significant” and removes any 
further interpretation of the data.203 A non-significant p value indicates that there is no 
difference between two or more groups, or that that the study is underpowered to detect the 
difference between groups; it does not indicate which of these two options is true.204 A 
more appropriate analysis is to calculate a confidence interval which allows an assessment 
of the strength of evidence.205 For analyses in this thesis 95% confidence intervals were 
calculated. Major scientific journals insist on the presentation of confidence 
intervals.201,205,206  As Altman204 states “The main purpose of confidence intervals is to 
indicate the (im)precision of the sample study estimates as population values.”  He 
discusses the interpretation of confidence intervals, making a number of important points 
about their interpretation.204 Firstly, values outside of the interval are not excluded by the 
interval, they are simply less likely. Secondly, the middle of the interval is more likely to 
contain the true population value than the two extreme quarters. The final, and perhaps the 
most often overlooked aspect of the interpretation of confidence intervals, is that regardless 
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of the width of the confidence interval, the sample estimate is the best indicator of the true 
population value.  
Confidence intervals, as with p values, are open to misuse.206 The most common misuse of 
confidence intervals occurs when they include the null value (the confidence interval 
crosses the value of no effect).203,204,207,208  In this case the confidence interval is often 
interpreted as proof of no effect.208 Whilst this is based on a correct link with the p value, 
interpretations of confidence intervals in this way effectively dichotomise the interval back 
into “significant” or “non-significant” test. This denies the reader the option of making a 
more informative interpretation of the interval as outlined above.204,207 Therefore, the 95% 
confidence intervals calculated are interpreted as intervals, following the above, and not as 
tests of significance.204 Finally, epidemiologists such as Bradford Hill209 suggest that the 
results of analyses should be interpreted in relation to the other analyses performed and of 
other published literature.210  Therefore, analyses were interpreted in relation to each other 
and whether they were consistent with the published literature if available.  
Rates 
Rates were calculated from date of screening to the date of event or censoring (death or 
end of follow up). Rates are expressed per 1000 person years follow up. Rate ratios were 
calculated using the Mantel-Cox method.  
Cox regression 
Cox proportional hazards regression211 was used to model the effect of a number of 
covariates and their association with the risk of various events. Models were used to adjust 
for the variation in distribution of various risk factors between individuals of differing 
SED. Initially variables which have been consistently associated with cardiovascular risk, 
were entered into the model to adjust for their variable distribution between socioeconomic 
groups. Next variables that are not considered “traditional” risk factors but have previously 
been shown to be associated with cardiovascular disease, body mass index, adjusted FEV1, 
history of bronchitis and cardiomegaly, were entered into the model. Backwards stepwise 
regression was used to determine those additional variables that would be adjusted for in 
further analyses after adjustment for the “traditional” cardiovascular risk factors, age, sex, 
smoking, blood pressure, cholesterol and diabetes mellitus. The significance level of the 
likelihood ratio test of these variables is given in table 14. 
 81 
Table 14 Significance level of additional variables entered into the model 
Variable P 
Body mass index 0.0004 
Adjusted FEV1 <0.0001 
Bronchitis on MRC questionnaire 0.0013 
Cardiomegaly (cardiothoracic ratio of 
>=0.5 on chest radiograph) 
<0.0001 
 
Therefore, the final models used in these analyses included, age, sex, SED (measured by 
Carstairs Morris index or social class), diabetes, smoking, cholesterol, systolic blood 
pressure, body mass index, adjusted FEV1, bronchitis and cardiomegaly.  
Inequality was measured by comparing the hazard and rate ratio in the most versus the 
least deprived. It was also measured using the population attributable fraction. These are 
the most common methods of exploring health inequalities in the literature. Other  methods 
do exist and have advantages and disadvantages, in particular they describe the relationship 
between health outcomes and the whole distribution of SED.212-215 The Gini coefficient, 
modified Gini coefficient and index of dissimilarity all enable inequalities in health to be 
measured from the most to least deprived and all levels between.212,213 However, they are 
univariate measures and were therefore unsuitable for examining the aims of this thesis.212  
The concentration index212,214,215 can discriminate between a situation where the most 
deprived are the sickest and where the least deprived are the sickest whilst describing the 
gradient in inequality (the Gini index cannot and will arrive at the same answer in both of 
these situations). However, it can only be used where the socioeconomic categories can be 
ranked in strict hierarchical order, for example when using education or income as a 
measure of SED. This measure is not suitable for measures such as social class where this 
very strict ordering is not true. Multivariable measures do exist. Regression coefficients 
and Pearson’s correlation coefficients may be calculated to fully describe the relationship 
between SED and health.214 However, they require that the health outcome and scale used 
to measure socioeconomic status are continuous variables. As such they were not 
appropriate for use in the setting of survival analysis as in this thesis. Finally, the slope 
index of inequality and a transformation of this, the relative index of inequality may also 
be used to describe the frequency of a health outcome and socioeconomic 
category.212,214,215  However, the indices rely on the assumptions of linear regression, and, 
most importantly, that again the socioeconomic categories must be strictly hierarchical. 
Therefore, these indices are not useful in the current thesis as linear regression would not 
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be a valid technique for the analysis of survival times and the measures of SED are not 
strictly hierarchical.  
As noted above, in this thesis I will examine inequalities in outcomes through the rate ratio 
and comparison of the hazard ratio of the most versus the least deprived. The hazard ratio 
has a number of advantages over the other measures outlined above. Firstly, it is easily 
interpretable. Secondly, the technique of survival analysis can be employed which is the 
most appropriate method of analysing these longitudinal data. Thirdly, adjustment can be 
made for traditional risk factors in examining the relationship between CVD and SED 
which is difficult with the above techniques. Finally, none of the techniques outlined above 
allow the relationship between SED and an outcome to be compared across outcome types 
which can be done using the Cox model and this is one of the aims of the thesis. Survival 
analysis and rate ratios are also the most commonly used methods in the literature for 
examining health inequalities making the analyses in this thesis easily comparable. These 
advantages outweigh the limitation of this approach, that only the ends of the 
socioeconomic spectrum will be described and not the relationship across all categories. 
The proportional hazards assumption was tested using Schoenfeld residuals216 and was met 
for all variables in the model.   
 83 
Risk of a first Cardiovascular Hospitalisation 
In this section I will present the results of analyses examining the association between SED 
and the risk of a number of first cardiovascular hospitalisations after adjustment for a 
number of recognised risk factors. The relationship is examined using traditional methods 
of survival analysis and competing risks analysis to account for the risk of various different 
cardiovascular diseases. As a result, I aim to determine if SED is associated with a higher 
risk of certain cardiovascular outcomes. In addition, a range of composite endpoints will be 
examined including endpoints incorporating all cause mortality.  
Methods 
Introduction to the competing risks model 
Cox regression is a well studied and frequently used method of analysing the survival 
experience of a cohort. Standard survival data measure the time from one point until the 
event of interest occurs e.g. myocardial infarction or death. In a typical setting, such as 
clinical trial, the effect of an intervention such as a new pharmacotherapy that is thought to 
prevent the outcome of interest is examined on the time to outcome in relation to a gold 
standard treatment or more commonly placebo. In epidemiological studies data are 
obtained from observational studies such as the present cohort study. In such studies we 
are interested in the association between a variable (in this case SED) and the event of 
interest. However, in cohort studies (and indeed clinical trials) more than one type of event 
can occur during follow up and the variable under study may be associated with a higher 
risk of more than one type of event. This situation arises in the current study where SED is 
associated with multiple cardiovascular outcomes and also death. Whilst one event is 
usually chosen as the event of interest the occurrence of the other event may prevent the 
event of interest from occurring (e.g. death prevents an individual experiencing a 
myocardial infarction) or it may lead to a change in therapy that alters the risk of the event 
of interest from occurring (e.g. the prescription of secondary prevention following a 
myocardial infarction). Similarly, as in this thesis, we may be concerned with the 
relationship between a variable and a number of different outcomes. In such a situation 
caution should be exercised when estimating the probability of the event of interest 
occurring in the presence of these "competing risks". Treating the events of the competing 
causes as censored observations, as is done in standard survival analysis techniques such as 
Kaplan-Meier analysis, will lead to a bias in the Kaplan-Meier estimate if one of the 
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fundamental assumptions underlying the Kaplan-Meier estimate is violated: the 
assumption of independence of the time to event and the censoring distributions. The Cox 
proportional hazards model can still be used in this situation though interpretation of the 
results becomes more problematic. One other situation where the competing risks approach 
is of use is worthy of mention at this point as I will not be expanding further on this in the 
thesis. Individuals throughout life, despite the best efforts of health care professionals, 
move between different states of ill-health and health. One simple example is that of a 
cancer that can be put into remission. An individual may start as "healthy", during follow 
up develop the cancer of interest and receive treatment and then enter remission. This 
individual may then move between the state of remission and disease throughout follow up 
or indeed die from the cancer at any point during follow up. A similar parallel in 
cardiovascular medicine would be angina. One may develop angina, receive 
revascularisation therapy and be free of angina though develop it again later in follow up 
whilst all the time being at risk of myocardial infarction. Therefore, instead of survival data 
or time-to-event data, data on the history of events are available. Multi-state models 
provide a framework that allow for the analysis of such event history data and they can be 
seen as an extension of competing risk models.217 I will not examine multistate models in 
this thesis though more detail can be found elsewhere.217 
Bias of the Kaplan Meier estimates 
The need for the competing risk approach comes from the finding that in certain situations 
the Kaplan-Meier approach is flawed because the assumptions of the technique are violated 
in this setting. The assumption of independence of the censoring distribution, i.e. the 
distribution of the time to the competing events is violated in a competing events situation. 
Putter et al 218succinctly state that "If the competing event time distributions were 
independent of the distribution of time to the event of interest, this would imply that at each 
point in time the hazard of the event of interest is the same for subjects that have not yet 
failed and are still under follow-up as for subjects that have experienced a competing event 
by that time. However, a subject that is censored because of failure from a competing risk 
will with certainty NOT experience the event of interest. Since subjects that will never fail 
are treated as if they could fail (they are censored), the naive Kaplan-Meier overestimates 
the probability of failure (and hence underestimates the corresponding survival 
probability)." An example is censoring people who die during follow up when examining a 
non-fatal event. This is theoretically different from censoring due to end of study or loss to 
follow-up. In the latter situation, individuals may still fail at a later time point. In such a 
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situation the naive Kaplan-Meier estimates describe what would happen if the competing 
event could be prevented, thus creating an imaginary world in which an individual remains 
at risk for failure from the event of interest. These issues have been the subject of debate in 
the literature though it is now accepted that in the presence of competing risks the Kaplan-
Meier estimates are biased. Putter et al218 in their paper explore the issues in much greater 
detail than I am able to do so here, and they are also succinctly discussed by Rao and 
Schoenfeld in another article 219.  
The analysis of competing risk data 
As noted the competing risks approach makes the used of traditional methods such as the 
Kaplan-Meier estimate problematic. Instead the presentation of cumulative survival curves 
is the preferred method for presenting these analyses. The mathematical derivation of 
cumulative incidence curves is beyond the scope of this thesis but is eloquently explained 
through worked examples by Putter et al218. In essence however the cumulative incidence 
curves are simply plots of the proportion of patients with the event of interest or the 
competing event as time progresses. In Kaplan-Meier analysis the two curves or groups of 
interest can be compared using a log-rank test and the association between the outcome 
and variable of interest examined using a Cox regression analysis whilst adjusting for other 
risk factors. In a competing risks situation, the equivalent steps are to generate cumulative 
incidence curves then test the difference between cumulative incidence curves using the 
Fine and Gray220 method, and perform a competing risk regression analysis. Again for the 
same reasons that the Kaplan-Meier plot is not suitable in this situation the standard Cox 
proportional hazards model analysis is not adequate in the presence of competing risks. 
This is because the cause-specific Cox model treats the competing risks of the event of 
interest as censored observations. To overcome this problem two methods of regression 
analysis have been proposed in the setting of competing risks, regression on cause-specific 
hazards, which will be used in this thesis, and regression on the cumulative incidence 
functions.  
Regression on the cause-specific hazards 
If the covariate is continuous or association between the cause-specific event is of interest, 
a competing risks analogue of a Cox proportional hazards model is possible as the 
regression on the cause-specific hazards is possible. In proportional hazards regression on 
the cause-specific hazards, we model the cause-specific hazard of cause k for a subject 
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with covariate vector Z, observation time t as  
 
 One advantage of this method over that of regression on the cumulative incidence 
functions is that the equality of covariate effects across different events or outcomes can be 
assessed. It is this feature of regression on the cause-specific hazards that will be utilised in 
this thesis to determine if the effect of SED on the risk of a cardiovascular event is equal 
across a number of different cardiovascular event types.  
Regression on the cumulative incidence functions 
Fine and Gray220 described a method to perform a regression directly on cumulative 
incidence functions that are calculated in a competing risk analysis.  
The Fine and Gray regression does not yet allow the flexibility (e.g. in testing for or 
assuming equality of covariate effects across different failures or events) of regression on 
cause-specific hazards. Given this limitation of this approach in not allowing the equality 
of covariate effects across different events, the Fine and Gray method is not used here.  
Implementation of the technique 
Both techniques are available in standard statistical packages. The method of Fine and 
Gray, regression on cumulative incidence is implemented in R using the cmprsk command. 
However, I have used the stcompet module in Stata to implement the regression on cause-
specific hazards in this thesis. Further information on implementing this command can be 
found online at http://www.stata.com/support/faqs/stat/stmfail.html.  
The use of composite endpoints to deal with competing 
risks 
One method of examining competing risks that has not been discussed above is the use of 
composite endpoints. The use of composite endpoints is widespread in the medical 
literature. They are commonly used to examine an outcome of interest in the presence of 
 87 
other outcomes of interest or competing outcomes such as death. Their use is widely 
debated in the medical literature.221-224 They can be useful from a number of standpoints: 
1. To decrease the sample size required to show and effect of the treatment in a clinical 
trial 
2. To examine the totality of effect of a therapy or association with a variable. 
3. To deal with competing risks 
I will concentrate on their third use above, that of a method to deal with competing risks. 
For example, if we take the scenario of a study of patients with angina, an endpoint of 
hospitalisation for myocardial infarction would be problematic as it does not account for 
death. In such an analysis deaths would be censored, however these deaths are 
‘‘informative’’. A patient who is censored due to death is not at the same risk of 
hospitalisation, had they survived, as a patient who survived as long and is still at risk for 
hospitalisation but say censored because they emigrated and left the study. If censoring 
because of death varied by groups of interest, the estimate of effect would be biased. 
Therefore, a composite of death or myocardial infarction hospitalisation is used. Therefore, 
in this thesis I also examine composite endpoints to assess the impact of SED on 
cardiovascular outcomes.  
The impact of regression dilution 
During the multivariable regression analyses, follow up was taken until the end of the 
study i.e. 28 years. For first hospitalisations models were also constructed at 5 year 
intervals up until this point. From the results of the multivariable analysis there was 
evidence of regression dilution when analyses were extended past 25 years. Regression 
dilution is a phenomenon that occurs when the association between a variable and outcome 
is underestimated because of the long period of time between the measurement of the 
variable and the occurrence of the event of interest.225 Whilst methods exist to account for 
regression dilution bias, given the magnitude of the potential loss to follow up by limiting 
analyses to a period where regression dilution was not occurring (i.e. the loss of 3 years of 
follow up), limiting the length of follow up was the most appropriate method. This did not 
alter the conclusions of the studies and removed this bias. Therefore, univariable and 
survival analyses are limited to 25 years of follow up. Hazard ratios for 28 years of follow 
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up are presented in the table of regression analyses of first cardiovascular hospitalisations 
to demonstrate this phenomenon. 
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Results  
 
Model Building and baseline characteristics of the cohort 
Model Building  
Prior to commencing analyses of the association between SED and cardiovascular disease 
a multivariable model was built and variables associated with the development of 
cardiovascular disease were examined. Individuals with no prior history suggestive of 
CHD were identified. Prior CHD was defined by a positive answer to the questions on MI 
in Rose questionnaire or definite angina as defined by the Rose questionnaire or ECG 
findings compatible with previous MI (Q waves or left bundle branch block). The outcome 
of admission for CVD was used as the endpoint in the model building stage.  Initially 
variables which have been consistently associated with cardiovascular risk were entered 
into the model to adjust for their variable distribution between socioeconomic groups. 
Next, variables that are not considered “traditional” risk factors but have previously been 
shown to be associated with CVD, body mass index, adjusted FEV1 , history of bronchitis 
and cardiomegaly, were entered into the model. Backwards stepwise regression was used 
to determine those additional variables that would be adjusted for in further analyses after 
adjustment for the “traditional” cardiovascular risk factors outlined in Table 15.  The 
significance level of the likelihood ratio test of these variables is given in Table 15 for SED 
measured by Carstairs Morris index of deprivation and Table 16 for SED measured by 
social class. 
Table 15 Significance level of cardiovascular risk factors in a multivariable model when 
Carstairs Morris index is used as a measure of socioeconomic deprivation 
Variable P 
Carstairs Morris index 0.0022 
Age <0.0001 
Sex  <0.0001 
Diabetes <0.0001 
Smoking <0.0001 
Cholesterol <0.0001 
Systolic blood pressure  <0.0001 
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Table 16 Significance level of cardiovascular risk factors in a multivariable model when 
social class is used as a measure of socioeconomic deprivation 
Variable P 
Social Class 0.0066 
Age <0.0001 
Sex  <0.0001 
Diabetes 0.0007 
Smoking <0.0001 
Cholesterol <0.0001 
Systolic blood pressure  <0.0001 
 
The relative contribution of these factors to the model can be measured using the Chi 
squared distribution and is given in Table 17. As can be seen from the Chi square value the 
largest contributor to the model is systolic blood pressure followed by age. These two 
variables contributed most to the model when modelling all cause cardiovascular 
hospitalisation. As can be seen from the values SED as measured by the Carstairs Morris 
index made a greater contribution to the model than either cholesterol or diabetes.  
A similar pattern was seen when social class was used as the measure of SED.  This was a 
greater contributor to the model than diabetes (Table 18). 
Table 17 Contribution of each variable to the multivariable model when Carstairs Morris 
index is used to measure socioeconomic deprivation  
Variable Chi 
Systolic blood pressure  225.1 
Age 178.4 
Sex  150.7 
Smoking 116 
Carstairs Morris Index 31.2 
Cholesterol 18.4 
Diabetes 9.6 
 
 
Table 18 Contribution of each variable to the multivariable model when Social Class is used 
to measure socioeconomic deprivation 
Variable Chi 
Systolic blood pressure  222.8 
Age 182.4 
Sex  140.8 
Smoking 125.9 
Cholesterol 23.7 
Social Class 16.1 
Diabetes 14.4 
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As noted above the contribution of each of the variables to the model was again tested for a 
model that included the variables of BMI, adjusted FEV1, history of bronchitis and 
cardiomegaly on chest x-ray. This was examined both for Carstairs Morris index of 
deprivation (Table 19) and social class (Table 20) as measures of deprivation.  
Table 19 Significance level of variables in the multivariable model with Carstairs Morris 
index as the measure of deprivation after stepwise selection of additional risk factors 
Variable P 
Carstairs Morris Index 0.0022 
Age <0.0001 
Sex  <0.0001 
Diabetes <0.0001 
Smoking <0.0001 
Cholesterol <0.0001 
Systolic blood pressure <0.0001 
BMI 0.0004 
FEV1 <0.0001 
Bronchitis 0.0013 
Cardiomegaly  <0.0001 
 
 
Table 20 Significance level of variables in the multivariable model with Social Class as the 
measure of deprivation after stepwise selection of additional risk factors  
Variable P 
Social Class 0.035 
Age <0.0001 
Sex  <0.0001 
Diabetes <0.0001 
Smoking <0.0001 
Cholesterol <0.0001 
Systolic blood pressure  <0.0001 
BMI 0.0003 
FEV1 <0.0001 
Bronchitis 0.0009 
Cardiomegaly  <0.0001 
 
 
 
Interactions 
Finally, for each of the main types of cardiovascular hospitalisation, interactions between 
age and sex and SED measured using the Carstairs Morris index and social class were 
examined (Table 21 and 22). No interactions were found with the exception of that 
between social class and age. This was the only interaction found, it was not congruent 
with the Carstairs Morris index or strongly suggested by previous literature and therefore it 
was not entered into the models.  
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Table 21 P value of interactions between age and sex with socioeconomic deprivation 
measured by Carstairs Morris index 
 Deprivation Age  Deprivation Sex 
CVD 0.6693 0.4215 
MI 0.5575 0.2446 
Stroke 0.3041 0.1364 
HF 0.4129 0.8635 
CHD  0.2151 0.8368 
 
 
 
Table 22 P value of interactions between age and sex with socioeconomic deprivation 
measured by social class 
 Social Class Age  Social Class Sex 
CVD 0.7379 0.9768 
MI 0.0069 0.1529 
Stroke 0.9696 0.2513 
HF 0.7923 0.8454 
CHD  0.7307 0.0709 
 
 
Baseline characteristics 
The baseline characteristics of the cohort according to SED are outlined in table 23 and 24 
according to both Carstairs Morris index and social class.  
As can be seen from Table 23 a number of variables were statistically significantly 
distributed unevenly across categories of the Carstairs Morris index. For example, mean 
age in the least deprived was 54.9 years and 54.6 in the most deprived (P<0.001). Similarly 
cholesterol and body mass index varied across groups and reached statistical significance. 
Each of systolic blood pressure, adjusted FEV1, the proportion of men, smokers, those 
with cardiomegaly and bronchitis was also statistically significantly different across each 
group.  
When individuals were split by social class mean age in the most deprived was higher than 
the least deprived. Similarly systolic blood pressure, adjusted FEV1, the proportion of 
men, smokers, those with cardiomegaly or bronchitis was also statistically significantly 
different across social groups. Cholesterol and body mass index were also statistically 
significantly different.  
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Missing data 
No variables were clinically significantly different between those with missing SED by 
Carstairs Morris index and those assigned SED (Table 20). Those with missing social class 
had a slightly higher blood pressure (149.3mmHg (SD 24.3mmHg)) than those who has 
social class assigned (151.8 (SD 25.8)), P=0.04. They were also less men, P<0.001 and less 
smokers, P<0.001. All other variables were not different between those with and without 
social class assigned.  
In those with missing social class there were fewer men, smokers, and less with 
cardiomegaly (Table 24).  
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Table 23 Baseline characteristics of individuals according to Carstairs Morris index of deprivation 
  1  3  4  5  6 & 7  P Missing  P 
  Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   54.9 (5.5) 53.7 (5.5) 54.0 (5.5) 53.7 (5.5) 54.6 (5.6) <0.001 53.6 (5.7) 0.3 
Systolic BP (mmHg)   148.9 (23.7) 149.4 (23.6) 145.5 (23.1) 151.3 (24.4) 147.9 (24.2) <0.001 145.8 (23.1) 0.55 
Cholesterol (mmol/l)   6.1 (1.0) 6.2 (1.0) 6.2 (1.0) 6.1 (1.1) 6.1 (1.0) <0.001 6.3 (1.0) 0.48 
Body mass index (kg/m2)   25.3 (3.6) 25.4 (3.7) 25.5 (3.8) 25.8 (4.0) 25.9 (4.3) <0.001 25.9 (2.8) 0.98 
adjusted FEV1 (% predicted)   97.7 (22.0) 95.7 (20.5) 92.8 (22.2) 91.8 (22.0) 88.2 (23.0) <0.001 97.1 (27.9) 0.15 
 
 N  % N  % N  % N  % N  %  N  %  
Men  363        (42.2) 830      (47.1) 1,236      (44.2) 2,100      (45.9) 1,213 (43.4) 0.03 20 (66.7) 0.01 
Smoker     597      (60.3) 1,281      (61.5) 2,242      (67.0) 3,837      (69.3) 2,402         (70.9) <0.001 20 (58.8) 0.28 
Diabetes  7         (0.7) 28         (1.3) 40         (1.2) 69         (1.3) 46  (1.4) 0.6 7 (0.5) 0.51 
Cardiomegaly  251                (25.4) 451 (21.6) 749      (22.4) 1,322        (23.9) 930 (27.4) <0.001 6 (23.1) 0.81 
Bronchitis    24                 (2.4) 68 (33) 154        (4.6) 276        (4.9) 231          (6.8) <0.001 2 (5.8) 0.79 
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Table 24 Baseline characteristics of individuals according to Social Class 
  I  II  III (NM)  III (M)  IV  V  P Missing  P 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   52.9 (5.1) 53.6 (5.4) 53.8 (5.5) 54.2 (5.6) 54.8 (5.4) 54.5 (5.8) <0.001 54.5 (5.8) 0.04 
Systolic BP (mmHg)   146.1 (20.9) 146.7 (23.0) 147.7 (23.6) 150.1 (23.7) 149.0 (24.7) 151.6 (26.0) <0.001 151.2 (24.81) 0.04 
Cholesterol (mmol/l)   6.2 (1.0) 6.2 (1.0) 6.3 (1.1) 6.0 (1.1) 6.1 (1.1) 6.1 (1.0) <0.001 6.1 (1.2) 0.58 
Body mass index (kg/m2)   25.2 (3.4) 25.6 (3.6) 25.2 (3.8) 26.0 (3.9) 25.8 (4.1) 26.2 (4.6) <0.001 25.2 (4.2) 0.08 
adjusted FEV1 (% predicted) 99.5 (21.3) 97.4 (21.2) 95.1 (21.6) 90.6 (21.9) 89.4 (22.4) 87.0 (23.1) <0.001 90.5 (22.6) 0.08 
 
 N  % N  % N  % N  % N  %    N  %  
Men  302        (64.4) 829      (43.3) 673      (27.9) 2,302      (65.5) 1,274 (40.7) 326 (31.1) <0.001 56 (16.2) <0.001 
Smoker     296      (63.1) 1,199      (62.6) 1,459      (60.7) 2,557      (72.7) 2,114         (67.6) 726         (69.3) <0.001 185 (53.6) <0.001 
Diabetes  5         (1.1) 22         (1.2) 20         (0.8) 34  (0.9) 36  (1.2) 14  (1.3) 0.77 6 (1.8) 0.08 
Cardiomegaly  70                (15.4) 374 (20.6) 549      (23.6) 775        (25.8) 302 (29.7) 773 (25.8) <0.001 93 (27.7) 0.26 
Bronchitis    3                 (0.6) 30 (1.6) 49   (2.0) 139       (3.9) 110          (3.5) 52          (4.8) <0.001 7 (2.0) 0.78 
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Study participants 
Of the 15,344 cohort members (which excludes 24 individuals who were lost to follow up) 
with an assigned deprivation category, 2,594 were excluded from the present analyses as 
they had a history of ischaemic heart disease, leaving 5,742 men and 7,053 women in the 
analyses. Of the 14,995 assigned to social class, 2,475 were excluded with a history of 
ischaemic heart disease (leaving 5,706 men and 6,774 women). 
The numbers of each type of first cardiovascular hospitalisation experienced by each 
deprivation group is outlined in Table 25 according to Carstairs Morris index and Table 26 
according to social class.  
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Table 25 Number of cardiovascular hospitalisations by Carstairs Morris 
index category and years of follow up 
 Years 1 3 4 5 6 & 7 
CVD 5 49 93 145 224 170 
 10 85 188 289 503 388 
 15 152 305 494 848 612 
 20 211 450 732 1295 878 
 25 273 594 956 1646 1060 
       
CHD 5 18 29 32 84 59 
 10 25 58 76 195 136 
 15 51 111 159 339 233 
 20 71 182 256 526 333 
 25 89 239 346 679 408 
       
MI 5 13 24 28 75 46 
 10 20 49 61 174 114 
 15 42 84 130 291 186 
 20 59 136 200 419 250 
 25 70 174 256 510 304 
       
Stroke 5 4 6 17 31 23 
 10 12 34 44 88 68 
 15 23 62 88 180 127 
 20 37 101 173 308 218 
 25 64 159 261 447 307 
       
HF 5 3 1 6 12 9 
 10 7 5 16 34 24 
 15 14 19 42 86 55 
 20 29 40 80 167 118 
 25 42 64 135 251 169 
 
Table 26 Number of cardiovascular hospitalisations by social class and 
years of follow up 
 Years I II III M III NM IV V 
CVD 5 19 100 129 206 153 64 
 10 35 196 264 444 367 124 
 15 62 340 422 740 597 206 
 20 105 515 646 1066 871 297 
 25 143 680 837 1311 1082 380 
        
CHD 5 8 30 38 83 43 19 
 10 13 62 84 175 112 40 
 15 21 128 147 311 206 72 
 20 38 194 245 450 315 108 
 25 55 266 320 553 405 136 
        
MI 5 6 24 29 75 35 16 
 10 11 51 70 157 94 31 
 15 18 103 117 265 168 57 
 20 28 150 189 366 244 79 
 25 43 186 235 432 302 101 
        
Stroke 5 1 9 13 29 16 13 
 10 6 23 35 83 72 25 
 15 9 51 81 142 134 49 
 20 25 100 150 237 221 83 
 25 38 157 221 345 321 130 
        
HF 5 1 4 2 12 8 4 
 10 4 7 9 26 25 12 
 15 6 25 29 71 58 22 
 20 14 53 62 135 124 40 
 25 20 97 100 200 173 59 
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Rates of cardiovascular hospitalisations  
The rate of non-fatal cardiovascular hospital discharges, after 25 years of follow up, was 
highest amongst the most deprived compared to the least deprived rate ratio (RR) = 1.48 
(95% confidence interval (CI) 1.23-1.61) (Figure 4). The strongest inverse relationship 
appeared to be between stroke and SED, RR most deprived vs. least deprived = 
1.75(95%CI 1.34-2.29), although 95% confidence intervals overlapped substantially. 
Similar results were observed when social class was examined as the measure of SED 
(Figure 5)  
Figure 4 Rate of cardiovascular events during 25 years of follow up by socioeconomic 
deprivation measured by Carstairs Morris index.  
Category 1 = least deprived, categories 6&7 = most deprived. RR = rate ratio with 95% confidence 
interval, CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure 
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Figure 5 Rate of cardiovascular events during 25 years of follow up by social class  
Class I=least deprived, Class V=most deprived. RR = rate ratio with 95% confidence interval, CVD 
= all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial infarction, 
Stroke = stroke, HF = chronic heart failure. 
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Unadjusted Kaplan Meier survival 
Survival from enrolment to experiencing a cardiovascular hospitalisation discharge was 
analysed using the Kaplan Meier estimates of survival (Figures 6-16). SED was 
significantly associated with the risk of a CVD, CHD, MI, stroke and HF hospitalisations. 
The association was present when both Carstairs Morris index and social class were used 
as the measures of SED.  
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Figure 6 Kaplan Meier estimates of survival to a first cardiovascular 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 7 Kaplan Meier estimates of survival to a first cardiovascular 
hospitalisation by social class over 25 years of follow up 
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Figure 8 Kaplan Meier estimates of survival to a first coronary heart disease 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 9 Kaplan Meier estimates of survival to a first coronary heart disease 
hospitalisation by social class over 25 years of follow up 
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Figure 10 Kaplan Meier estimates of survival to a first myocardial infarction 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 11 Kaplan Meier estimates of survival to a first myocardial infarction 
hospitalisation by social class over 25 years of follow up 
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Figure 12 Kaplan Meier estimates of survival to a first stroke hospitalisation 
by Carstairs Morris index of deprivation over 25 years of follow up 
 
Figure 13 Kaplan Meier estimates of survival to a first stroke hospitalisation 
by social class over 25 years of follow up 
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Figure 14 Kaplan Meier estimates of survival to a first heart failure 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 15 Kaplan Meier estimates of survival to a first heart failure 
hospitalisation by social class over 25 years of follow up 
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Adjusted risk of cardiovascular hospitalisation 
The higher risk associated with higher deprivation was similar for each type of 
cardiovascular event, with the exception of HF where there was a weaker association. For 
example in the most deprived individuals (measured by Carstairs Morris index) the 
unadjusted risk of a non-fatal cardiovascular hospitalisation over 25 years was 42% higher 
than the least deprived (hazard ratio HR=1.42, 95% CI 1.24-1.62) (Table 27). Again stroke 
displayed one of the strongest gradients of association with SED with an approximate 
doubling of risk in the most versus least deprived. Whilst adjustment for “traditional” 
cardiovascular risk factors attenuated these associations, the relationship was clearly 
evident with all outcomes. Further adjustment for body mass index, FEV1 and 
cardiomegaly attenuated the relationship only slightly. The excess risk associated with 
higher SED was evident, albeit non-significant, after 5 years follow up, was clearer and 
significant by 10 years, and persisted over 25 years of follow up. Similar results were 
observed when social class was used as the measure of SED (Table 28). In analyses of both 
Carstairs Morris index and social class, by 28 years of follow up (i.e. until the end of 
follow up), the HR associated with SED started to fall. This most likely represents 
regression dilution. In subsequent models in this chapter, follow up for 25 years only is 
therefore presented.  
The results of the full models with the HR associated with each variable, in each model, 
are presented in Appendix 1. Only the results for the hospitalisations of any cardiovascular 
diseases are presented, however, results for the other outcomes analysed separately were 
similar.  
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Table 27 Unadjusted and adjusted risk of non-fatal cardiovascular hospitalisation over 28 years at 5 year intervals by Carstairs Morris index of deprivation 
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction, HF = heart failure 
  Unadjusted    Adjusted (“traditional” risk factors*)  Fully adjusted ** 
 
Follow 
up 
(years) HR 95% CI P  HR 95% CI P  HR 95%CI P 
CVD 5 1.07 0.78 1.48 0.656  1.02 0.74 1.40 0.904  0.97 0.70 1.35 0.855 
 10 1.46 1.15 1.85 0.002  1.38 1.09 1.75 0.007  1.34 1.05 1.71 0.019 
 15 1.33 1.12 1.59 0.001  1.28 1.07 1.53 0.007  1.22 1.01 1.46 0.035 
 20 1.45 1.25 1.69 <0.001  1.41 1.21 1.64 <0.001  1.33 1.14 1.56 <0.001 
 25 1.42 1.24 1.62 <0.001  1.39 1.21 1.58 <0.001  1.30 1.14 1.49 <0.001 
 28 1.36 1.20 1.54 <0.001  1.34 1.18 1.51 <0.001  1.27 1.11 1.44 <0.001 
                
CHD 5 1.02 0.60 1.72 0.955  1.02 0.60 1.72 0.955  0.97 0.56 1.67 0.905 
 10 1.73 1.13 2.65 0.012  1.65 1.08 2.53 0.022  1.62 1.04 2.50 0.032 
 15 1.51 1.12 2.05 0.008  1.45 1.07 1.96 0.017  1.45 1.06 1.98 0.021 
 20 1.63 1.26 2.10 <0.001  1.57 1.22 2.03 0.001  1.55 1.19 2.02 0.001 
 25 1.66 1.32 2.08 <0.001  1.61 1.28 2.02 <0.001  1.57 1.24 1.99 <0.001 
 28 1.55 1.25 1.91 <0.001  1.51 1.22 1.86 <0.001  1.46 1.18 1.81 0.001 
                
MI 5 1.10 0.59 2.03 0.767  1.04 0.56 1.92 0.903  1.08 0.57 2.04 0.824 
 10 1.81 1.13 2.92 0.014  1.73 1.07 2.78 0.024  1.77 1.08 2.88 0.023 
 15 1.46 1.04 2.03 0.028  1.38 0.99 1.93 0.058  1.42 1.00 2.01 0.049 
 20 1.45 1.09 1.92 0.011  1.39 1.04 1.84 0.024  1.40 1.04 1.88 0.026 
 25 1.53 1.18 1.99 0.001  1.48 1.14 1.92 0.003  1.49 1.14 1.95 0.004 
 28 1.48 1.16 1.89 0.002  1.43 1.12 1.83 0.004  1.43 1.11 1.84 0.005 
                
Stroke 5 1.78 0.62 5.15 0.286  1.74 0.60 5.05 0.305  1.55 0.53 4.55 0.424 
 10 1.80 0.98 3.33 0.059  1.73 0.94 3.20 0.079  1.56 0.84 2.90 0.16 
 15 1.82 1.16 2.83 0.009  1.78 1.14 2.78 0.011  1.53 0.98 2.40 0.063 
 20 2.04 1.44 2.89 <0.001  2.04 1.44 2.90 <0.001  1.87 1.31 2.68 0.001 
 25 1.75 1.34 2.29 <0.001  1.78 1.36 2.33 <0.001  1.60 1.22 2.11 0.001 
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 28 1.66 1.31 2.12 <0.001  1.71 1.34 2.17 <0.001  1.56 1.22 2.00 <0.001 
                
HF 5 0.93 0.25 3.44 0.916  0.88 0.24 3.25 0.846  0.88 0.18 4.19 0.87 
 10 1.09 0.47 2.54 0.836  1.03 0.44 2.40 0.938  0.78 0.31 1.95 0.6 
 15 1.30 0.72 2.34 0.379  1.26 0.70 2.27 0.436  1.05 0.56 1.99 0.869 
 20 1.42 0.95 2.13 0.089  1.41 0.94 2.12 0.097  1.11 0.73 1.70 0.628 
 25 1.48 1.05 2.07 0.024  1.49 1.06 2.09 0.022  1.22 0.86 1.74 0.258 
 28 1.32 0.98 1.78 0.066  1.34 0.99 1.80 0.055  1.10 0.81 1.49 0.555 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Table 28 Unadjusted and adjusted risk of non-fatal cardiovascular events over 28 years at 5 year intervals by social class 
Hazard ratio for social class V (most deprived) versus I (least deprived). RR= rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary 
heart disease, MI = acute myocardial infarction, HF = chronic heart failure 
  Unadjusted     Adjusted (“traditional” risk factors)*  Fully adjusted*  
 
Follow 
Up 
(Years) HR 95% CI P  HR 95% CI P  HR 95% CI P 
CVD 5 1.55 0.93 2.58 0.095  1.64 0.98 2.75 0.061  1.68 0.96 2.93 0.07 
 10 1.68 1.15 2.44 0.007  1.69 1.16 2.46 0.007  1.63 1.10 2.42 0.015 
 15 1.63 1.23 2.17 0.001  1.67 1.26 2.23 <0.0001  1.63 1.21 2.20 0.001 
 20 1.44 1.15 1.80 0.001  1.48 1.19 1.86 0.001  1.40 1.11 1.76 0.005 
 25 1.40 1.16 1.70 0.001  1.44 1.19 1.75 <0.0001  1.36 1.11 1.66 0.003 
 28 1.36 1.14 1.63 0.001  1.40 1.17 1.68 <0.0001  1.31 1.08 1.57 0.005 
                
CHD 5 1.08 0.47 2.47 0.855  1.31 0.57 3.02 0.524  1.65 0.65 4.19 0.295 
 10 1.43 0.76 2.67 0.265  1.63 0.87 3.06 0.129  1.77 0.90 3.49 0.099 
 15 1.65 1.02 2.69 0.043  1.94 1.19 3.16 0.008  1.99 1.19 3.33 0.008 
 20 1.42 0.98 2.06 0.061  1.65 1.13 2.39 0.009  1.60 1.09 2.35 0.017 
 25 1.28 0.94 1.75 0.122  1.47 1.07 2.02 0.016  1.42 1.03 1.97 0.035 
 28 1.23 0.93 1.63 0.153  1.43 1.07 1.90 0.015  1.37 1.02 1.84 0.035 
                
MI 5 1.22 0.48 3.11 0.682  1.47 0.57 3.78 0.427  1.80 0.65 4.96 0.257 
 10 1.31 0.66 2.60 0.443  1.49 0.75 2.99 0.255  1.65 0.80 3.38 0.175 
 15 1.52 0.89 2.58 0.121  1.77 1.04 3.01 0.037  1.82 1.05 3.14 0.033 
 20 1.40 0.91 2.16 0.124  1.64 1.06 2.53 0.026  1.61 1.03 2.51 0.036 
 25 1.20 0.84 1.71 0.323  1.41 0.98 2.02 0.061  1.39 0.96 2.02 0.078 
 28 1.22 0.88 1.71 0.23  1.44 1.03 2.01 0.032  1.41 1.00 1.99 0.049 
                
Stroke 5 5.95 0.78 45.48 0.086  4.99 0.65 38.49 0.123     0 
 10 1.97 0.81 4.79 0.137  1.39 0.57 3.41 0.471  1.44 0.54 3.81 0.462 
 15 2.65 1.30 5.39 0.007  1.99 0.97 4.07 0.059  1.91 0.90 4.07 0.093 
 20 1.68 1.08 2.63 0.023  1.41 0.90 2.22 0.134  1.29 0.81 2.06 0.276 
 25 1.81 1.26 2.59 0.001  1.57 1.09 2.26 0.015  1.45 0.99 2.11 0.054 
 109 
 28 1.71 1.23 2.38 0.001  1.50 1.07 2.09 0.017  1.36 0.97 1.92 0.076 
                
HF 5 1.83 0.20 16.38 0.589  1.56 0.17 14.24 0.692  1.08 0.12 10.02 0.946 
 10 1.41 0.45 4.37 0.553  1.22 0.39 3.83 0.737  0.74 0.23 2.37 0.612 
 15 1.79 0.73 4.42 0.206  1.68 0.67 4.16 0.266  1.09 0.43 2.72 0.858 
 20 1.47 0.80 2.69 0.218  1.39 0.75 2.57 0.294  1.06 0.56 2.01 0.853 
 25 1.57 0.95 2.61 0.081  1.47 0.88 2.46 0.138  1.22 0.71 2.09 0.476 
 28 1.90 1.21 3.00 0.006  1.78 1.12 2.81 0.014  1.43 0.88 2.31 0.146 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Accounting for the impact of all cause mortality 
A number of composite outcomes incorporating all cause mortality were also examined. 
As with each individual cardiovascular disease type, the most deprived displayed higher 
rates of each of the composite outcomes (Tables 29 and 30 and Figures16 and 17). For 
example, the risk of a non-fatal cardiovascular hospitalisations or all cause mortality was 
higher in the most deprived vs. the least deprived measured using Carstairs Morris index  
RR=1.44(95%CI 1.30-1.59). Similarly the higher unadjusted risk associated with SED was 
observed for each of the composite outcomes (Table 31), for example the unadjusted 
hazard of death or cardiovascular disease was HR=1.44 (95%CI 1.31-1.59). The 
association again persisted after adjustment for “traditional” major cardiovascular risk 
factors and following the addition of further risk factors (Table 31). Again, similar results 
were seen using social class as the measure of SED (Table 32). 
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Table 29 Number of events by composite outcome according to Carstairs Morris index of deprivation 
  1 3 4 5 6 & 7 
Death/CVD 5 25/49 64/93 99/145 191/224 120/170 
 10 59/85 155/188 249/289 430/503 292/388 
 15 104/152 248/305 429/494 716/848 507/612 
 20 160/211 370/450 619/732 999/1295 727/878 
 25 232/273 475/594 811/956 1334/1646 928/1060 
       
Death/CHD 5 31/18 75/29 113/32 224/84 148/59 
 10 73/25 188/58 303/76 523/195 385/136 
 15 135/51 328/111 558/159 921/339 682/233 
 20 220/71 490/182 833/256 1375/526 1025/333 
 25 330/89 667/239 1156/346 1918/679 1377/408 
       
Death/ MI 5 32/13 75/24 113/28 225/75 151/46 
 10 76/20 189/49 306/61 524/174 391/114 
 15 193/42 335/84 563/130 932/291 695/186 
 20 225/59 506/136 851/200 1404/419 1055/250 
 25 336/70 694/174 1190/256 1988/510 1421/304 
       
Death/Stroke 5 34/4 75/6 113/17 233/31 151/23 
 10 80/12 193/34 311/44 547/88 397/68 
 15 147/23 339/62 566/88 963/180 714/127 
 20 236/37 517/101 857/173 1445/308 1059/218 
 25 335/64 705/159 1164/261 2001/447 1410/307 
       
Death/ HF 5 32/3 78/1 117/6 240/12 161/9 
 10 78/7 206/5 321/16 570/34 425/24 
 15 148/14 361/19 594/42 1022/86 757/55 
 20 237/29 554/40 901/80 1523/167 1127/118 
 25 348/42 760/64 1246/135 2121/251 1503/169 
       
Death/ MI / Stroke 5 31/13/4 72/24/6 107/27/17 211/75/27 137/45/20 
 112 
 10 71/19/12 174/49/33 287/60/43 486/172/76 348/112/64 
 15 127/41/23 302/84/58 508/128/85 834/288/155 616/181/121 
 20 205/57/37 447/135/93 752/195/161 1234/409/265 916/240/202 
 25 297/66/60 599/170/142 1020/245/244 1712/495/388 1209/290/281 
       
Death/ CHD / Stroke 5 30/18/4 72/29/6 107/30/17 21/84/27 137/58/20 
 10 69/24/11 173/58/33 285/74/43 485/193/76 342/135/63 
 15 124/50/22 295/111/58 504/156/83 824/336/153 64/227/120 
 20 201/69/36 432/179/91 736/249/158 1209/512/260 890/321/197 
 25 292/85/59 575/233/139 991/333/235 1657/659/373 1172/392/271 
       
Death/ MI / Stroke/ HF 5 28/9/4/2 72/17/6/1 107/22/16/6 205/45/28/12 133/40/20/8 
 10 67/14/11/6 172/97/33/5 282/46/41/15 468/119/89/32 336/87/64/23 
 15 118/33/22/12 289/63/59/18 488/96/80/41 798/206/159/80 587/134/120/53 
 20 190/46/35/27 426/98/93/36 714/146/154/76 1153/297/275/158 856/177/204/112 
 25 273/54/61/40 564/127/148/60 961/187/236/126 1589/372/396/237 1118/213/286/160 
       
Death/ CHD / Stroke/ HF 5 27/13/4/2 72/22/1/6 107/24/16/6 204/51/28/12 130/51/20/8 
 10 65/18/11/6 171/45/33/5 281/55/41/15 467/136/83/32 330/106/64/23 
 15 115/41/22/12 282/85/59/18 485/115/80/41 790/242/159/80 575/174/120/53 
 20 186/55/35/27 413/136/94/35 702/186/154/76 1135/377/275/158 834/244/204/112 
 25 269/69/61/40 543/183/149/59 941/251/236/126 1553/496/396/237 1087/299/286/160 
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Table 30 Number of events by composite outcome according to social class 
  
I II III N III M IV V 
Death/CVD 5 12/19 61/100 77/129 158/206 117/153 57/64 
 10 35/35 125/196 169/264 391/444 298/367 126/124 
 15 60/62 227/340 285/422 638/740 529/597 197/206 
 20 93/105 346/515 406/646 903/1066 761/871 273/297 
 25 119/143 476/680 593/837 1155/1311 984/1082 347/380 
        
Death/CHD 5 15/8 72/30 94/38 190/83 137/43 64/19 
 10 42/13 153/62 213/84 490/175 376/112 151/40 
 15 72/21 298/128 378/147 830/311 703/206 258/72 
 20 12/38 472/194 590/245 1221/450 1046/315 375/108 
 25 164/55 693/266 878/320 1636/553 1426/405 504/136 
        
Death/ MI 5 15/6 73/24 95/29 192/75 137/35 65/16 
 10 43/11 154/51 215/70 493/157 381/94 154/31 
 15 73/18 303/103 386/117 841/265 712/168 267/57 
 20 123/28 484/150 608/189 1247/366 1072/244 385/79 
 25 172/43 720/186 909/235 1686/432 1469/302 520/101 
        
Death/Stroke 5 15/1 70/9 93/13 199/29 139/16 71/13 
 10 43/6 158/23 224/35 513/83 389/72 157/25 
 15 75/9 320/51 391/81 879/142 727/134 260/49 
 20 120/25 501/100 619/150 1311/237 1084/221 368/83 
 25 173/38 727/157 906/221 1732/345 1439/321 497/130 
        
Death/ HF 5 15/1 75/4 97/2 206/12 142/8 74/4 
 10 43/4 167/7 234/9 540/26 406/25 166/12 
 15 74/6 337/25 417/29 925/71 768/58 277/22 
 20 126/14 524/53 671/62 1361/135 1134/124 402/40 
 25 182/20 761/97 985/100 1821/200 1533/173 540/59 
        
Death/ MI / Stroke 5 14/0/6 66/24/9 89/29/12 179/75/25 130/34/15 61/15/13 
 114 
 10 40/11/4 140/51/23 201/34/68 448/156/76 351/92/66 142/30/23 
 15 68/18/7 270/103/50 350/114/72 753/263/131 636/164/122 235/55/46 
 20 107/28/20 430/146/94 529/183/130 1106/362/217 944/233/200 332/76/77 
 25 148/42/33 623/179/145 777/225/197 1464/421/310 1256/288/286 438/96/119 
        
Death/ CHD / Stroke 5 14/8/0 65/30/9 88/38/12 177/82/25 130/42/15 60/18/13 
 10 40/13/3 139/62/23 199/173/76 446/173/76 346/110/66 139/39/23 
 15 68/21/6 265/128/50 342/145/71 744/307/130 627/201/121 230/70/44 
 20 106/38/19 420/190/92 512/240/126 1084/439/213 920/302/198 323/104/75 
 25 143/54/30 599/259/140 748/311/192 1427/535/299 1218/389/279 425/129/114 
        
Death/ MI / Stroke/ HF 5 13/5/0/1 64/18/9/4 87/21/12/2 175/50/26/10 127/24/14/8 60/14/13/4 
 10 38/9/3/4 136/41/23/7 197/48/33/9 435/114/79/23 337/65/69/25 140/23/23/11 
 15 65/13/6/6 257/74/50/25 339/86/73/26 718/195/133/66 603/117/119/56 225/45/45/21 
 20 100/22/19/14 403/109/92/52 504/140/133/57 1036/265/222/123 877/164/197/119 315/60/77/39 
 25 138/33/32/20 576/139/144/93 733/174/195/94 1365/314/322/184 1162/208/289/165 405/76/119/5613 
        
Death/ CHD / Stroke/ HF 5 13/6/0/1 63/23/9/4 86/27/12/2 173/57/26/10 127/30/14/8 59/17/13/4 
 10 38/10/3/4 135/50/23/7 195/59/33/9 433/128/79/23 333/79/69/25 137/31/23/11 
 15 65/14/6/6 252/94/50/25 331/111/73/26 711/231/133/66 595/147/119/56 220/56/45/21 
 20 100/28/19/14 394/144/93/51 488/188/133/57 1020/327/222/123 860/216/197/119 307/84/77/39 
 25 136/40/32/20 557/201/145/92 709/247/195/94 1341/401/322/184 1134/288/289/165 394/104/119/56 
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Figure 16 Rate of composite cardiovascular events during 25 years of follow up by socioeconomic deprivation measured by Carstairs Morris index deprivation 
category  
Category 1 = least deprived, categories 6&7 = most deprived. RR = rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary heart 
disease, MI = acute myocardial infarction, Stroke = stroke, HF = chronic heart failure. 
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Figure 17 Rate of composite events during 25 years of follow up by social class 
Class I=least deprived, Class V=most deprived, RR = rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure.  
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Table 31 Unadjusted and adjusted risk of composite endpoints with death 
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived).  CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction, Stroke = stroke, HF = chronic heart failure. 
    Unadjusted       Adjusted (“traditional” risk factors*)   Fully adjusted ** 
  Years HR 95% CI P   HR 95% CI P   HR 95%CI P 
Death or CVD 5 1.21 0.94 1.57 0.136  1.16 0.90 1.50 0.254  1.08 0.83 1.40 0.58 
 10 1.51 1.26 1.81 <0.001  1.45 1.21 1.73 <0.001  1.34 1.12 1.62 0.002 
 15 1.45 1.27 1.66 <0.001  1.40 1.22 1.60 <0.001  1.30 1.13 1.49 <0.001 
 20 1.51 1.35 1.69 <0.001  1.47 1.31 1.65 <0.001  1.37 1.22 1.54 <0.001 
  25 1.44 1.31 1.59 <0.001   1.42 1.28 1.56 <0.001   1.31 1.19 1.45 <0.001 
Death or CHD 5 1.31 0.96 1.79 0.089  1.25 0.92 1.71 0.155  1.17 0.85 1.61 0.342 
 10 1.70 1.37 2.10 <0.001  1.64 1.32 2.03 <0.001  1.49 1.19 1.85 <0.001 
 15 1.63 1.39 1.90 <0.001  1.58 1.35 1.85 <0.001  1.45 1.24 1.71 <0.001 
 20 1.62 1.43 1.84 <0.001  1.59 1.40 1.81 <0.001  1.47 1.29 1.67 <0.001 
  25 1.55 1.40 1.73 <0.001   1.54 1.38 1.71 <0.001   1.41 1.27 1.58 <0.001 
Death or MI 5 1.36 0.98 1.88 0.064  1.30 0.94 1.80 0.111  1.22 0.87 1.70 0.246 
 10 1.66 1.34 2.06 <0.001  1.61 1.29 2.00 <0.001  1.47 1.17 1.83 0.001 
 15 1.59 1.35 1.86 <0.001  1.54 1.32 1.81 <0.001  1.42 1.20 1.67 <0.001 
 20 1.57 1.38 1.78 <0.001  1.54 1.35 1.75 <0.001  1.42 1.24 1.62 <0.001 
  25 1.52 1.36 1.69 <0.001   1.51 1.36 1.68 <0.001   1.39 1.24 1.55 <0.001 
Death or Stroke 5 1.42 1.00 2.02 0.05  1.36 0.96 1.94 0.083  1.24 0.87 1.78 0.235 
 10 1.61 1.28 2.01 <0.001  1.56 1.25 1.95 <0.001  1.39 1.11 1.75 0.005 
 15 1.62 1.37 1.91 <0.001  1.58 1.34 1.87 <0.001  1.42 1.20 1.68 <0.001 
 20 1.60 1.40 1.82 <0.001  1.59 1.39 1.81 <0.001  1.45 1.27 1.66 <0.001 
  25 1.54 1.38 1.72 <0.001   1.55 1.39 1.73 <0.001   1.41 1.26 1.58 <0.001 
Death or HF 5 1.51 1.05 2.17 0.027  1.45 1.00 2.08 0.047  1.30 0.90 1.89 0.166 
 10 1.68 1.33 2.12 <0.001  1.63 1.29 2.05 <0.001  1.45 1.14 1.84 0.002 
 15 1.64 1.39 1.94 <0.001  1.61 1.36 1.90 <0.001  1.44 1.21 1.71 <0.001 
 20 1.60 1.40 1.82 <0.001  1.58 1.39 1.81 <0.001  1.43 1.24 1.63 <0.001 
  25 1.53 1.37 1.71 <0.001   1.54 1.38 1.72 <0.001   1.39 1.24 1.56 <0.001 
Death/MI/Stroke 5 1.31 0.95 1.79 0.097  1.25 0.91 1.72 0.162  1.18 0.85 1.63 0.317 
 118 
 10 1.64 1.33 2.03 <0.001  1.59 1.28 1.96 <0.001  1.45 1.17 1.80 <0.001 
 15 1.59 1.36 1.85 <0.001  1.54 1.32 1.81 <0.001  1.42 1.21 1.67 <0.001 
 20 1.57 1.38 1.78 <0.001  1.54 1.36 1.75 <0.001  1.43 1.26 1.63 <0.001 
  25 1.52 1.37 1.69 <0.001   1.52 1.36 1.69 <0.001   1.40 1.25 1.56 <0.001 
Death/CHD/Stroke  5 1.26 0.93 1.71 0.131  1.21 0.89 1.64 0.216  1.13 0.83 1.55 0.425 
 10 1.66 1.35 2.05 <0.001  1.60 1.30 1.97 <0.001  1.45 1.17 1.80 0.001 
 15 1.61 1.38 1.88 <0.001  1.56 1.34 1.83 <0.001  1.44 1.23 1.68 <0.001 
 20 1.60 1.42 1.82 <0.001  1.58 1.39 1.78 <0.001  1.46 1.29 1.66 <0.001 
  25 1.54 1.39 1.71 <0.001   1.53 1.38 1.70 <0.001   1.41 1.27 1.57 <0.001 
                
Death/MI/Stroke/HF 5 1.45 1.05 2.02 0.026  1.40 1.00 1.94 0.047  1.29 0.92 1.80 0.137 
 10 1.66 1.34 2.07 <0.001  1.61 1.30 2.00 <0.001  1.45 1.17 1.81 0.001 
 15 1.60 1.36 1.87 <0.001  1.56 1.33 1.82 <0.001  1.42 1.21 1.67 <0.001 
 20 1.56 1.38 1.77 <0.001  1.54 1.36 1.75 <0.001  1.42 1.25 1.62 <0.001 
  25 1.51 1.36 1.67 <0.001   1.50 1.35 1.67 <0.001   1.38 1.24 1.54 <0.001 
Death/CHD/Stroke/HF 5 1.41 1.03 1.94 0.034  1.36 0.98 1.87 0.062  1.25 0.90 1.73 0.181 
 10 1.67 1.35 2.07 <0.001  1.61 1.30 2.00 <0.001  1.45 1.17 1.81 0.001 
 15 1.61 1.38 1.88 <0.001  1.57 1.34 1.83 <0.001  1.43 1.22 1.68 <0.001 
 20 1.60 1.42 1.82 <0.001  1.58 1.39 1.79 <0.001  1.46 1.28 1.66 <0.001 
  25 1.53 1.38 1.70 <0.001   1.53 1.38 1.69 <0.001   1.40 1.26 1.56 <0.001 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Table 32. Unadjusted and adjusted risk of composite endpoints with death at 5 year intervals  
Hazard ratio for social class V (most deprived) versus I (least deprived). (CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure)   
 
  Unadjusted    Adjusted (“traditional” risk factors)*   Fully adjusted**   
 Years HR 95% CI P  HR 95% CI P  HR 95% CI P 
Death or CVD 5 1.79 1.21 2.66 0.004  1.75 1.18 2.61 0.006  1.66 1.10 2.53 0.017 
 10 1.69 1.30 2.21 <0.0001  1.64 1.26 2.14 <0.0001  1.52 1.15 2.00 0.003 
 15 1.62 1.33 1.99 <0.0001  1.61 1.31 1.98 <0.0001  1.47 1.19 1.81 <0.0001 
 20 1.47 1.25 1.73 <0.0001  1.47 1.25 1.73 <0.0001  1.33 1.13 1.57 0.001 
  25 1.47 1.28 1.69 <0.0001  1.46 1.27 1.68 <0.0001  1.33 1.15 1.54 <0.0001 
Death or CHD 5 1.64 1.04 2.61 0.035  1.56 0.98 2.48 0.061  1.55 0.95 2.54 0.082 
 10 1.61 1.20 2.18 0.002  1.54 1.14 2.08 0.005  1.44 1.05 1.96 0.024 
 15 1.71 1.36 2.15 <0.0001  1.68 1.34 2.12 <0.0001  1.50 1.18 1.90 0.001 
 20 1.52 1.27 1.82 <0.0001  1.51 1.26 1.81 <0.0001  1.37 1.13 1.65 0.001 
  25 1.52 1.31 1.78 <0.0001  1.50 1.28 1.75 <0.0001  1.34 1.14 1.57 <0.0001 
Death or MI 5 1.76 1.09 2.85 0.021  1.66 1.02 2.69 0.041  1.61 0.97 2.66 0.066 
 10 1.59 1.18 2.16 0.003  1.51 1.12 2.06 0.008  1.41 1.03 1.93 0.033 
 15 1.70 1.34 2.14 <0.0001  1.66 1.31 2.10 <0.0001  1.46 1.15 1.86 0.002 
 20 1.53 1.28 1.84 <0.0001  1.52 1.26 1.83 <0.0001  1.36 1.13 1.65 0.001 
  25 1.49 1.28 1.75 <0.0001  1.47 1.25 1.71 <0.0001  1.31 1.12 1.54 0.001 
Death or Stroke 5 2.41 1.41 4.11 0.001  2.11 1.23 3.62 0.006  1.89 1.08 3.29 0.025 
 10 1.75 1.28 2.40 0.001  1.56 1.13 2.14 0.006  1.38 1.00 1.91 0.052 
 15 1.78 1.40 2.27 <0.0001  1.65 1.29 2.10 <0.0001  1.42 1.11 1.82 0.005 
 20 1.56 1.30 1.88 <0.0001  1.49 1.24 1.80 <0.0001  1.33 1.09 1.61 0.004 
  25 1.55 1.33 1.81 <0.0001  1.47 1.26 1.72 <0.0001  1.32 1.12 1.55 0.001 
Death or HF 5 2.23 1.30 3.82 0.004  1.93 1.12 3.32 0.017  1.74 0.99 3.04 0.052 
 10 1.77 1.29 2.45 <0.0001  1.61 1.16 2.22 0.004  1.42 1.02 1.98 0.037 
 15 1.80 1.41 2.31 <0.0001  1.69 1.32 2.17 <0.0001  1.45 1.13 1.87 0.004 
 20 1.58 1.31 1.92 <0.0001  1.52 1.25 1.84 <0.0001  1.34 1.10 1.63 0.004 
  25 1.54 1.32 1.81 <0.0001  1.47 1.25 1.72 <0.0001  1.31 1.11 1.55 0.001 
Death/MI/Stroke 5 2.04 1.26 3.32 0.004  1.93 1.19 3.15 0.008  1.77 1.07 2.92 0.026 
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 10 1.66 1.23 2.24 0.001  1.56 1.15 2.11 0.004  1.41 1.04 1.92 0.028 
 15 1.75 1.39 2.20 <0.0001  1.69 1.34 2.13 <0.0001  1.47 1.16 1.86 0.001 
 20 1.57 1.31 1.88 <0.0001  1.56 1.30 1.87 <0.0001  1.39 1.15 1.67 0.001 
  25 1.53 1.31 1.78 <0.0001  1.51 1.29 1.76 <0.0001  1.35 1.15 1.58 <0.0001 
Death/CHD/Stroke  5 1.89 1.19 3.01 0.007  1.81 1.13 2.89 0.013  1.70 1.04 2.78 0.034 
 10 1.68 1.25 2.26 0.001  1.59 1.18 2.14 0.002  1.44 1.06 1.96 0.02 
 15 1.75 1.40 2.20 <0.0001  1.72 1.36 2.16 <0.0001  1.50 1.19 1.90 0.001 
 20 1.55 1.30 1.85 <0.0001  1.54 1.29 1.85 <0.0001  1.38 1.15 1.66 0.001 
  25 1.54 1.33 1.80 <0.0001  1.53 1.31 1.78 <0.0001  1.36 1.17 1.59 <0.0001 
Death/MI/Stroke/HF 5 2.20 1.34 3.61 0.002  2.04 1.24 3.36 0.005  1.86 1.12 3.11 0.017 
 10 1.71 1.27 2.31 <0.0001  1.59 1.17 2.15 0.003  1.43 1.05 1.95 0.024 
 15 1.81 1.44 2.29 <0.0001  1.75 1.38 2.21 <0.0001  1.50 1.18 1.91 0.001 
 20 1.60 1.34 1.92 <0.0001  1.58 1.32 1.90 <0.0001  1.40 1.16 1.68 <0.0001 
 25 1.55 1.33 1.80 <0.0001  1.53 1.31 1.78 <0.0001  1.37 1.17 1.60 <0.0001 
 Death/CHD/Stroke/HF 5 2.13 1.32 3.46 0.002  2.00 1.23 3.26 0.005  1.91 1.14 3.18 0.013 
 10 1.72 1.28 2.32 <0.0001  1.61 1.19 2.18 0.002  1.46 1.07 1.99 0.016 
 15 1.83 1.45 2.30 <0.0001  1.78 1.41 2.25 <0.0001  1.55 1.22 1.97 <0.0001 
 20 1.60 1.34 1.91 <0.0001  1.59 1.33 1.90 <0.0001  1.42 1.18 1.71 <0.0001 
 25 1.57 1.35 1.82 <0.0001  1.56 1.34 1.81 <0.0001  1.39 1.19 1.62 <0.0001 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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In a competing risk multivariable regression (Table 33), the most deprived (measured 
using Carstairs Morris index) displayed a higher risk of a cardiovascular hospitalisation 
than the least deprived (HR=1.47 95%CI 1.27-1.69), whilst also exhibiting a higher risk of 
all cause mortality (HR=1.41, 95%CI 1.24-1.61) before adjustment for the “traditional” 
risk factors. This association persisted after adjustment so that the most deprived were at 
higher risk of cardiovascular events than the least deprived (HR=1.45 95%CI 1.26-1.68) 
whilst still displaying a higher risk of all cause mortality (HR= 1.39 95%CI 1.24-1.58). 
Again, similar results were observed when social class was used to determine SED (Table 
34) 
Comparison of the association of SED with different 
cardiovascular events 
Although the relationship between SED and various cardiovascular outcomes were broadly 
similar it appeared that the relationship with stroke was strongest. This was formally tested 
in a competing events analysis between all coronary heart disease and stroke, and, 
myocardial infarction and stroke (Tables 33 and 34). The unadjusted risk of coronary heart 
disease was higher in the most versus least deprived HR=1.67 (95%CI 1.33-2.12) whilst 
the risk of stroke was also higher HR=1.72 (95%CI 1.29-2.28). When these hazards were 
formally tested no statistically significant difference was found indicating the risk 
associated with socioeconomic deprivation and coronary heart disease is not statistically 
different from that with stroke. The relationship did not change after adjustment. The risk 
associated with SED was also not different when myocardial infarction was compared with 
stroke. Whilst the association with HF was the weakest this could not be tested due to a 
lack of statistical power.  
This comparison is displayed graphically in the cumulative incidence curves for death and 
cardiovascular disease (Figures 18 and 19), coronary heart disease and stroke (Figures 20 
and 21) and myocardial infarction and stroke (Figures 22 and 23). As can be seen from the 
plots the relationship between SED and each outcome is similar as tested by the competing 
risks analysis. 
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Table 33. Unadjusted and adjusted risk of non-fatal cardiovascular events as composite endpoints and in a competing risk model by Carstairs Morris index  
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction. 
 
N  
Category 6&7 
Events 
Category 6&7 Unadjusted  95% CI 
Adjusted 
(“traditional” 
risk factors*) 95% CI 
Fully 
adjusted ** 95% CI 
Death or CVD 2796 1060 deaths, 928 CVD 1.47 1.28 1.69 1.46 1.27 1.68 1.33 1.15 1.54 
Competing risk  
(Death and CVD)           
Death 2796 1060 1.41 1.24 1.61 1.39 1.24 1.58 1.30 1.13 1.49 
CVD 2796 928 1.47 1.27 1.69 1.45 1.26 1.68 1.32 1.14 1.53 
            
CHD or Stroke 2796 392 CHD, 271 Stroke 1.69 1.41 2.02 1.67 1.21 1.71 1.60 1.33 1.92 
Competing risk 
 (CHD or Stroke) 
          
CHD 2796 392 1.67 1.33 2.12 1.62 1.28 2.05 1.60 1.26 2.04 
Stroke 2796 271 1.72 1.29 2.28 1.74 1.31 2.30 1.58 1.19 2.11 
            
MI or Stroke 2796 290 MI, 281 Stroke 1.64 1.35 1.99 1.62 1.33 1.96 1.56 1.28 1.9 
Competing risk  
(MI or Stroke)           
MI 2796 290 1.56 1.19 2.03 1.50 1.15 1.96 1.52 1.15 2.00 
Stroke 2796 281 1.73 1.31 2.29 1.75 1.33 2.32 1.60 1.20 2.13 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
 
 
 
 
 
 
 
 123 
Table 34 Unadjusted and adjusted risk of non-fatal cardiovascular events as composite endpoints and in a competing risk model by social class 
Hazard ratio for social class V (most deprived) versus social class I (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction 
 
N  
Social Class V 
Events  
Social Class V Unadjusted  95% CI 
Adjusted 
(“traditional” 
risk factors*) 95% CI 
Fully 
adjusted ** 95% CI 
Death or CVD 1301 
347 deaths,  
380 CVD 1.40 1.16 1.70 1.58 1.23 2.02 1.48 1.15 1.92 
Competing risk  
(Death and CVD)           
Death 1301 347 1.40 1.16 1.70 1.44 1.19 1.75 1.35 1.11 1.66 
CVD 1301 380 1.55 1.26 1.91 1.47 1.20 1.82 1.30 1.05 1.60 
            
CHD or Stroke 1301 
176 CHD, 
137 Stroke 1.52 1.19 1.95 1.58 1.23 2.02 1.39 1.00 1.93 
Competing risk 
 (CHD or Stroke)           
CHD 1301 176 1.24 0.91 1.71 1.45 1.05 1.99 1.60 1.26 2.04 
Stroke 1301 137 2.03 1.35 3.03 1.75 1.17 2.63 1.59 1.05 2.41 
            
MI or Stroke 1301 
131 MI,  
144 Stroke 1.50 1.15 1.95 1.54 1.78 2.00 1.45 1.11 1.91 
Competing risk  
(MI or Stroke)           
MI 1301 131 1.17 0.82 1.68 1.39 0.97 2.00 1.37 0.94 2.00 
Stroke 1301 144 1.92 1.30 2.81 1.66 1.13 2.46 1.50 1.01 2.24 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Figure 18 Cumulative incidence curve for death and all cardiovascular 
disease according to Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Cumulative incidence curve for death and all cardiovascular 
disease according to social class 
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Figure 20 Cumulative incidence curve for coronary heart disease and 
stroke according to Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 Cumulative incidence curve for coronary heart disease and 
stroke according to social class 
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Figure 22 Cumulative incidence curve for myocardial infarction and stroke 
according Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23 Cumulative incidence curve for myocardial infarction and stroke 
according to social class 
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Discussion 
In this large prospective cohort study of men and women in the West of Scotland the risk 
of cardiovascular hospitalisation was higher in the most deprived. This association was 
persisted following adjustment for a number of “traditional” risk factors and importantly, 
the risk of a number of different forms of cardiovascular disease was higher in the most 
deprived. This risk was present despite the most deprived also being at a higher risk of all 
cause mortality. Finally, SED conferred a higher risk of a cardiovascular hospitalisation 
over a long period, 28 years. 
Comparison of cardiovascular outcomes 
Previous studies have examined cardiovascular outcomes in isolation 61,105,125 or composite 
cardiovascular outcomes56,59. Socioeconomic deprivation is associated with a higher risk of 
myocardial infarction61, coronary heart disease59, stroke99,105 and heart failure125. However, 
this is the first study to compare the risk associated with SED on a number of 
cardiovascular outcomes in one single population. There was no statistical difference in the 
risk associated with SED and the cardiovascular outcome studied. This may suggest that 
the mechanism by which SED confers its higher risk (and there is debate as to how this 
occurs38,169) is via a mechanism that may be shared by each disease type. The finding 
would also suggest that any interventions aimed at improving the socioeconomic 
conditions of an individual may have the opportunity to reduce the risk of a number of 
cardiovascular diseases rather than one in particular.  
Adjustment for “traditional” cardiovascular risk factors 
In these analyses the risk associated with SED persisted after adjusting for “traditional” 
cardiovascular risk factors 140 of age, sex, smoking status, cholesterol, diabetes and systolic 
blood pressure.  The relationship was evident after adjusting for further risk factors such as 
body mass index, FEV1 and cardiomegaly on a chest x-ray. Obviously this would suggest 
that I was unable to adjust for the factors that confer the excess risk, but as noted 
previously, it is unclear what these causal pathways are.38,169 In a large study of 22,688 
participants in the Women’ health study, adjustment for a number of novel risk factors 
indicative of inflammation ( C-reactive protein, intracellular adhesion molecule-1, 
fibrinogen and homocysteine), on top of the “traditional” risk factors of smoking, 
cholesterol, diabetes etc., did not completely attenuate the risk of CVD related to level of 
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education.71 This finding in conjunction with that of mine and other authors38,40,142,226 
would suggest that the risk associated with SED is not completely mediated via traditional 
or even novel risk factors. 
Prolonged excess risk 
In the present study, the risk associated with low SED was evident after 5 years of follow 
up and persisted as individuals were followed through 28 years. Whilst others have 
reported such long lasting effects of SED on ischaemic heart disease mortality40 few have 
examined the relationship with non-fatal cardiovascular outcomes over such long follow 
up123. The present analyses demonstrate that the excess risk is higher for a number of 
different types of cardiovascular disease and that the risk persists over a long period of 
time. However, there was evidence of regression dilution bias in the results at 28 years of 
follow up225. The cohort was not re-screened during follow up, and, therefore, I was not 
able to examine the effect of changing risk factor profiles on outcomes. Instead of using a 
correction technique for regression dilution I truncated follow up at 25 years to limit the 
observed impact of this bias. It is therefore possible that the risk of CVD associated with 
SED was underestimated in these analyses.225  
The increased risk of death 
Socioeconomic deprivation is associated with higher all cause31 and cardiovascular 
mortality7,32,227,228, therefore it is possible that the risk of non-fatal cardiovascular disease 
may be underestimated in this group as they succumb to fatal disease before they can 
experience a non-fatal event. I have reported that the risk of a number of composite 
cardiovascular events which included all cause mortality is higher in the most deprived. 
However, composite endpoints are only one method to account for the competing risk of 
death. In a further analysis where a competing events analysis was performed, despite a 
higher risk of all cause mortality, the risk of a cardiovascular hospitalisation was still 
higher in the most deprived as compared to the least deprived individuals. This suggests 
that the risk of cardiovascular hospitalisations is still higher despite the increased risk of 
death that the most deprived experience. 
Summary  
Socioeconomic deprivation as measured by an area based score and social class is 
associated with an increased risk of cardiovascular hospitalisations, irrespective of the 
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disease type studied. In the multivariable models, SED was as significant contributor to the 
model, as much as the traditional risk factors. The risk associated with SED is evident after 
adjustment for multiple cardiovascular risk factors and is present over a prolonged period 
of follow up. Furthermore, the most deprived are at a higher risk of cardiovascular events 
despite also being at a higher risk of all cause mortality.  
In the next chapter I will go on to describe the results of analyses examining the impact of 
SED on the risk of a recurrent hospitalisation following this first cardiovascular 
hospitalisation. 
 130 
Recurrent hospitalisations and subsequent 
survival 
Introduction and aims 
The literature surrounding the relationship between SED and cardiovascular disease is 
sparse in relation to recurrent (as opposed to “first” or “incident”) cardiovascular events. 
While some data do exist on the risk of recurrent myocardial infarction76,92,94 and 
stroke105,117, only one study has examined the association between SED and readmission 
with heart failure126. No studies have examined the relationship in one cohort making 
comparison difficult. Finally, many studies have either performed unadjusted analyses or 
have adjusted for a number of different risk factors, again making comparison between 
studies difficult. In this chapter I will explore the relationship between SED and the risk of 
a subsequent cardiovascular hospitalisation. I will also examine the relationship between 
SED and subsequent survival following a first cardiovascular hospitalisation. Finally, I will 
explore the risk of suffering a subsequent cardiovascular hospitalisation in a composite 
outcome taking into account of death. 
Methods 
For each of the analyses presented the time of origin was specified as the time at which a 
person experienced a non-fatal cardiovascular hospitalisation. Age in the model was 
entered as the age at which the non-fatal cardiovascular hospitalisation occurred. Follow 
up continued to the point of a subsequent recurrent hospitalisation, or death, or a composite 
of these. Cox proportional hazards models were used to model these outcomes again 
adjusting for known cardiovascular risk factors. Of the cardiovascular risk factors smoking 
has one of the greatest potentials to change over time. In a study of men and women 
deprived women were more likely to quit smoking as they grew older than their least 
deprived counterparts.150 No association was seen in men.  Higher levels of education and 
occupation are associated with a higher likelihood of smoking cessation following an 
admission to a coronary care unit.229 Therefore to explore this potential bias, a sensitivity 
analysis was conducted using models with and without smoking in the model. 
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Results  
Baseline characteristics 
The characteristics of those individuals that had experienced a cardiovascular 
hospitalisation during follow up were analysed according to SED.  
Cardiovascular disease 
Of those that experienced a cardiovascular hospitalisation during follow up, when SED 
was measured using Carstairs Morris index the most deprived were more likely to be 
smokers, have bronchitis and have a lower FEV1 (Table 35). Whilst other variables were 
statistically significantly different across SED groups, none showed a clear gradient of 
change. When social class was used as the measure of SED the most deprived were older, 
had higher systolic blood pressure, were less likely to be men and more likely to have 
cardiomegaly and bronchitis (Table 36).  
The individuals who suffered a cardiovascular admission but could not be assigned a 
Carstairs Morris index deprivation category were more likely to have a history of 
bronchitis though the magnitude of this difference was negligible as numbers were small 
(Table 35). Those who were not assigned a social class that suffered a cardiovascular 
admission had higher blood pressure and were less likely to be men or smokers (Table 36). 
 
Coronary Heart Disease 
In statistical testing there were significant differences in the baseline characteristics of 
individuals according to Carstairs Morris index that experienced a coronary heart disease 
hospitalisation during follow up (Table 37). The same was observed using social class as 
the measure of SED, that the most deprived were older, had higher blood pressure, were 
less likely to be men but more likely to be smokers (Table 38).  
Those with missing SED defined by Carstairs Morris index or social class were not 
different to those who were assigned a deprivation category by either classification system 
with the exception that those missing a social class classification were again less likely to 
be men. 
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Table 35 Characteristics of individuals with a non-fatal CVD hospitalisation according to Carstairs Morris index 
  1  3  4  5  6 & 7  P Missing  P 
N  320  711  1097  1912  1163   11   
  Mean SD Mean SD 
Mea
n SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   55.2 (5.5) 54.0 (5.4) 54.1 (5.6) 53.7 (5.5) 54.7 (5.7) <0.001 53.6 (5.7) 0.89 
Systolic BP (mmHg)   153.3 (24.0) 151.7 (24.2) 147.6 (24.0) 154.2 (25.2) 150.7 (25.1) <0.001 148.3 (27.7) 0.87 
Cholesterol (mmol/l)   6.2 (1.1) 6.2 (1.0) 6.2 (1.0) 6.2 (1.1) 6.2 (1.0) 0.29 6.3 (1.0) 0.70 
Body mass index (kg/m2)   25.7 (3.6) 25.6 (3.6) 25.7 (3.9) 26.3 (4.1) 26.4 (4.6) <0.001 26.7 (2.7) 0.99 
adjusted FEV1 (% predicted)   98.2 (20.7) 95.4 (20.4) 92.9 (21.1) 91.6 (21.4) 88.3 (22.7) <0.001 91.9 (34.2) 0.81 
 
 N  % N  % N  % N  % N  %  N  %  
Men  153        (47.8) 387      (54.4) 519      (47.3) 929 (48.5) 529 (45.4) 0.005 7 (63.7) 0.35 
Smoker     203      (63.4) 453 (63.7) 743 (67.7) 1345 (70.3) 858 (73.7) <0.001 20 (58.8) 0.25 
Diabetes  3         (0.9) 8         (1.1) 17         (1.6) 25         (1.3) 22  (1.9) 0.59 0 (0) 0.64 
Cardiomegaly  81               (26.2) 139 (20.0) 259      (24.9) 485 (26.3) 344 (31.1) <0.001 2 (25.0) 0.57 
Bronchitis    7                 (2.2) 17 (2.4) 26        (2.4) 47        (2.5) 63          (5.4) <0.001 1 (5.8) 0.09 
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Table 36 Characteristics of individuals with a non-fatal CVD hospitalisation according to social class 
 I  II  
III -
NM 
 III-M  IV  V 
 P 
Missing  
P 
N 169  782  989  1483  1246  422   123   
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   52.7 (5.5) 53.9 (5.4) 54.1 (5.5) 54.0 (5.5) 54.4 (5.7) 54.9 (5.5) 0.0002 54.8 (6.0) 0.48 
Systolic BP (mmHg)   148.1 (20.4) 149.4 (23.9) 150.4 (25.0) 152.1 (23.7) 151.9 (25.7) 155.8 (27.5) <0.001 156.8 (25.9) 0.01 
Cholesterol (mmol/l)   6.2 (1.0) 6.3 (1.0) 6.4 (1.1) 6.0 (1.0) 6.2 (1.1) 6.2 (0.9) <0.001 6.1 (1.0) 0.5 
Body mass index (kg/m2)   25.3 (3.3) 25.9 (3.8) 25.5 (3.8) 26.4 (3.8) 26.9 (4.9) 25.7 (4.4) <0.001 25.7 (4.4) 0.9 
adjusted FEV1 (% 
predicted) 98.0 (20.8) 96.5 (19.6) 94.5 (22.6) 90.5 (21.3) 88.5 (22.3) 90.2 (23.3) 
<0.001 
102.9 (20.1) 
0.5 
 N  % N  % N  % N  % N  % N  %  N  %  
Men 116       (68.6) 387     (49.5) 308     (31.1) 1022 (68.9) 535 (42.9) 134 (31.8) <0.001 22 (17.9) <0.001 
Smoker    110   (65.1) 518 (66.2) 637 (64.4) 1111 (74.9) 874 (70.1) 290 (68.7) <0.001 71 (57.7) 0.05 
Diabetes 3         (1.8) 11        (1.4) 10        (1.0) 15        (1.0) 23 (1.9) 9  (2.1) 0.27 4 (3.2) 0.12 
Cardiomegaly 33                (20.5) 174 (23.5) 242      (25.3) 347       (24.5) 341          (28.5) 133          (32.6) 0.001 40 (33) 0.08 
Bronchitis 2                (1.2) 12 (1.5) 20      (2.3) 56       (3.8) 49         (3.9) 20          (4.7) 0.001 2 (1.6) 0.66 
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Table 37 Characteristics of individuals with a non-fatal CHD hospitalisation according to Carstairs Morris index  
  1  3  4  5  6 & 7  P Missing  P 
N  108  296  406  788  1163   5   
  Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for trend 
(excluding 
missing SED) Mean SD 
Missing 
vs. rest 
Age (years)   54.7 (5.7) 53.5 (5.3) 53.4 (5.6) 53.4 (5.8) 54. (5.8) 0.009 56.6 (5.4) 0.29 
Systolic BP (mmHg)   152.3 (23.5) 152.5 (23.1) 147.5 (24.1) 152.6 (23.1) 151.4 (24.3) 0.009 148.3 (27.7) 0.95 
Cholesterol (mmol/l)   6.3 (1.1) 6.4 (1.0) 6.3 (1.1) 6.2 (1.2) 6.3 (1.0) 0.28 6.4 (0.9) 0.90 
Body mass index (kg/m2)   25.8 (3.6) 25.9 (3.6) 25.9 (3.8) 26.4 (3.8) 26.7 (4.8) 0.009 26.0 (2.7) 0.85 
adjusted FEV1 (% predicted)   97.4 (19.5) 97.5 (18.0) 93.1 (19.8) 92.5 (19.8) 89.2 (21.1) <0.001 82.8 (46.4) 0.37 
 
 N  % N  % N  % N  % N  %  N  %  
Men  62        (57.4) 182      (61.5) 223      (54.9) 425 (48.3) 232 (51.7) 0.15 4 (80.0) 0.24 
Smoker     77      (71.3) 203 (68.6) 295 (72.7) 566 (71.8) 346 (77.1) 0.12 5 (100) 0.17 
Diabetes  2         (1.9) 4         (1.4) 6         (1.5) 9         (1.1) 5  (1.1) 0.97 5 (0) 0.77 
Cardiomegaly  20                (19.2) 58 (19.8) 93      (23.7) 195 (25.6) 139 (32.3) 0.004 1 (20) 0.83 
Bronchitis    4                 (3.7) 6 (2.0) 9        (2.2) 20        (2.5) 19          (4.2) 0.29 1 (20) 0.14 
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Table 38 Characteristics of individuals with a non-fatal CHD hospitalisation according to social class 
 I  II  
III -
NM  III-M  IV  V 
 P 
Missing  
P 
N 69  305  377  635  467  158   41   
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   51.5 (5.7) 53.4 (5.2) 53.4 (5.5) 53.7 (5.5) 54.0 (5.7) 54.5 (5.5) 0.004 55.2 (6.0) 0.16 
Systolic BP (mmHg)   148.2 (22.1) 150.2 (23.6) 149.2 (22.5) 151.6 (22.6) 151.6 (25.1) 156.5 (26.9) 0.02 155.1 (20.5) 0.09 
Cholesterol (mmol/l)   6.1 (1.0) 6.4 (1.0) 6.5 (1.2) 6.2 (1.1) 6.2 (1.1) 6.3 (1.1) 0.001 6.0 (1.1) 0.5 
Body mass index (kg/m2)   25.6 (2.7) 26.1 (3.4) 25.4 (3.6) 26.8 (3.9) 26.4 (4.7) 27.0 (5.0) <0.001 24.8 (3.6) 0.3 
adjusted FEV1 (% 
predicted) 97.9 (18.9) 96.2 (18.6) 95.2 (22.2) 92.5 (21.3) 88.5 (21.1) 93.9 (19.2) <0.001 93.9 (19.2) 0.8 
 N  % N  % N  % N  % N  % N  %  N  %  
Men 53       (76.8) 187     (61.3) 145     (38.5) 459 (72.2) 233 (47.8) 49 (31.1) <0.001 12 (29.3) <0.001 
Smoker  47  (68.1) 213 (69.8) 258 (68.4) 492 (77.5) 341 (73.0) 112 (70.8) 0.02 29 (70.7) 0.9 
Diabetes 1         (1.5) 3        (1.0) 3    (1.0) 6        (1.0) 83 (1.7) 4  (2.5) 0.56 1 (2.4) 0.36 
Cardiomegaly 16                (24.6) 64 (22.1) 88      (24.0) 150       (24.3) 123          (27.2) 51 (33.3) 0.13 14 (35) 0.32 
Bronchitis 1                (1.5) 5 (1.6) 9      (2.4) 17       (2.7) 20         (4.3) 7          (4.4) 0.2 0 (0) 0.78 
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Acute myocardial infarction  
Of those that experienced a hospitalisation for myocardial infarction during follow up, the 
most deprived individuals, as measured by Carstairs Morris index were more likely to be 
smokers and also have a lower adjusted FEV1 and to have cardiomegaly (Table 39). When 
social class was used as the measure of SED the most deprived were older, had higher 
blood pressure , lower adjusted FEV1, and less likely to be male (Table 40). Of those who 
experienced a myocardial infarction admission during follow up, those who could not be 
assigned a SED category (either using Carstairs Morris index or social class) were not 
different with respect to baseline variables from those who could be assigned a SED 
category. The only exception was that those who were not assigned a social class were 
again less likely to be male. 
 
Stroke 
In the individuals who were discharged from hospital with a diagnosis of stroke the most 
deprived (measured by Carstairs Morris index) were more likely to have lower adjusted 
FEV1 and have cardiomegaly or bronchitis (Table 41). When social class was used to 
define SED, the most deprived were less likely to be men and have lower adjusted FEV1. 
Whilst other statistically significant differences were found they were not of clinically 
relevant magnitudes (Table 42). Again, no difference was found in those who were 
assigned a deprivation category by either method as compared to those who were not. The 
only exception was that those who were not assigned a social class were again less likely to 
be male. 
 
Heart failure 
A lower adjusted FEV1, younger age, lower systolic blood pressure and more 
cardiomegaly and bronchitis was observed in the most deprived who experienced an 
hospitalisation with HF as compared to the least deprived as measured by the Carstairs 
Morris index(Table 43). When social class was examined the most deprived had lower 
adjusted FEV1, were less likely to be men and had more bronchitis (Table 44). Again only 
the proportion of men in those unassigned a social class was statistically significantly 
different  
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Table 39 Characteristics of individuals with a non-fatal myocardial infarction hospitalisation according to Carstairs Morris index  
  1  3  4  5  6 & 7  P Missing  P 
N  81  204  290  566  332   2   
  Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excludin
g missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   54.5 (5.7) 53.8 (5.3) 53.7 (5.7) 53.4 (5.8) 54.5 (5.6) 0.25 58.5 (4.9) 0.28 
Systolic BP (mmHg)   152.4 (23.8) 152.2 (22.1) 148.3 (25.0) 154.1 (24.0) 151.7 (23.8) 0.02 145.0 (4.2) 0.7 
Cholesterol (mmol/l)   6.3 (1.0) 6.3 (1.1) 6.3 (1.0) 6.2 (1.3) 6.3 (1.0) 0.59 6.7 (1.3) 0.58 
Body mass index (kg/m2)   25.8 (3.6) 25.9 (3.4) 25.9 (3.8) 26.3 (3.9) 26.7 (4.7) 0.07 27.6 (0.2) 0.7 
adjusted FEV1 (% predicted)   97.2 (20.1) 96.9 (17.7) 92.9 (20.8) 93.5 (19.2) 88.8 (21.4) <0.001 75.7 (3.7) 0.3 
 
 N  % N  % N  % N  % N  %  N  %  
Men  49        (60.5) 133      (65.2) 170      (58.6) 318 (56.2) 181 (54.5) 0.14 1 (50) 0.85 
Smoker     59      (72.8) 144 (70.6) 211 (72.6) 422 (72.8) 269 (81.0) 0.04 2 (100) 0.4 
Diabetes  2         (2.7) 4         (1.9) 5         (1.7) 8         (1.4) 2  (0.6) 0.86 2 (100) 0.85 
Cardiomegaly  14                (18.8) 36 (17.8) 65      (22.7) 139 (25.5) 99 (30.9) 0.01 1 (50) 0.5 
Bronchitis   3                 (3.7) 5 (2.0) 6        (2.1) 18        (3.2) 16          (4.8) 0.36 21 (100) 0.7 
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Table 40 Characteristics of individuals with a non-fatal myocardial infarction hospitalisation outcome according to social class 
 I  II  
III -
NM 
 III-M  IV  V 
 P 
Missing  
P 
N 50  207  268  469  343  87   21   
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   50.6 (5.4) 53.7 (5.6) 53.6 (5.4) 54.3 (5.5) 54.3 (5.7) 54.8 (5.5) 0.0001 54.5 (5.6) 0.7 
Systolic BP (mmHg)   145.8 (22.1) 151.7 (23.9) 150.3 (22.5) 152.3 (22.8) 152.7 (25.7) 156.5 (26.5) 0.1 150.1 (17.3) 0.9 
Cholesterol (mmol/l)   6.1 (1.0) 6.4 (1.0) 6.5 (1.2) 6.1 (1.1) 6.3 (1.1) 6.4 (1.0) 0.002 6.2 (1.1) 0.6 
Body mass index (kg/m2)   25.6 (2.4) 26.1 (3.3) 25.5 (3.7) 26.5 (3.8) 26.4 (4.8) 26.6 (4.4) 0.01 24.6 (4.1) 0.23 
adjusted FEV1 (% 
predicted) 98.4 (20.2) 96.9 (18.6) 95.9 (21.2) 92.0 (18.8) 90.5 (22.1) 88.99 (22.1) 
<0.001 
90.9 (16.7) 
0.48 
 N  % N  % N  % N  % N  % N  %  N  %  
Men 40       (80.0) 131     (63.3) 115     (42.9) 345 (73.6) 174 (50.7) 42 (35.9) <0.001 5 (23.8) 0.0002 
Smoker  34  (68.0) 149 (72.0) 184 (68.7) 377 (80.4) 260 (75.8) 87 (74.5) 0.009 16 (76.2) 0.77 
Diabetes 1         (2.0) 2        (0.9) 3        (1.1) 5        (1.1) 6 (1.7) 3  (2.6) 0.79 1 (4.8) 0.61 
Cardiomegaly 9                (18.7) 44 (22.2) 64      (24.4) 111       (24.1) 87          (26.2) 33 (28.9) 0.67 64 (30) 0.99 
Bronchitis 1                (2.0) 3 (1.5) 8      (2.9) 14       (2.9) 16         (4.6) 6          (5.1) 0.3 0 (0) 0.46 
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Table 41 Characteristics of individuals with a non-fatal stroke hospitalisation according to Carstairs Morris index 
  1  3  4  5  6 & 7  P Missing  P 
N  81  216  340  546  356   4   
  Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excludin
g missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   55.8 (5.5) 55.0 (5.2) 55.4 (5.8) 54.6 (5.4) 56.1 (5.6) 0.003 54.5 (5.8) 0.27 
Systolic BP (mmHg)   156.1 (25.7) 154.6 (23.6) 149.3 (22.9) 158.6 (26.2) 154.9 (26.2) <0.001 130.8 (13.8) 0.2 
Cholesterol (mmol/l)   6.3 (1.2) 6.2 (1.1) 6.2 (1.0) 6.2 (1.1) 6.2 (1.1) 0.79 6.0 (1.3) 0.77 
Body mass index (kg/m2)   25.3 (3.5) 25.2 (3.5) 25.6 (3.5) 26.7 (4.2) 26.5 (4.5) <0.001 26.7 (2.2) 0.9 
adjusted FEV1 (% predicted)   98.1 (19.8) 93.9 (20.8) 93.6 (20.3) 90.4 (22.0) 88.9 (22.8) <0.001 102.9 (20.1) 0.4 
 
 N  % N  % N  % N  % N  %  N  %  
Men  29        (35.8) 109      (50.5) 151      (44.4) 254 (46.5) 128 (35.9) 0.002 3 (75) 0.11 
Smoker     48    (59.2) 138 (63.8) 227 (66.8) 375 (68.7) 238 (66.9) 0.4 2 (50) 0.7 
Diabetes  1         (1.2) 3         (1.4) 6         (1.7) 11        (2.0) 7  (1.9) 0.97 4 (100) 0.77 
Cardiomegaly  22                (27.9) 48 (22.5) 80      (24.9) 157 (29.7) 107 (32.0) 0.01 1 (25) 0.6 
Bronchitis  2                 (2.5) 4 (1.9) 7        (2.1) 15        (2.1) 23          (6.5) 0.005 4 (100) 0.1 
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Table 42 Characteristics of individuals with a non-fatal stroke hospitalisation according to social class 
 I  II  
III -
NM 
 III-M  IV  V 
 P 
Missing  
P 
N 47  200  280  428  404  146   38   
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   54.5 (5.5) 54.9 (5.4) 55.2 (5.6) 54.9 (5.5) 55.4 (5.7) 55.9 (5.3) 0.43 54.9 (5.8) 0.39 
Systolic BP (mmHg)   147.3 (20.7) 152.6 (23.7) 155.4 (27.3) 153.6 (23.7) 156.4 (26.1) 157.4 (26.5) 0.08 162.3 (24.4) 0.17 
Cholesterol (mmol/l)   6.2 (1.1) 6.3 (1.0) 6.1 (1.2) 6.2 (1.0) 6.3 (1.1) 6.3 (1.0) 0.015 6.2 (0.8) 0.57 
Body mass index (kg/m2)   25.0 (3.3) 25.8 (3.9) 25.6 (3.9) 26.2 (3.8) 26.6 (4.4) 26.2 (4.8) 0.009 26.3 (5.0) 0.31 
adjusted FEV1 (% 
predicted) 96.7 (17.3) 94.9 (21.1) 93.8 (22.0) 91.2 (21.0) 88.9 (21.5) 90.6 (23.1) 
0.004 
92.79 (26.3) 
0.59 
 N  % N  % N  % N  % N  % N  %  N  %  
Men 26       (55.3) 85   (42.5) 85    (30.4) 282 (65.9) 152 (37.6) 41 (28.1) <0.001 3 (7.9) <0.001 
Smoker  32  (68.0) 130 (65.0) 179 (63.9) 307 (71.7) 265 (65.8) 98 (67.1) 0.28 17 (44.7) 0.02 
Diabetes 1         (2.1) 7        (3.5) 6        (2.1) 4        (1.0) 5 (1.2) 3  (2.0) 0.28 2 (5.2) 0.11 
Cardiomegaly 10               (22.2) 47 (25.0) 80      (29.2) 103       (24.8) 121         (31.6) 38 (26.9) 0.27 16 (43.2) 0.021 
Bronchitis 1                (2.1) 4 (2.0) 7      (2.5) 17       (3.9) 13    (3.2) 8          (5.5) 0.47 1 (2.6) 0.82 
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Table 43 Characteristics of individuals with a non-fatal heart failure hospitalisation outcome according to Carstairs Morris index  
  1  3  4  5  6 & 7  P Missing  P 
N  56  91  173  327  195   2   
  Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excludin
g missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   57.3 (5.3) 55.3 (5.5) 54.9 (5.8) 54.6 (5.5) 55.5 (5.7) 0.003 61.5 (3.5) 0.27 
Systolic BP (mmHg)   159.8 (21.3) 154.4 (27.0) 149.4 (22.2) 157.9 (25.9) 154.2 (24.7) 0.004 197 (21.2) 0.02 
Cholesterol (mmol/l)   6.1 (0.9) 6.2 (1.0) 6.3 (1.0) 6.2 (1.2) 6.2 (1.0) 0.79 6.3 (0.9) 0.90 
Body mass index (kg/m2)   25.3 (3.5) 25.2 (3.5) 25.6 (3.5) 26.7 (4.2) 26.5 (4.5) <0.001 26.7 (2.2) 0.9 
adjusted FEV1 (% predicted)   98.1 (19.8) 93.9 (20.8) 93.6 (20.3) 90.4 (22.0) 88.9 (22.8) <0.001 102.9 (20.1) 0.4 
 
 N  % N  % N  % N  % N  %  N  %  
Men  28        (50.0) 44      (48.4) 85      (49.1) 163 (49.9) 92 (47.2) 0.98 1 (50) 0.98 
Smoker     35    (62.6) 568 (61.5) 121 (70.0) 237 (72.4) 139 (71.3) 0.4 2 (50) 0.7 
Diabetes  1         (1.2) 3         (1.4) 6         (1.7) 11        (2.0) 7  (1.9) 0.97 4 (100) 0.77 
Cardiomegaly  22                (27.9) 48 (22.5) 80     (24.9) 157 (29.7) 107 (32.0) 0.01 1 (25) 0.6 
Bronchitis  2                 (2.5) 4 (1.9) 7        (2.1) 15        (2.1) 23          (6.5) 0.005 4 (100) 0.1 
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Table 44 Characteristics of individuals with a non-fatal heart failure hospitalisation outcome according to social class 
 I  II  
III -
NM  III-M  IV  V 
 P 
Missing  
P 
N 24  127  139  243  214  82   15   
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Test for 
trend 
(excluding 
missing 
SED) Mean SD 
Missing 
vs. rest 
Age (years)   54.4 (5.8) 55.6 (5.6) 54.9 (5.8) 54.6 (5.5) 55.5 (5.7) 55.5 (5.6) 0.48 55.8 (5.9) 0.94 
Systolic BP (mmHg)   159.6 (24.4) 150.5 (23.7) 154.3 (27.3) 155.8 (24.3) 155.9 (25.3) 158.3 (27.4) 0.22 156.8 (30.4) 0.78 
Cholesterol (mmol/l)   6.0 (1.0) 6.3 (1.2) 6.3 (1.1) 6.1 (1.0) 6.3 (1.1) 6.2 (1.0) 0.044 5.9 (1.3) 0.86 
Body mass index (kg/m2)   27.1 (5.5) 26.8 (4.4) 26.6 (3.9) 27.4 (4.1) 26.9 (5.0) 28.8 (5.3) 0.012 25.3 (4.6) 0.49 
adjusted FEV1 (% 
predicted) 92.6 (21.3) 92.9 (19.5) 90.9 (23.4) 87.9 (22.6) 87.1 (22.1) 83.8 (24.8) 
0.035 
89.39 (24.9) 
0.27 
 N  % N  % N  % N  % N  % N  %  N  %  
Men 17       (70.8) 60   (47.2) 45    (32.8) 170 (70.0) 94 (43.9) 22 (26.8) <0.001 5 (33.3) 0.003 
Smoker  15  (62.5) 89 (70.1) 89 (64.0) 190 (78.2) 147 (68.7) 51 (62.2) 0.02 8 (53.3) 0.26 
Diabetes 1         (4.1) 0        (0) 1        (0.7) 3        (1.2) 9  (4.2) 2  (2.4) 0.06 0 (0) 0.42 
Cardiomegaly 5              (22.7) 43 (34.7) 46    (35.1) 76    (32.5) 71       (34.6) 30 (37.5) 0.84 76 (46.8) 0.24 
Bronchitis 0                (0) 3 (2.4) 2      (1.4) 14         (5.8) 17         (7.9) 3        (3.6) 0.04 0 (0) 0.93 
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The risk of recurrent hospitalisation 
Crude rates of recurrent hospitalisation 
The number of recurrent hospitalisations is outlined in Table 45 and 46. The rate of 
recurrent hospitalisation after an initial cardiovascular disease type by SED as measured by 
Carstairs Morris index is displayed in Figure 24. A trend towards higher rates of recurrent 
hospitalisation was seen for each initial disease type. The rate ratio (RR) for CVD was 1.03 
(95% CI 0.78-0.86), p=0.08. For CHD this was 1.28 (0.87-1.88), p=0.21, MI 1.21(0.65-
2.25) p=0.55, stroke=0.99 (0.97-1.62), p=0.97 and HF 1.12(0.64-1.93), p=0.13 (Table 
47).A similar trend was observed when social class was used as the marked of SED (Table 
48 and Figure 25). 
 
Table 45 Numbers of individuals according to Carstairs Morris index who experienced a 
recurrent cardiovascular admission  
1st 
hospitalisation 
Recurrent 
hospitalisation 1 3 4 5 6 & 7 
CVD CVD 149 335 533 908 547 
CHD CHD 31 116 152 271 159 
MI MI 12 45 63 113 57 
Stroke Stroke 20 41 87 116 83 
HF HF 16 23 55 95 60 
 
Table 46 Numbers of individuals according to social class who experienced a recurrent 
cardiovascular admission 
1st 
hospitalisation 
Recurrent 
hospitalisatio
n I II IIIN IIIM IV V 
CVD CVD 88 374 471 683 587 213 
CHD CHD 25 111 129 235 164 54 
MI MI 9 39 49 102 66 23 
Stroke Stroke 13 51 44 95 90 43 
HF HF 10 43 42 61 64 25 
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Table 47 Rate ratio of most versus least deprived (measured by Carstairs Morris index) for a 
recurrent cardiovascular hospitalisation 
1st 
hospitalisation 
Recurrent 
hospitalisation RR 
95% 
CI  P 
CVD CVD 1.03 0.86 1.23 0.77 
CHD CHD 1.28 0.87 1.89 0.20 
MI MI 1.21 0.65 2.26 0.54 
Stroke Stroke 0.99 0.61 1.61 0.97 
HF HF 1.11 0.64 1.93 0.72 
 
Table 48 Rate ratio of most versus least deprived (measured by social class) for a recurrent 
cardiovascular hospitalisation 
1st 
hospitalisation 
Recurrent 
hospitalisation RR 
95% 
CI  P 
CVD CVD 1.00 0.78 1.28 0.97 
CHD CHD 0.97 0.60 1.58 0.91 
MI MI 1.10 0.51 2.38 0.81 
Stroke Stroke 1.05 0.56 1.96 0.88 
HF HF 0.65 0.31 1.37 0.25 
 
 
Kaplan Meier Analysis of Recurrent cardiovascular hospitalisation 
In a Kaplan Meier analysis of recurrent cardiovascular hospitalisation there was no 
significant difference in the rates of recurrent cardiovascular disease hospitalisation 
according to SED measured by Carstairs Morris index or social class (Figures 26-35). 
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Figure 24 Rate of subsequent cardiovascular hospitalisation of the same type according to SED measured by Carstairs Morris index.  
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Figure 25 Rate of subsequent cardiovascular hospitalisation of the same type according to SED measured by social class 
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Figure 26 Kaplan Meier analysis of recurrent cardiovascular hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 Kaplan Meier analysis of recurrent cardiovascular hospitalisation 
over follow up according to social class 
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Figure 28 Kaplan Meier analysis of a recurrent coronary heart disease 
hospitalisation over up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 Kaplan Meier analysis of a recurrent coronary heart disease 
hospitalisation over follow up according to social class 
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Figure 30 Kaplan Meier analysis of recurrent myocardial infarction 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 Kaplan Meier analysis of recurrent myocardial infarction 
hospitalisation over follow up according to social class 
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Figure 32 Kaplan Meier analysis of recurrent stroke hospitalisation over 
follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33 Kaplan Meier analysis of recurrent stroke hospitalisation over 
follow up according to social class 
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Figure 34 Kaplan Meier analysis of recurrent heart failure hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35 Kaplan Meier analysis of recurrent heart failure hospitalisation 
over follow up according to social class 
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Adjusted survival to a recurrent hospitalisation 
In a regression model the association between SED and recurrent events was examined 
(Tables 49 and 50). In both unadjusted and adjusted analyses the risk of a second recurrent 
event was not associated with SED. The removal of smoking from the multivariable model 
made no discernable difference to the results only altering the hazard ratios at the 4th or 
smaller decimal place. Therefore, smoking was retained in the model. 
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Table 49 Hazard of recurrent hospitalisation of the same type in the most versus least deprived as measured by the Carstairs Morris index.  
 HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
CVD 1.02 0.85 1.23 0.797 0.99 0.83 1.19 0.928 1.00 0.83 1.19 0.967 0.97 0.81 1.17 0.761 
CHD 1.28 0.87 1.88 0.205 1.21 0.82 1.77 0.34 1.22 0.83 1.79 0.321 1.27 0.85 1.88 0.239 
MI 1.22 0.65 2.26 0.539 1.16 0.62 2.16 0.647 1.15 0.61 2.14 0.668 1.19 0.62 2.28 0.611 
Stroke 0.99 0.61 1.62 0.972 0.97 0.60 1.58 0.905 0.99 0.60 1.61 0.956 0.98 0.60 1.61 0.935 
HF 1.10 0.64 1.91 0.728 1.04 0.60 1.81 0.894 1.06 0.61 1.84 0.848 1.02 0.58 1.81 0.936 
 
Table 50 Hazard of recurrent hospitalisation of the same type in the most versus least deprived as measured by social class. 
 HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
CVD 0.99 0.77 1.28 0.944 1.03 0.79 1.33 0.833 1.03 0.80 1.34 0.807 1.03 0.79 1.35 0.811 
CHD 0.96 0.59 1.56 0.874 0.96 0.59 1.56 0.868 1.02 0.63 1.66 0.936 1.11 0.66 1.84 0.7 
MI 1.30 0.61 2.78 0.494 1.49 0.69 3.22 0.308 1.37 0.63 2.95 0.428 1.52 0.68 3.43 0.31 
Stroke 0.97 0.50 1.86 0.927 0.94 0.49 1.82 0.86 0.92 0.48 1.79 0.814 1.07 0.54 2.13 0.849 
HF 0.63 0.29 1.36 0.24 0.65 0.30 1.42 0.283 0.66 0.30 1.43 0.289 0.60 0.27 1.32 0.206 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly 
 
 154 
Death following a cardiovascular hospitalisation 
Crude rates  
The numbers of individuals who died following a particular cardiovascular hospitalisation 
are outlined in Tables 51 and 52. The rate of death following a non-fatal cardiovascular 
hospitalisation did show evidence of a gradient by SED (Figure 36 and 37). Following any 
CVD hospitalisation the rate ratio for the rate of death in the most versus least deprived 
was 1.33 (95%CI 1.14-1.56), p=0.0003 (Table 53). Similar trends were observed following 
a CHD hospitalisation 1.21 (0.921-1.59), p=0.1689, MI 1.29(0.95-1.75),p=0.11, stroke 
1.23 (0.93-1.62), p=0.148 and HF 1.20 (0.84-1.69), p=0.314. As with Carstairs Morris 
index, only the rate ratio for death following a CVD hospitalisation was significant when 
social class was used to measure SED (Table 54). Overall rates of death were highest 
following a stroke or heart failure.  
Table 51 Number of Deaths by type of first hospitalisation and socioeconomic deprivation 
measured by Carstairs Morris index 
 
Table 52 Number of Deaths by type of first hospitalisation and socioeconomic deprivation 
measured by social class 
1st 
hospitalisation Outcome I II IIIN IIIM IV V 
CVD Death 99 500 641 1063 884 320 
CHD Death 42 181 243 433 326 110 
MI Death 31 133 196 338 255 85 
Stroke Death 33 158 203 341 321 124 
HF Death 21 99 109 204 182 69 
 
1st 
hospitalisation Outcome 1 3 4 5 6 & 7 
CVD Death 192 468 738 1321 867 
CHD Death 62 190 265 525 317 
MI Death 49 144 198 411 249 
Stroke Death 61 163 262 433 290 
HF Death 40 70 138 277 167 
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Table 53 Rate ratio of most versus least deprived (measured by Carstairs Morris index) for 
death following a first cardiovascular hospitalisation 
Initial 
hospitalisation  
Subsequent 
Event  RR 
95% 
CI  P 
CVD Death 1.34 1.14 1.53 0.0003 
CHD Death 1.21 0.92 1.59 0.17 
MI Death 1.29 0.95 1.75 0.12 
Stroke Death 1.23 0.93 1.62 0.15 
HF Death 1.19 0.84 1.69 0.31 
 
Table 54 Rate ratio of most versus least deprived (measured by social class) for death 
following a first cardiovascular hospitalisation 
Initial 
hospitalisation  
Subsequent 
Event  RR 
95% 
CI  P 
CVD Death 1.36 1.09 1.71 0.007 
CHD Death 1.14 0.79 1.63 0.48 
MI Death 1.24 0.80 1.84 0.36 
Stroke Death 1.19 0.81 1.75 0.37 
HF Death 0.97 0.41 1.11 0.12 
 
Figure 36 Rate of death following a first cardiovascular hospitalisation according to 
Carstairs Morris index 
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Figure 37 Rate of death following a first cardiovascular hospitalisation according to social 
class 
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Kaplan Meier Analysis 
Following a cardiovascular hospitalisation the risk of death was higher in the most 
deprived during the remaining follow up (log rank p=0.0001) (Figures 38 and 39). A trend 
towards a similar association was seen with each of the other cardiovascular events though 
did not reach statistical significance (Figures 40-47).  
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 Figure 38 Kaplan Meier analysis of death following a cardiovascular 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39 Kaplan Meier analysis of death following a cardiovascular 
hospitalisation over follow up according to social class 
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Figure 40 Kaplan Meier analysis of death following a coronary heart 
disease hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41 Kaplan Meier analysis of death following a coronary heart 
disease hospitalisation over follow up according to social class 
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Figure 42 Kaplan Meier analysis of death following a myocardial infarction 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43 Kaplan Meier analysis of death following a myocardial infarction 
hospitalisation over follow up according to social class 
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Figure 44 Kaplan Meier analysis of death following a stroke hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45 Kaplan Meier analysis of death following a stroke hospitalisation 
over follow up according to social class 
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Figure 46 Kaplan Meier analysis of death following a heart failure 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47 Kaplan Meier analysis of death following a heart failure 
hospitalisation over follow up according to social class 
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Adjusted survival  
In a regression model the association between SED (measured by Carstairs Morris index) 
and death following an initial hospitalisation was examined (Table 55). In unadjusted 
analyses there was no association with SED. After adjustment for age at event and sex, a 
significantly higher risk of death following a hospitalisation for CVD, HR1.53 (1.31-1.79), 
CHD 1.38(1.05-1.81), and MI 1.37(1.01-1.87) was observed. After adjustment for the 
traditional risk factors (diabetes, cholesterol, systolic blood pressure) and the year of the 
initial event, these associations between SED and death following a CVD, CHD and MI 
event persisted. After further adjustment for BMI, FEV1 and cardiomegaly only the 
relationship between SED and death following a CVD hospitalisation remained significant. 
Whilst the risk of death following a stroke or HF hospitalisation did not reach statistical 
significance a trend towards an increased risk was observed. When social class was used to 
measure SED only recurrent CVD hospitalisations showed a statistically significant 
association with SED after adjustment for traditional risk factors (Table 56). 
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Table 55 Hazard of death following a first cardiovascular hospitalisation in the most versus least deprived as measured by Carstairs Morris index  
 HR* 95% CI  P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
CVD 1.34 1.15 1.57 <0.001 1.53 1.31 1.79 <0.001 1.53 1.31 1.79 <0.001 1.38 1.18 1.63 <0.001 
CHD 1.21 0.92 1.59 0.175 1.38 1.05 1.81 0.021 1.41 1.07 1.85 0.014 1.29 0.97 1.71 0.075 
MI 1.28 0.94 1.73 0.119 1.37 1.01 1.87 0.044 1.42 1.04 1.93 0.026 1.31 0.95 1.80 0.099 
Stroke 1.21 0.91 1.59 0.184 1.24 0.94 1.63 0.133 1.19 0.90 1.57 0.226 1.13 0.85 1.51 0.386 
HF 1.21 0.86 1.71 0.272 1.39 0.98 1.97 0.065 1.36 0.96 1.93 0.085 1.34 0.93 1.92 0.115 
 
Table 56 Hazard of death following a first cardiovascular hospitalisation in the most versus least deprived as measured by social class 
 HR* 95% CI  P HR** 95% CI  P HR† 95% CI  P HR‡ 95% CI  P 
CVD 1.36 1.09 1.71 0.007 1.47 1.17 1.84 0.001 1.31 1.04 1.64 0.021 1.18 0.93 1.49 0.165 
CHD 1.12 0.79 1.60 0.519 1.07 0.75 1.54 0.699 0.94 0.65 1.35 0.733 0.92 0.63 1.34 0.668 
MI 1.22 0.81 1.84 0.349 1.24 0.85 1.80 0.267 0.89 0.59 1.35 0.584 0.91 0.59 1.40 0.664 
Stroke 1.19 0.81 1.74 0.381 1.26 0.86 1.85 0.244 1.13 0.77 1.66 0.537 1.05 0.71 1.56 0.793 
HF 0.72 0.44 1.17 0.187 0.71 0.43 1.16 0.174 0.64 0.39 1.06 0.083 0.63 0.37 1.07 0.086 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly 
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Crude rate of death or subsequent recurrent hospitalisation 
The numbers of each of the outcome of death or recurrent hospitalisation are shown in 
Tables 57 and 58. With the exception of cardiovascular disease and coronary heart disease 
there is an imbalance in the numbers of deaths as compared to recurrent myocardial 
infarction, stroke and heart failure hospitalisations.  
Table 57 Number of deaths or recurrent hospitalisation according to first cardiovascular 
event and Carstairs Morris index 
 
 
Table 58 Number of deaths or recurrent hospitalisation according to first cardiovascular 
event and social class 
1st 
hospitalisation Outcome I II IIIN IIIM IV V 
CVD Death/ CVD 47/88 252/374 324/471 573/683 453/587 154/213 
CHD Death/ CHD 32/25 116/111 164/129 281/235 215/164 74/54 
MI Death/ MI 27/9 105/39 154/49 258/102 202/66 66/23 
Stroke Death/ Stroke 24/13 114/51 169/44 264/95 246/90 85/43 
HF Death/ HF 13/10 65/43 72/42 146/61 126/64 46/25 
 
 
The rate of death or subsequent recurrent hospitalisation was examined. A clear gradient of 
risk emerged in the risk of recurrent hospitalisation when death was included in the 
composite endpoint when SED was measured by Carstairs Morris index. The relationship 
1st 
hospitalisation Outcome 1 3 4 5 6 & 7 
CVD Death/CVD 96/149 242/335 386/533 669/908 449/547 
CHD Death/CHD 46/31 116/116 177/152 350/271 210/159 
MI Death/MI 41/12 110/45 152/63 321/113 199/57 
Stroke Death/Stroke 46/20 128/41 192/87 334/116 221/83 
HF Death/HF 27/16 49/23 91/55 194/95 112/60 
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was not as clear with social class as the measure of SED. The rate ratios are given below in 
Table 59 and 60 and the rates displayed in Figures 48 and 49.  
Table 59 Rate ratio for death or recurrent hospitalisation according in the most versus least 
deprived as measured by Carstairs Morris index 
Initial 
hospitalisation  
Subsequent 
hospitalisation  RR 
95% 
CI  P 
CVD Death/CVD 1.24 1.08 1.43 0.0025 
CHD Death/CHD 1.36 1.07 1.74 0.0135 
MI Death/MI 1.35 1.01 1.82 0.0447 
Stroke Death/Stroke 1.26 0.96 1.64 0.0964 
HF Death/HF 1.47 1.05 2.06 0.0239 
 
Table 60 Rate ratio for death or recurrent hospitalisation according in the most versus least 
deprived as measured by social class  
Initial 
hospitalisation  
Subsequent 
hospitalisation  RR 
95% 
CI  P 
CVD Death/CVD 1.18 0.97 1.44 0.09 
CHD Death/CHD 0.96 0.70 1.31 0.78 
MI Death/MI 1.10 0.74 1.63 0.64 
Stroke Death/Stroke 1.23 0.85 1.78 0.28 
HF Death/HF 0.63 0.39 1.02 0.055 
 
Figure 48. Rate of death or recurrent hospitalisation according to first cardiovascular event 
type and Carstairs Morris index 
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Figure 49 Rate of death or recurrent hospitalisation according to first cardiovascular event 
type and social class 
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Kaplan Meier analysis of the risk of death or recurrent cardiovascular 
hospitalisation 
Kaplan Meier analysis of the association between SED and the composite outcome of 
death or recurrent hospitalisation illustrated the higher risk experienced by the most 
deprived versus the least deprived (Figures 50-59). Whilst the association was not 
statistically significant for those who had experienced a coronary hospitalisation or 
myocardial infarction, the higher risk was still evident in the most deprived.  
Adjusted rates 
The hazard of recurrent hospitalisation or death varied according to socioeconomic 
deprivation when measured by Carstairs Morris index (Table 61). This association was 
statistically significant for CVD and subsequent death or CVD, CHD and subsequent death 
or CHD even after adjustment for traditional risk factors. The risk of death or recurrent MI 
was associated with SED in the unadjusted and adjusted analyses although just failed to 
reach statistical significance. There was no clear association with social class (Table 62). 
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Figure 50 Kaplan Meier analysis of death or recurrent cardiovascular 
hospitalisation following a cardiovascular hospitalisation over follow up 
according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51 Kaplan Meier analysis of death or recurrent cardiovascular 
hospitalisation following a cardiovascular hospitalisation over follow up 
according to social class 
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Figure 52 Kaplan Meier analysis of death or recurrent coronary 
hospitalisation disease event following a coronary heart disease 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53 Kaplan Meier analysis of death or recurrent coronary heart 
disease hospitalisation following a coronary heart disease hospitalisation 
over follow up according to social class 
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Figure 54 Kaplan Meier analysis of death or recurrent myocardial infarction 
hospitalisation following a myocardial infarction hospitalisation over follow 
up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55 Kaplan Meier analysis of death or recurrent myocardial infarction 
hospitalisation following a myocardial infarction hospitalisation over follow 
up according to social class 
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Figure 56 Kaplan Meier analysis of death or recurrent stroke hospitalisation 
following a stroke over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 57 Kaplan Meier analysis of death or recurrent stroke hospitalisation 
following a stroke over follow up according to social class 
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Figure 58 Kaplan Meier analysis of death or recurrent heart failure 
hospitalisation following a heart failure hospitalisation over follow up 
according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59 Kaplan Meier analysis of death or recurrent heart failure 
hospitalisation following a heart failure hospitalisation over follow up 
according to social class 
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Table 61 Hazard of death or recurrent cardiovascular hospitalisation in the most versus least deprived as measured by Carstairs Morris index.  
Initial 
hospitalisation 
Subsequent 
Event HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
CVD Death/CVD 1.23 1.07 1.42 0.004 1.21 1.05 1.40 0.007 1.22 1.06 1.41 0.005 1.14 0.98 1.31 0.08 
CHD Death/CHD 1.35 1.05 1.72 0.017 1.31 1.02 1.67 0.033 1.35 1.06 1.73 0.017 1.30 1.01 1.67 0.044 
MI Death/MI 1.34 1.00 1.80 0.054 1.34 1.00 1.81 0.051 1.34 1.00 1.81 0.052 1.25 0.92 1.70 0.147 
Stroke Death/Stroke 1.25 0.95 1.63 0.106 1.23 0.94 1.60 0.133 1.18 0.90 1.54 0.233 1.15 0.87 1.50 0.328 
HF Death/HF 1.46 1.04 2.04 0.027 1.24 0.88 1.73 0.218 1.21 0.86 1.70 0.269 1.12 0.79 1.59 0.532 
Table 62 Hazard of death or recurrent cardiovascular hospitalisation in the most versus least deprived as measured by social class 
Initial 
hospitalisation 
Subsequent  
Event HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
CVD Death/CVD 1.18 0.97 1.44 0.098 1.29 1.06 1.57 0.012 1.13 0.92 1.37 0.242 1.08 0.88 1.33 0.458 
CHD Death/CHD 0.95 0.70 1.30 0.758 1.01 0.73 1.38 0.971 0.82 0.59 1.13 0.217 0.83 0.59 1.15 0.257 
MI Death/MI 1.15 0.78 1.67 0.481 1.31 0.89 1.92 0.169 0.93 0.64 1.37 0.726 0.94 0.63 1.41 0.776 
Stroke Death/Stroke 1.13 0.79 1.61 0.511 1.16 0.81 1.66 0.429 0.93 0.65 1.33 0.685 0.95 0.65 1.38 0.778 
HF Death/HF 0.63 0.39 1.01 0.055 0.63 0.39 1.01 0.057 0.63 0.39 1.02 0.06 0.57 0.35 0.94 0.026 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly 
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Discussion 
As described earlier in the first chapter, SED is related to the first occurrence of a 
cardiovascular event after adjustment for multiple cardiovascular risk factors. However, 
little evidence is available from the literature to suggest that SED is related to the risk of a 
recurrent cardiovascular hospitalisation.92,105 The analyses presented here indicate that 
SED is not associated with a higher risk of a recurrent cardiovascular hospitalisation but is 
associated with a higher risk of death. A composite outcome of death or recurrent 
hospitalisation revealed similar trends, mainly driven by the association with death.  
Risk of a recurrent hospitalisation 
It is somewhat surprising that the risk of recurrent hospitalisation was not related to SED. 
It has been reported that the most deprived individuals receive less intensive therapy for 
their cardiovascular disease. For example, the most deprived are less likely to receive 
aspirin, beta-blockers and thrombolysis for myocardial infarction230 and rehabilitation 
following a stroke118. Those with ischaemic heart disease as less likely to be referred for 
surgical (coronary artery bypass grafting79) or percutaneous (coronary angioplasty79,231,232) 
revascularisation with possibly detrimental effects on subsequent mortality93. For those 
who experience a stroke, rates of carotid endarterectomy were not different according to 
SED but waiting times were longer in the most deprived in one study from Canada 118. 
Furthermore, more deprived individuals are less likely to adhere to preventative 
medications233 and attend rehabilitation classes234,235 and then to complete them235. Finally, 
lifestyle modification is recommended following the development of cardiovascular 
disease but in a cohort of survivors of a myocardial infarction, the most deprived were less 
likely to reduce their alcohol intake, exercise and adopt a healthier diet.236 As many of 
these therapies and interventions potentially reduce morbidity as well as mortality we may 
expect that the rates of recurrent cardiovascular events would be higher amongst the most 
deprived who do not receive these treatments or make such changes. However, the lack of 
such treatments may predispose the most deprived to a greater risk of death following their 
cardiovascular hospitalisation and this was evident in this cohort. As a consequence it may 
be that the most deprived simply die before they can experience a recurrent cardiovascular 
hospitalisation. In analyses where a composite of death or recurrent cardiovascular event 
were performed the most deprived were at higher risk. However, from these results I can 
only hypothesise that this is the case for all recurrent CVD hospitalisations as the 
composite was balanced in terms of numbers of events for the fatal and non-fatal parts of 
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the outcome. For all the other composite outcomes, death with CHD, MI, stroke or HF, the 
composite outcome mainly consisted of deaths. 
After experiencing and surviving a cardiovascular event, it is perhaps unsurprising that 
SED, as measured by an area based measure, would continue to confer an excess risk of 
death or recurrence of cardiovascular disease. After discharge it is highly likely that the 
individual will return to their home and their neighbourhood. Therefore, all the potential 
causal mechanisms associated with living in a deprived area will still be present, e.g. 
higher crime, damp housing, poor access to health services, lack of leisure activity etc. 
These will therefore continue to exert a potentially detrimental effect on health.  
Following a cardiovascular event it is possible that individuals may become too ill to 
continue to work. One confounding issue that I was not able to address was the potential 
bias that following a cardiovascular event an individual’s social status may change. Due to 
continuing ill health an individual may not return to work. This would then lower their 
socioeconomic status, thus, possibly increasing their risk of a subsequent mortality and 
possibly cardiovascular events. Indeed, there is evidence that following a myocardial 
infarction recovery of functional status is poorer in the most deprived as compared to least 
deprived in one study of men237, and, that following a stroke, greater levels of disability are 
experienced by the most deprived238, both factors which could lead to a loss of 
employment.  
A number of studies have reported that more deprived individuals present with more 
severe disease during their first event. This may explain the higher risk of death and trend 
toward a higher risk of recurrent hospitalisations amongst the most deprived. There is no 
more severe a presentation than death and a number of studies of coronary heart disease 
have reported that more deprived individuals are less likely to reach hospital alive when 
presenting with CHD. In the MONICA studies individuals with a first myocardial 
infarction were less likely to reach hospital alive if they were deprived.61 In another study 
of coronary deaths in Scotland, the most deprived were more likely to die out of hospital 
with a first coronary event.64 In a study of patients with MI admitted to a coronary care unit 
more individuals in the deprived cohort presented with heart failure.133 A number of 
studies have reported that stroke severity is higher in the most deprived as compared to the 
least deprived.115,117 In one study, the most deprived were more likely to be dependant for 
their activities of daily living at 28 days following a stroke.99 It has also been reported that 
stroke longer term disability and handicap are higher in the most deprived.238 Again we 
may expect that the greater severity of disease in the most deprived would increase rates of 
 175 
recurrent events, but it may simply serve to increase case fatality and mortality, reducing 
the chances of a deprived individual to experience further non-fatal outcomes. 
It is not only the presentation that is more severe in patients with CVD. Following a 
cardiovascular event, multiple studies have demonstrated that access to health care 
professionals is lower during or after an event. In individuals with HF129, stroke119 and 
coronary disease, the most deprived were less likely to be treated by a specialist, attend a 
high volume i.e. expert hospital, and receive appropriate investigations or further 
interventions113. All of these factors may explain the higher rates of death and possibly 
recurrence. Indeed, when discharged following a cardiovascular hospitalisation a deprived 
individual may be less likely to have contact with their general practitioner. In a study from 
primary care practices from Scotland those deprived individual with a diagnosis of HF 
were less likely to see their general practitioner each year than the least deprived 
individuals with the diagnosis of HF.121  
In general deprived individuals tend to exhibit a higher burden of other diseases too. Prior 
studies have documented a higher prevalence in the deprived of comorbidities that increase 
the risk of death following a cardiovascular event such as diabetes, chronic obstructive 
airways disease, cancer and renal impairment.77,92 This differential distribution of 
comorbidities may partly explain why more deprived individuals are more likely to die 
following a cardiovascular event.  
Limitations 
In these analyses the adjustment was made for risk factors that were measured prior to the 
first hospitalisation an individual experienced. This may bias the result, as risk factors may 
have changed subsequent to experiencing a first cardiovascular hospitalisation.236  It is 
unlikely that factors such as cholesterol and blood pressure changed substantially as it has 
only been possible to modify these risk factors adequately through pharmacotherapy in the 
latter period of follow up.   
The choice of adjusting variables may also have been incorrect. Whist the risk factors of 
smoking, blood pressure, diabetes and cholesterol may have a deleterious effect on the risk 
of a first cardiovascular event67, other factors related to the form of cardiovascular event 
experienced, e.g. disability following stroke117, heart failure after a myocardial 
infarction77,92, may be more important mediators of subsequent risk following a 
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cardiovascular event. However, for risk factors such as diabetes, the risk associated with 
them persists following a first cardiovascular hospitalisation such as heart failure.239 
Summary  
The risk of death or a recurrent cardiovascular hospitalisation is higher in the most 
deprived as compared to the least deprived. This is mainly driven by the higher rates of 
death amongst the most deprived. The risk of recurrent hospitalisations displays a trend 
towards higher rates in the deprived though this was not consistent or statistically 
significant. This may be due to the fact that socioeconomic status changes following a 
cardiovascular hospitalisation or that other factors are more important once cardiovascular 
disease has led to a hospitalisation in an individual.  
In the next chapter I will explore how SED is related to the total hospital burden of CVD. 
On the basis of the last chapter where was associated with a higher risk of subsequent 
mortality but not recurrent cardiovascular hospitalisations, and the chapter before where 
SED was associated with a greater risk of a first hospitalisations for CVD, it remains to be 
seen what the total burden by SED is.  
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The Burden of Cardiovascular Disease and Death 
In this section I will examine the burden of disease in relation to SED. Firstly the rate of 
death and premature deaths will be determined, including cardiovascular deaths. The 
numbers of hospitalisations according to SED for each cardiovascular disease type will be 
described. The costs associated with CVD hospitalisations will be calculated by SED. The 
population attributable fraction of SED in relation to a number of cardiovascular disease 
types will be calculated. 
Methods 
Burden of cardiovascular disease 
Hospital burden 
Using the linked Scottish Morbidity Record data the number of discharges for a particular 
cardiovascular disease type was calculated. The length of stay in hospital for the entire stay 
pertaining to that admission was calculated. Mean length of stay for each cardiovascular 
cause was calculated. The total time a person spent out of hospital before their first 
cardiovascular event was calculated from the time on enrolment to the first admission with 
that cardiovascular disease type. Time spent in hospital was computed over the length of 
follow up and the time free from hospital also calculated. Analyses were stratified by SED.  
Burden of death 
Using the linked General Registrar Office data on deaths, the number of deaths in each 
socioeconomic group was calculated. The number of days from enrolment to the end of 
study or death was calculated according to SED and the number of days until death was 
calculated. Deaths occurring before a specific age were also calculated. At the start of the 
study the life expectancy of the cohort was until the age of 75 years approximately (71 
years for men and 76 years for women). This figure was obtained from the General 
Register Office records of life expectancy from the 1970-1972 census for individuals aged 
45-64 years of age at that time (personal communication, General Register Office, 2008). 
All analyses of deaths have examined deaths at end of follow up of the cohort. In addition 
to ascertain if SED had an effect on premature deaths, deaths at age 65 and 70 years, and 
75 (life expectancy) were calculated. These were stratified by SED.  
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Adjusted risk of death 
The adjusted risk of death was calculated using Cox regression. The effect of SED was 
tested in unadjusted and age and sex adjusted models. Models were then additionally 
adjusted for traditional cardiovascular risk factors (diabetes, smoking, cholesterol and 
systolic blood pressure). Finally, other factors known to influence cardiovascular and all 
cause mortality were added to the model (body mass index, FEV1, cardiomegaly).  
Population attributable fraction   
The contribution of a risk factor to a disease or a death can be quantified using the 
population attributable fraction (PAF). The PAF is the proportional reduction in population 
disease or mortality that we would expect to occur if exposure to that risk factor were 
reduced to an alternative ideal exposure scenario (e.g. reduction of smoking levels to nil). 
As with cardiovascular disease, many diseases are caused by multiple risk factors, 
therefore, individual risk factors may interact in their impact on overall risk of disease. 
Consequently, PAFs for individual risk factors often overlap and add up to more than 100 
percent. 
The PAF can be calculated using the formula below:  
 
Where: 
Pr = proportion of population at exposure level with the outcome 
RR = relative risk 
For risk factors with continuous rather than discrete exposure levels there is an analogous 
formula for PAF involving integration of the exposure level distribution. 
However, as noted, calculation of the population attributable fraction can in theory lead to 
all percentages adding to over 100%. This is of course counterintuitive. Furthermore, the 
method above makes no allowance for the potential confounders of the outcome. By failing 
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to adjust for confounders the potential attributable fraction will be overestimated. A 
number of methods are available to adjust for this concern. The commonest approach is to 
use the Levin formula: 
 
Where  p = the prevalence of the risk factor and RR = the relative risk estimate. 
This method requires the assumption that the number of cases in the exposed is the same as 
the unexposed. An assumption that would be violated in this setting. Furthermore, this 
approach can also yield results that add to over 100%. Adjusted risk estimates can also be 
used in this formula. However this method yields inconsistent and biased results.  
The calculation of the average attributable fraction overcomes these limitations by 
producing an estimate of the attributable fraction from a multivariable model adjusted for 
other factors.240 It uses a logistic regression model to calculate the attributable fraction 
using the following method: 
1. The risk factor is coded into a dichotomous variable. 
2. Predicted probabilities for each individual are calculated using the following 
formula: 
 
Where alpha = the estimate of the intercept for the regression model, beta = the 
parameter vector for the covariate in the model and xi = the observations of the 
covariates for each individual with the removed variable set to zero for all individuals 
3. The sum of the predicted probabilities is the adjusted number of cases that would 
be expected if the risk factor was removed from the population 
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4. The average attributable fraction is calculated by subtracting the expected cases 
calculated above from the observed number of cases and then dividing by the 
observed number of cases.  
Using this method more meaningful results and unbiased results of the proportion of 
disease attributable to a risk factor in a population can be obtained. In these analyses 
both the simple formula for attributable fraction and the average attributable fraction 
are used. As the average attributable fraction requires that variables be dichotomous, 
age was split in to age 45-54 years and 55-64 years, blood pressure into groups 
<140mmHg and ≥140mmHg, cholesterol into groups <5 mmol/l and ≥5 mmol/l and 
SED into Carstairs Morris index categories 1,3 and 4 (the least deprived) and 5,6 and 
7(the most deprived) and social class into I,II, III-NM and III-M, IV and V.  
Economic costs 
The cost associated with a cardiovascular admission was calculated for each 
socioeconomic group. The cost associated with each type of cardiovascular disease type 
was also calculated. The costs pertaining to the admission type were calculated using the 
NHS Greater Glasgow and Clyde costs for 2007 from the NHS cost book.241 The health 
board costs for a particular type of admission are collated by the Information Services 
Division of NHS Scotland and updated every year. The summary costs for the whole 
health board were used to try and ensure that a representative figure was used that captured 
the possibility that individuals may have been admitted to hospitals across the Glasgow  
area during their lifetime.  
 
Inflation 
To account for inflation over time the costs for admissions in NHS Greater Glasgow and 
Clyde from 2007 were taken and discounted back by 5% per annum. In a sensitivity 
analysis the historical rates of inflation were obtained from the Office of National 
Statistics.242 These inflation rates are based on the consumer price inflation index.  These 
rates were then used to calculate the equivalent historical costs associated with admissions. 
As no discernable difference was observed using either method a consistent 5% deflation 
was used.  
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Cost  
The cost associated with a particular type of stay in an acute hospital was obtained. A cost 
per day from the NHS cost book was calculated and multiplied by the actual number of 
days spent in hospital for an admission by an individual. For example, to calculate the cost 
per day of a stroke admission from the NHS cost book, an admission for stroke was 
presumed to have occurred in a general medical ward as stroke units have only recently 
been introduced. The cost per day on a general medical ward was then multiplied by the 
number of days actually spent by an individual in hospital during a hospitalisation for 
stroke during follow up. A myocardial infarction was on average assumed to last 7 days of 
which 2 days would be spent in a coronary care unit. All other cardiovascular, coronary 
heart disease and chronic heart failure admissions were assumed to occur in a cardiology 
ward. The costs per day for an admission to each type of these wards was calculated using 
Greater Glasgow and Clyde data in the NHS cost book. These costs were then totalled 
according to the assumptions above. For example the cost of a myocardial infarction 
admission was calculated as thus: 
Step 1: Calculate average cost per day  
Total cost of myocardial infarction stay = (Cost of stay in coronary care unit/ average 
length of stay in NHS cost book) * 2 + (cost of stay in cardiology ward/ average length of 
stay in cost book)*5 
This was then divided by 7 to give a cost per day. 
Step 2: Calculate the cost for a hospitalisation 
Multiply the actual number of days in hospital during a myocardial infarction 
hospitalisation by the cost per day calculated in step 1.  
 Step 3: Deflation 
This cost was then deflated as outlined above.  
Outpatient and pharmacotherapy costs 
The costs of outpatient attendance were not calculated in these analyses. It has been 
reported that attendance at out patient clinics varies by socioeconomic status in one study 
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243
, though not in another244. The most deprived may attend outpatients clinics more often 
than the least deprived members of society.243 Due to the uncertainty surrounding the 
direction of effect of socioeconomic status on out patient attendances and the lack of data 
on outpatient attendances in the dataset an average number of visits per admission type 
would have to be applied to all socioeconomic groups, lessening the ability to detect 
between group differences.  
Similarly, the costs of pharmacotherapy were not included. These were not calculated as 
two large assumptions would have to be made thus reducing the validity of such analyses. 
Firstly, assumptions regarding which pharmacotherapies may have been prescribed at 
which time points would have to be made. Over the study period effective 
pharmacotherapies for cardiovascular disease were established. There is no record of 
pharmacotherapies in the Renfrew/Paisley dataset therefore multiple assumptions would 
have to be made in determining which therapies were prescribed. Secondly, the 
prescription of pharmacotherapies differs by socioeconomic status.155,165,245 Some studies 
have reported no difference246 and others do not agree on the direction of effect.165,247 
Therefore, again an assumption around the direction and size of effect of socioeconomic 
deprivation and rates pharmacotherapy prescription would have to be made on top of the 
assumption made previously regarding when certain pharmacotherapies would have been 
likely to have been prescribed over time. This was deemed to introduce an unacceptable 
degree of uncertainty. Therefore, only costs associated with inpatient care were studied so 
that the size and direction of effect associated with socioeconomic deprivation could be 
measured with a degree of certainty. Indirect costs, such as loss of earnings were similarly 
not calculated due to insufficient evidence in the published literature to determine possible 
directions of effect.  
Results 
All cause mortality 
The number of deaths according to deprivation category are outlined in Table 63.The 
absolute numbers in the most deprived groups are higher than in the least deprived and this 
is reflected in the fact that by the end of follow up nearly 72% of the most deprived were 
dead from all causes as compared to only 58% of the least deprived. This gradient was 
evident when deaths prior to the age of 65 years, 70 years and finally 75 years were 
examined. At the age of life expectancy, 75 years, 46% of the most deprived members of 
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the cohort had died as opposed to 31% of the least deprived with a gradient in the 
proportion dead in between. 
Table 63 Number of deaths and proportions of deaths at end of follow up and before 65 
years, 70 years and 75 years of age according to Carstairs Morris index.  
 N All deaths %  65 years   %  70 years % 75 years  % 
1 990 578 58.38 108 10.91 197 19.90 307 31.01 
3 2084 1,337 64.16 272 13.05 491 23.56 769 36.90 
4 3347 2,169 64.80 440 13.15 809 24.17 1,288 38.48 
5 5534 3,742 67.62 871 15.74 1,532 27.68 2,355 42.56 
6&7 3389 2,437 71.91 606 17.88 1,031 30.42 1,548 45.68 
Total 15344 10,263 66.89 2,297 14.97 4,060 26.46 6,267 40.84 
 
The number of deaths occurring during follow up by social class is outlined in Table 64. 
As with Carstairs Morris index a gradient in the numbers and proportions on individuals 
dying was seen for all cause mortality at the end of follow up. The gradient in proportion 
of all cause deaths was as clear according to social class for deaths when compared to 
Carstairs Morris index, though the deprived experienced a greater number of deaths.  
Table 64 Number of deaths and proportions of deaths at end of follow up and before 65 
years, 70 years and 75 years of age in each social class.  
 N All deaths % 65 years  % 70 years  % 75 years  % 
I 545 315 57.80 69 12.66 121 22.20 191 35.05 
II 2,235 1,330 59.51 268 11.99 488 21.83 760 34.00 
III-
NM 2,804 1,698 60.56 342 12.20 601 21.43 961 34.27 
III-M 4,299 3,114 72.44 785 18.26 1,316 30.61 2,026 47.13 
IV 3,771 2,575 68.28 573 15.19 1,047 27.76 1,589 42.14 
V 1,301 949 72.94 202 15.53 384 29.52 575 44.20 
 14,955 9,981 66.74 2,239 14.97 3,957 26.46 6,102 40.80 
 
 
Years of life lived until death 
The number of years a person lived between enrolment and death was examined according 
to SED (Table 65). On average an individual in the most deprived group lived 
approximately 2 ½ years less than an individual in the least deprived group.  
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Table 65 Number of years between enrolment and death or censoring according to Carstairs 
Morris index. 
 N total 95% CI mean 95% CI  
1 990 21838 21324 22352 22.06 21.54 22.58 
3 2084 46430 45630 47230 22.28 21.90 22.66 
4 3347 72167 71177 73157 21.56 21.27 21.86 
5 5534 116802 115475 118129 21.11 20.87 21.35 
6&7 3389 66633 65623 67643 19.66 19.36 19.96 
 15344 323870 319229 328511 21.33 20.99 21.68 
 
A similar pattern was observed when social class was used as the measure of SED (Table 
66). The least deprived survived on average just over 2 ½ years longer than the most 
deprived members of the cohort.  
Table 66. Number of years between enrolment and death or censoring according to social 
class.  
 N total 95% CI mean 95% CI  
I 545 12401 12016 12786 22.75 22.05 23.46 
II 2,235 50281 49499 51063 22.50 22.15 22.85 
III-NM 2,804 62943 62059 63827 22.45 22.13 22.76 
III-M 4,299 85917 84736 87098 19.99 19.71 20.26 
IV 3,771 78130 77061 79199 20.72 20.44 21.00 
V 1,301 26085 25436 26734 20.05 19.55 20.55 
 14,955 315757 310807 320707 21.41 21.00 21.81 
 
Adjusted risk of death 
The risk of death from all causes was modelled in a multivariable Cox regression model 
(Table 67) to allow adjustment for multiple cardiorespiratory risk factors. In unadjusted 
analyses the risk of all cause death was highest in the most deprived, approximately 50% 
higher than the least deprived. After adjustment this association persisted. A similar pattern 
of risk was observed when social class was used as the measure of SED (Table 68).  
The risk of death by the age of 65 years, 70 years and 75 years was also modelled. As was 
observed in the proportions of deaths in each SED group above, there was evidence that 
after age and sex adjustment the risk of death associated with SED was higher in the most 
deprived versus the least deprived (Tables 69-74). After adjustment for further 
cardiorespiratory risk factors the risk of death at 65, 70 and 75 years of age were similar to 
that of the risk of death at the end of follow up.  
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Table 67 Hazard of all cause death during complete follow up by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.09 0.98 1.20 0.101 1.20 1.09 1.32 <0.001 1.19 1.08 1.32 <0.001 1.15 1.04 1.27 0.008 
4 3347 1.18 1.07 1.29 <0.001 1.27 1.15 1.39 <0.001 1.26 1.15 1.38 <0.001 1.19 1.08 1.31 <0.001 
5 5534 1.22 1.12 1.33 <0.001 1.36 1.24 1.48 <0.001 1.30 1.19 1.42 <0.001 1.21 1.10 1.32 <0.001 
6&7 3389 1.49 1.36 1.63 <0.001 1.58 1.44 1.73 <0.001 1.53 1.39 1.67 <0.001 1.39 1.27 1.53 <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 68 Hazard of all cause death during complete follow up by social class 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 1.06 0.93 1.19 0.386 1.07 0.95 1.22 0.251 1.05 0.93 1.19 0.405 1.03 0.91 1.17 0.631 
III-
NM 3,894 1.07 0.95 1.21 0.265 1.17 1.04 1.32 0.011 1.14 1.01 1.29 0.034 1.09 0.96 1.23 0.177 
III-
M 6,710 1.52 1.35 1.70 <0.001 1.39 1.24 1.57 <0.001 1.33 1.19 1.50 <0.001 1.25 1.11 1.40 <0.001 
IV 5,815 1.37 1.22 1.54 <0.001 1.39 1.24 1.56 <0.001 1.33 1.18 1.50 <0.001 1.20 1.07 1.36 0.003 
V 2,112 1.52 1.34 1.73 <0.001 1.56 1.38 1.78 <0.001 1.45 1.27 1.65 <0.001 1.29 1.13 1.47 <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Table 69 Hazard of all cause death prior to the age of 65 years by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.06 0.85 1.33 0.582 1.12 0.90 1.40 0.314 1.09 0.87 1.36 0.472 1.03 0.82 1.30 0.776 
4 3347 1.13 0.92 1.40 0.249 1.17 0.95 1.45 0.135 1.13 0.92 1.40 0.241 1.03 0.83 1.27 0.808 
5 5534 1.30 1.07 1.59 0.01 1.38 1.13 1.69 0.001 1.26 1.03 1.54 0.023 1.13 0.92 1.39 0.25 
6&7 3389 1.66 1.35 2.03 <0.001 1.71 1.39 2.10 <0.001 1.59 1.29 1.95 <0.001 1.38 1.12 1.70 0.003 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 70 Hazard of all cause death prior to the age of 65 years by social class 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 1.03 0.79 1.34 0.849 1.10 0.84 1.43 0.481 1.06 0.81 1.38 0.681 1.08 0.82 1.43 0.576 
III-
NM 3,894 1.05 0.81 1.37 0.687 1.25 0.97 1.63 0.089 1.20 0.92 1.55 0.177 1.11 0.84 1.46 0.456 
III-
M 6,710 1.69 1.32 2.16 <0.001 1.57 1.23 2.01 <0.001 1.45 1.13 1.85 0.003 1.31 1.01 1.69 0.044 
IV 5,815 1.41 1.10 1.80 0.008 1.50 1.17 1.93 0.001 1.39 1.08 1.79 0.01 1.25 0.96 1.63 0.094 
V 2,112 1.55 1.18 2.04 0.002 1.69 1.29 2.23 <0.001 1.49 1.13 1.97 0.004 1.30 0.98 1.74 0.074 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Table 71 Hazard of all cause death prior to the age of 70 years by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.10 0.94 1.30 0.239 1.17 0.99 1.38 0.067 1.15 0.97 1.35 0.11 1.08 0.91 1.28 0.365 
4 3347 1.19 1.02 1.39 0.029 1.24 1.06 1.45 0.008 1.21 1.04 1.42 0.015 1.10 0.93 1.29 0.265 
5 5534 1.33 1.15 1.55 <0.001 1.42 1.23 1.65 <0.001 1.32 1.14 1.53 <0.001 1.19 1.02 1.38 0.028 
6&7 3389 1.62 1.39 1.89 <0.001 1.67 1.44 1.95 <0.001 1.58 1.35 1.84 <0.001 1.37 1.17 1.61 <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 72 Hazard of all cause death prior to the age of 70 years by social class  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 1.05 0.86 1.28 0.623 1.13 0.93 1.38 0.23 1.10 0.90 1.34 0.367 1.11 0.91 1.37 0.309 
III-
NM 3,894 1.04 0.85 1.26 0.702 1.23 1.01 1.50 0.038 1.19 0.97 1.44 0.09 1.12 0.91 1.37 0.278 
III-
M 6,710 1.62 1.34 1.95 <0.001 1.50 1.25 1.81 <0.001 1.40 1.16 1.69 <0.001 1.29 1.06 1.56 0.011 
IV 5,815 1.45 1.20 1.75 <0.001 1.55 1.28 1.87 <0.001 1.45 1.20 1.75 <0.001 1.30 1.06 1.58 0.01 
V 2,112 1.63 1.33 2.00 <0.001 1.79 1.45 2.20 <0.001 1.60 1.30 1.97 <0.001 1.41 1.14 1.75 0.002 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Table 73 Hazard of all cause death prior to the age of 75 years by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.13 0.99 1.29 0.075 1.20 1.05 1.37 0.006 1.18 1.03 1.35 0.015 1.13 0.99 1.29 0.079 
4 3347 1.23 1.09 1.40 0.001 1.29 1.14 1.47 <0.001 1.27 1.12 1.44 <0.001 1.18 1.04 1.34 0.011 
5 5534 1.35 1.20 1.52 <0.001 1.46 1.30 1.65 <0.001 1.36 1.21 1.53 <0.001 1.24 1.10 1.41 <0.001 
6&7 3389 1.61 1.43 1.82 <0.001 1.67 1.47 1.88 <0.001 1.57 1.39 1.78 <0.001 1.40 1.24 1.59 <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 74 Hazard of all cause death prior to the age of 75 years by social class  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 1.03 0.88 1.20 0.755 1.09 0.93 1.28 0.299 1.06 0.90 1.24 0.475 1.06 0.90 1.25 0.46 
III-
NM 3,894 1.04 0.89 1.22 0.616 1.21 1.03 1.41 0.018 1.17 1.00 1.37 0.052 1.11 0.95 1.31 0.194 
III-
M 6,710 1.60 1.38 1.86 0 1.48 1.27 1.72 0 1.39 1.20 1.61 0 1.29 1.11 1.51 0.001 
IV 5,815 1.40 1.20 1.62 0 1.47 1.27 1.71 0 1.39 1.19 1.62 0 1.25 1.07 1.47 0.005 
V 2,112 1.55 1.32 1.83 0 1.68 1.42 1.98 0 1.52 1.29 1.80 0 1.35 1.14 1.61 0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Death due to cardiovascular disease 
The numbers of deaths due to cardiovascular causes are outlined in Table 75 according to 
Carstairs Morris index. Most cardiovascular deaths occurred in the most deprived. As with 
all cause deaths, a greater proportion of the most deprived individuals suffered a 
cardiovascular death than the least deprived. At the end of follow up 36% of the most 
deprived group had died due to cardiovascular causes, the respective figure was only 29% 
of the least deprived group. This gradient was evident for cardiovascular deaths before the 
age of 65 years and 70 years. At the age of 75 years (life expectancy) 22% of the deprived 
individuals had died of cardiovascular diseases whereas only 17% of the least deprived 
group had died due to cardiovascular disease.  
Table 75 Number of cardiovascular deaths and proportions of cardiovascular deaths at end 
of follow up and before 65 years, 70 years and 75 years of age according to Carstairs Morris 
index .  
 
 N CVD Deaths % 65 years % 70 years % 75 years % 
1 990 288 29.09 61 6.16 103 10.40 166 16.77 
3 2084 674 32.34 124 5.95 238 11.42 378 18.14 
4 3347 1,074 32.09 217 6.48 407 12.16 652 19.48 
5 5534 1,849 33.41 417 7.54 761 13.75 1,183 21.38 
6&7 3389 1,232 36.35 291 8.59 507 14.96 741 21.86 
 15344 5,117 33.35 1,110 7.23 2,016 13.14 3,120 20.33 
 
 
When SED was measured using social class the same gradients in cardiovascular deaths 
was observed as with Carstairs Morris index (Table 76). In the most deprived group 37% 
of individuals had died of cardiovascular causes over the course of follow up whilst only 
29% of the least deprived had died of cardiovascular disease.  
Table 76. Number of cardiovascular deaths and proportions of deaths at end of follow up 
and before 65 years, 70 years and 75 years of age in each social class.  
 N CVD Deaths % 65 years % 70 years % 75 years % 
I 545 159 29.17 37 6.79 63 11.56 101 18.53 
II 2,235 670 29.98 120 5.37 240 10.74 387 17.32 
III-
NM 2,804 818 29.17 161 5.74 283 10.09 451 16.08 
III-M 4,299 1,568 36.47 403 9.37 675 15.70 1,019 23.70 
IV 3,771 1,283 34.02 276 7.32 530 14.05 802 21.27 
V 1,301 481 36.97 87 6.69 180 13.84 287 22.06 
 14,955 4,979 33.29 1,084 7.25 1,971 13.18 3,047 20.37 
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Adjusted risk of cardiovascular death 
The risk of a cardiovascular death varied according to socioeconomic status. The risk of 
suffering a cardiovascular death at the end of follow up was 60% higher in the most 
deprived versus the least deprived after adjustment for age and sex (Table 77). This excess 
risk persisted after adjustment for multiple cardiovascular risk factors. These relationships 
were evident when social class was used as the marker of socioeconomic deprivation 
(Table 78).  
Cardiovascular deaths prior to the age of 65, 70 and 75 years were also modelled (Tables 
79-84). The age and sex adjusted risk of a cardiovascular death in the most versus the least 
deprived was 40% higher by the age of 65 years (Table 79). The risk of dying from 
cardiovascular disease by the age of 70 years was 50% higher after adjustment for age and 
sex, which was attenuated to a 40% higher risk after adjustment for traditional 
cardiovascular risk factors (Table 81). The risk of cardiovascular death by the age of 75 
was approximately 30% higher in the most deprived versus the least deprived (Table 83).  
The same association between social class and cardiovascular death was observed for 
deaths at each age (Tables 80, 82 and 84). 
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Table 77 Hazard of cardiovascular death by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.11 0.96 1.27 0.152 1.24 1.08 1.42 0.003 1.19 1.03 1.36 0.015 1.15 1.00 1.33 0.049 
4 3347 1.17 1.03 1.34 0.017 1.27 1.12 1.45 <0.001 1.27 1.11 1.44 <0.001 1.22 1.07 1.40 0.003 
5 5534 1.22 1.07 1.38 0.002 1.37 1.21 1.55 <0.001 1.27 1.12 1.44 <0.001 1.21 1.06 1.38 0.003 
6&7 3389 1.51 1.33 1.72 <0.001 1.61 1.41 1.83 <0.001 1.55 1.36 1.76 <0.001 1.43 1.25 1.63 <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 78 Hazard of cardiovascular death by social class 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 1.05 0.89 1.25 0.561 1.07 0.90 1.27 0.46 1.06 0.89 1.26 0.512 1.06 0.89 1.27 0.531 
III-
NM 3,894 1.02 0.86 1.21 0.81 1.11 0.94 1.32 0.227 1.11 0.93 1.31 0.245 1.09 0.92 1.31 0.316 
III-
M 6,710 1.51 1.28 1.78 <0.001 1.37 1.17 1.62 <0.001 1.33 1.13 1.56 0.001 1.28 1.08 1.51 0.005 
IV 5,815 1.34 1.14 1.59 <0.001 1.36 1.15 1.60 <0.001 1.33 1.12 1.57 0.001 1.25 1.05 1.48 0.011 
V 2,112 1.52 1.27 1.82 <0.001 1.55 1.29 1.86 <0.001 1.46 1.22 1.75 <0.001 1.33 1.10 1.60 0.003 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
  192 
Table 79 Hazard of cardiovascular death by the age of 65 years by Carstairs Morris index  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 0.85 0.63 1.16 0.307 0.89 0.65 1.21 0.454 0.84 0.62 1.14 0.259 0.82 0.60 1.12 0.204 
4 3347 0.98 0.73 1.30 0.863 1.01 0.76 1.34 0.957 0.97 0.73 1.29 0.838 0.93 0.69 1.24 0.614 
5 5534 1.09 0.83 1.43 0.53 1.15 0.88 1.50 0.31 1.01 0.77 1.33 0.932 0.93 0.71 1.23 0.62 
6&7 3389 1.37 1.04 1.81 0.025 1.40 1.06 1.85 0.016 1.30 0.98 1.71 0.065 1.15 0.87 1.53 0.331 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 80 Hazard of cardiovascular death by the age of 65 years by social class 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 0.85 0.59 1.23 0.381 0.96 0.66 1.38 0.809 0.92 0.63 1.33 0.643 0.95 0.65 1.41 0.807 
III-
NM 3,894 0.91 0.64 1.31 0.618 1.19 0.83 1.71 0.335 1.14 0.80 1.64 0.469 1.13 0.77 1.65 0.532 
III-
M 6,710 1.59 1.13 2.22 0.007 1.45 1.04 2.04 0.03 1.34 0.96 1.88 0.089 1.29 0.90 1.85 0.158 
IV 5,815 1.24 0.88 1.74 0.226 1.39 0.98 1.96 0.063 1.29 0.92 1.83 0.143 1.24 0.86 1.78 0.252 
V 2,112 1.22 0.83 1.79 0.315 1.42 0.96 2.09 0.077 1.26 0.86 1.87 0.236 1.15 0.76 1.73 0.503 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
  193 
Table 81 Hazard of cardiovascular death by the age of 70 years by Carstairs Morris index 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.00 0.79 1.26 0.988 1.06 0.84 1.34 0.618 1.00 0.79 1.26 0.993 0.96 0.76 1.21 0.731 
4 3347 1.11 0.90 1.38 0.326 1.16 0.93 1.44 0.181 1.13 0.91 1.41 0.256 1.07 0.85 1.33 0.572 
5 5534 1.22 1.00 1.50 0.055 1.30 1.06 1.60 0.012 1.16 0.95 1.43 0.152 1.08 0.87 1.33 0.488 
6&7 3389 1.44 1.17 1.78 0.001 1.48 1.20 1.83 0 1.40 1.13 1.73 0.002 1.24 0.99 1.54 0.056 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 82 Hazard of cardiovascular death by the age of 70 years by social class 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 0.98 0.74 1.29 0.886 1.08 0.81 1.42 0.606 1.05 0.79 1.38 0.745 1.08 0.80 1.44 0.621 
III-
NM 3,894 0.93 0.71 1.22 0.588 1.14 0.86 1.50 0.357 1.11 0.84 1.46 0.451 1.10 0.82 1.47 0.516 
III-
M 6,710 1.53 1.19 1.99 0.001 1.41 1.09 1.82 0.01 1.32 1.02 1.71 0.036 1.29 0.98 1.69 0.07 
IV 5,815 1.36 1.05 1.77 0.021 1.47 1.13 1.91 0.004 1.41 1.08 1.83 0.011 1.34 1.02 1.77 0.037 
V 2,112 1.41 1.06 1.88 0.019 1.56 1.17 2.08 0.003 1.42 1.07 1.90 0.017 1.31 0.97 1.78 0.081 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Table 83 Hazard of cardiovascular death by the age of 75 years by Carstairs Morris index 
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
1 990 1    1    1    1    
3 2084 1.01 0.84 1.21 0.952 1.08 0.90 1.29 0.429 1.02 0.85 1.22 0.831 1.00 0.83 1.20 0.989 
4 3347 1.13 0.95 1.34 0.169 1.18 0.99 1.40 0.062 1.16 0.98 1.37 0.094 1.12 0.94 1.34 0.196 
5 5534 1.22 1.03 1.43 0.019 1.30 1.11 1.53 0.001 1.18 1.00 1.38 0.051 1.12 0.95 1.32 0.182 
6&7 3389 1.33 1.12 1.57 0.001 1.36 1.15 1.61 0 1.30 1.10 1.53 0.003 1.19 1.00 1.41 0.051 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
 
Table 84 Hazard of cardiovascular death by the age of 75 years by social class  
 N HR* 95% CI P HR** 95% CI P HR† 95% CI P HR‡ 95% CI P 
I 744 1    1    1    1    
II 3,209 0.97 0.78 1.21 0.783 1.04 0.84 1.30 0.719 1.02 0.82 1.27 0.85 1.03 0.82 1.29 0.81 
III-
NM 3,894 0.91 0.73 1.12 0.367 1.06 0.85 1.32 0.591 1.05 0.84 1.30 0.672 1.05 0.84 1.32 0.671 
III-
M 6,710 1.43 1.17 1.75 0.001 1.31 1.07 1.61 0.01 1.24 1.01 1.53 0.037 1.22 0.99 1.52 0.064 
IV 5,815 1.26 1.03 1.56 0.026 1.33 1.08 1.64 0.007 1.29 1.04 1.58 0.018 1.24 1.00 1.55 0.049 
V 2,112 1.37 1.09 1.72 0.007 1.45 1.15 1.82 0.001 1.36 1.08 1.71 0.009 1.27 1.00 1.61 0.05 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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The burden of admissions  
The number of hospital admissions for all cardiovascular causes is outlined in Table 85. 
The number of admissions per individual in each deprivation category is given. There was 
no clear trend in the number of admissions per person according to SED as measured by 
Carstairs Morris index.  
Similarly no clear trend was observed when social class was used as the measure of 
socioeconomic deprivation (Table 86).  
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Table 85 Number of cardiovascular admissions and admissions per person for any cardiovascular cause according to Carstairs Morris index.  
 N CVD  
N per  
person CHD 
N per  
person MI 
N per  
person Stroke 
N per  
person HF 
N per  
person 
1 990 818 0.83 227 0.23 130 0.13 118 0.12 103 0.10 
3 2084 2,011 0.96 734 0.35 341 0.16 336 0.16 159 0.08 
4 3347 3,214 0.96 1,054 0.31 479 0.14 536 0.16 420 0.13 
5 5534 5,362 0.97 1,927 0.35 897 0.16 846 0.15 604 0.11 
6&7 3389 3,272 0.97 1,131 0.33 538 0.16 558 0.16 426 0.13 
 15344 14,677 0.96 5,073 0.33 2,385 0.16 2,394 0.16 1,712 0.11 
 
 
Table 86 Number of cardiovascular admissions and admissions per person for all cardiovascular admissions according to social class.  
 N CVD 
N per  
person CHD 
N per  
person MI 
N per  
person Stroke 
N per  
person HF 
N per  
person 
I 545 494 0.91 164 0.30 82 0.15 77 0.14 68 0.12 
II 2,235 2,281 1.02 811 0.36 352 0.16 311 0.14 264 0.12 
III-NM 2,804 2,566 0.92 804 0.29 401 0.14 398 0.14 262 0.09 
III-M 4,299 4,133 0.96 1,566 0.36 759 0.18 686 0.16 460 0.11 
IV 3,771 3,588 0.95 1,190 0.32 541 0.14 615 0.16 433 0.11 
V 1,301 1,222 0.94 423 0.33 204 0.16 246 0.19 170 0.13 
 14,955 14,284 0.96 4,958 0.33 2,339 0.16 2,333 0.16 1,657 0.11 
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Admissions according to age at admission 
The number of admissions occurring before pre-defined ages was calculated. The number 
of cardiovascular admissions per person increased from the least to the most deprived 
when SED was measured using the Carstairs Morris Index when admissions prior to the 
age of 65 were examined (Table 87) . Similarly the number of coronary heart disease 
admissions also increased from the least to the most deprived. When admissions prior to 
the age of 70 and 74were examined the gradient of risk was attenuated. When social class 
was examined no clear gradation of risk was seen (Table 88). 
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Table 87 Number of admissions and number of admissions per person for each cardiovascular disease according to deprivation category. 
 
 
N CVD 
Number/ 
person CHD 
Number/ 
person MI 
Number/ 
person Stroke 
Number/ 
person HF 
Number/ 
person 
Age less 65 1 990 185 0.19 62 0.06 45 0.05 10 0.01 8 0.01 
 3 2084 517 0.25 189 0.09 112 0.05 48 0.02 16 0.01 
 4 3347 781 0.23 249 0.07 139 0.04 61 0.02 38 0.01 
 5 5534 1,446 0.26 556 0.10 337 0.06 157 0.03 91 0.02 
 6&7 3389 978 0.29 375 0.11 216 0.06 78 0.02 71 0.02 
  15344 3,907 0.25 1,431 0.09 849 0.06 354 0.02 224 0.01 
Age less 70 1 990 329 0.33 102 0.10 73 0.07 22 0.02 22 0.02 
 3 2084 880 0.42 340 0.16 182 0.09 97 0.05 39 0.02 
 4 3347 1,407 0.42 482 0.14 248 0.07 149 0.04 106 0.03 
 5 5534 2,548 0.46 947 0.17 532 0.10 325 0.06 184 0.03 
 6&7 3389 1,649 0.49 615 0.18 329 0.10 174 0.05 162 0.05 
  15344 6,813 0.44 2,486 0.16 1,364 0.09 767 0.05 513 0.03 
Age less 75 1 990 515 0.52 155 0.16 98 0.10 56 0.06 41 0.04 
 3 2084 1,338 0.64 527 0.25 255 0.12 177 0.08 85 0.04 
 4 3347 2,206 0.66 750 0.22 371 0.11 283 0.08 231 0.07 
 5 5534 3,813 0.69 1,408 0.25 704 0.13 544 0.10 375 0.07 
 6&7 3389 2,323 0.69 832 0.25 423 0.12 338 0.10 252 0.07 
  15344 10,195 0.66 3,672 0.24 1,851 0.12 1,398 0.09 984 0.06 
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Table 88 Number of admissions and number of admissions per person for each cardiovascular disease according to social class. 
 
 N CVD 
Number/ 
person CHD 
Number/ 
person MI 
Number/ 
person Stroke 
Number/ 
person HF 
Number/ 
person 
Age less 
65 I 545 120 0.22 50 0.09 33 0.06 4 0.01 7 0.01 
 II 2,235 550 0.25 188 0.08 113 0.05 45 0.02 19 0.01 
 III-NM 2,804 717 0.26 241 0.09 140 0.05 55 0.02 43 0.02 
 III-M 4,299 1,176 0.27 502 0.12 310 0.07 116 0.03 65 0.02 
 IV 3,771 993 0.26 326 0.09 183 0.05 99 0.03 64 0.02 
 V 1,301 278 0.21 106 0.08 63 0.05 28 0.02 18 0.01 
 
 14,955 3,834 0.26 1,413 0.09 842 0.06 347 0.02 216 0.01 
Age less 
70 I 545 224 0.41 90 0.17 51 0.09 24 0.04 17 0.03 
 II 2,235 1,047 0.47 406 0.18 201 0.09 105 0.05 57 0.03 
 III-NM 2,804 1,205 0.43 392 0.14 219 0.08 119 0.04 84 0.03 
 III-M 4,299 1,957 0.46 799 0.19 463 0.11 222 0.05 160 0.04 
 IV 3,771 1,701 0.45 548 0.15 300 0.08 210 0.06 120 0.03 
 V 1,301 526 0.40 200 0.15 114 0.09 77 0.06 56 0.04 
  14,955 6,660 0.45 2,435 0.16 1,348 0.09 757 0.05 494 0.03 
Age less 
75 I 545 360 0.66 133 0.24 68 0.12 50 0.09 39 0.07 
 II 2,235 1,537 0.69 578 0.26 272 0.12 186 0.08 126 0.06 
 III-NM 2,804 1,762 0.63 580 0.21 300 0.11 223 0.08 144 0.05 
 III-M 4,299 2,978 0.69 1,193 0.28 619 0.14 404 0.09 291 0.07 
 IV 3,771 2,516 0.67 826 0.22 420 0.11 356 0.09 250 0.07 
 V 1,301 799 0.61 300 0.23 150 0.12 149 0.11 96 0.07 
  14,955 9,952 0.67 3,610 0.24 1,829 0.12 1,368 0.09 946 0.06 
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Length of Stay 
The length of stay for each cardiovascular disease according to SED measured by Carstairs 
Morris index is outlined in Table 89. There was a trend towards increased length of stay 
for any CVD admission in the most deprived. However, when specific cardiovascular 
diseases were examined socioeconomic gradients in the mean length of stay were 
observed, though many were non-significant. The length of stay for a coronary heart 
disease admission was nearly 4 days longer in the most deprived versus the least deprived. 
When social class was used as the measure of SED (Table 90) a gradient in the length of 
stay for any CVD admission was seen but no clear gradient for each of the specific 
cardiovascular diseases was observed.  
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Table 89 Length of stay for each type of cardiovascular hospitalisation over follow up according to Carstairs Morris index 
  N total los 95% CI Mean 95% CI P Median IQR P 
CVD 1 990 11727 9375 14079 14.34 11.46 17.21  6 2 13  
 3 2084 40261 30149 50373 20.02 14.99 25.05  6 2 13  
 4 3347 62666 50287 75045 19.50 15.65 23.35  6 2 13  
 5 5534 93185 82194 104176 17.38 15.33 19.43  6 2 13  
 6&7 3389 71791 58436 85146 21.94 17.86 26.02 0.06 7 3 15 0.005 
  15344 279630 230440 328820 18.63 15.06 22.21  6 2 14  
              
CHD 1 990 1933 1667 2199 8.52 7.34 9.69  7 2 11  
 3 2084 5968 5469 6467 8.13 7.45 8.81  6 2 10  
 4 3347 9489 8341 10637 9.00 7.91 10.09  6 2 11  
 5 5534 21703 16406 27000 11.26 8.51 14.01  7 3 11  
 6&7 3389 14105 7827 20383 12.47 6.92 18.02 0.5 6 2 11 0.36 
  15344 53198 39709 66687 9.88 7.63 12.12  6 2 11  
              
MI 1 990 1283 1097 1469 9.87 8.44 11.30  8 4 14  
 3 2084 3652 3296 4008 10.71 9.67 11.75  9 5 14  
 4 3347 6197 5123 7271 12.94 10.70 15.18  9 5 15  
 5 5534 13507 9037 17977 15.06 10.07 20.04  10 6 15  
 6&7 3389 10232 3976 16488 19.02 7.39 30.65 0.45 9 5 15 0.008 
  15344 34871 22529 47213 13.52 9.25 17.78  9 5 15  
              
Stroke 1 990 4622 2696 6548 39.17 22.85 55.49  16 3 37  
 3 2084 25290 15462 35118 75.27 46.02 104.52  15 5 45  
 4 3347 33942 22113 45771 63.32 41.26 85.39  13 4 41  
 5 5534 44877 35743 54011 53.05 42.25 63.84  12 4 37  
 6&7 3389 38372 27244 49500 68.77 48.82 88.71 0.18 14 5 43 0.56 
  15344 147103 103258 190948 59.92 40.24 79.59  14 4 14  
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HF 1 990 1304 1008 1600 12.66 9.79 15.53  7 3 15  
 3 2084 1842 1545 2139 11.58 9.72 13.45  8 4 16  
 4 3347 7052 5387 8717 16.79 12.83 20.76  9 5 17  
 5 5534 8575 7231 9919 14.20 11.97 16.42  8 4 16  
 6&7 3389 6098 5486 6710 14.31 12.88 15.75 0.18 10 5 18 0.03 
  15344 24871 20658 29084 13.91 11.44 16.38  9 5 16  
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Table 90 Length of stay for each type of cardiovascular hospitalisation over follow up according to social class 
  N total los 95% CI Mean 95% CI P Median IQR P 
CVD I 545 7112 4254 9970 14.40 8.61 20.18  6 2 12  
 II 2,235 30508 27557 33459 13.37 12.08 14.67  6 2 13  
 III-NM 2,804 47009 36862 57156 18.32 14.37 22.27  6 2 13  
 III-M 4,299 72285 60328 84242 17.49 14.60 20.38  7 2 14  
 IV 3,771 77456 64434 90478 21.59 17.96 25.22  7 2 14  
 V 1,301 33349 23976 42722 27.29 19.62 34.96 0.04 7 2 15 <0.001 
  14,955 267719 217412 318026 18.74 14.54 22.95  6 2 14  
              
CHD I 545 1306 1074 1538 7.96 6.55 9.38  6 2 11  
 II 2,235 6544 5977 7111 8.07 7.37 8.77  6 2 10  
 III-NM 2,804 10720 4459 16981 13.33 5.55 21.12  7 2 10  
 III-M 4,299 16987 12465 21509 10.85 7.96 13.73  7 2 12  
 IV 3,771 11358 10160 12556 9.54 8.54 10.55  3 3 11  
 V 1,301 3836 3394 4278 9.07 8.02 10.11 0.26 6 3 12 0.17 
  14,955 50751 37529 63973 9.80 7.33 12.28  6 2 11  
              
MI I 545 927 725 1129 11.30 8.84 13.77  9 5 14  
 II 2,235 3888 3461 4315 11.05 9.83 12.26  9 5 15  
 III-NM 2,804 8215 1974 14456 20.49 4.92 36.05  9 6 13  
 III-M 4,299 11715 7257 16173 15.43 9.56 21.31  10 6 15  
 IV 3,771 7074 5971 8177 13.08 11.04 15.11  9 5 15  
 V 1,301 2471 2095 2847 12.11 10.27 13.96 0.49 10 5 15 0.2 
  14,955 34290 21484 47096 13.91 9.08 18.74  9 5 15  
              
Stroke I 545 3531 757 6305 45.86 9.83 81.89  11 5 25  
 II 2,235 11933 9679 14187 38.37 31.12 45.62  14 4 43  
 III-NM 2,804 21663 14099 29227 54.43 35.42 73.44  13 4 38  
 III-M 4,299 36157 25433 46881 52.71 37.07 68.34  12 4 35  
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 IV 3,771 45294 32920 57668 73.65 53.53 93.77  14 5 40  
 V 1,301 22096 13256 30936 89.82 53.89 125.76 0.19 17 6 50 0.039 
  14,955 140674 96144 185204 59.14 36.81 81.47  14 4 40  
              
HF I 545 908 721 1095 13.35 10.60 16.11  11 5 18  
 II 2,235 3639 3092 4186 13.78 11.71 15.86  8 5 16  
 III-NM 2,804 3930 2581 5279 15.00 9.85 20.15  8 5 16  
 III-M 4,299 6132 5358 6906 13.33 11.65 15.01  9 4 16  
 IV 3,771 6746 5358 8134 15.58 12.37 18.79  9 5 17  
 V 1,301 2943 2217 3669 17.31 13.04 21.58 0.26 10 5 18 0.53 
  14,955 24298 19326 29270 14.73 11.54 17.92  9 5 17  
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The cost cardiovascular disease 
The total cost of admissions over the course of follow up was calculated using NHS costs. 
Over the course of follow up the most deprived accrued costs of £10.4 million (95%CI 
£8.6 -12.1 million) whereas the least deprived accrued costs of only £1.8 (1.47-2.2 
million), nearly a fifth of the costs (Table 91). The cost per person was higher in the most 
deprived groups. To account for the shorter life expectancy, the cost per 100 person years 
of follow up were calculated and were similarly higher with increasing deprivation.  
The cost of admissions was also calculated using social class (Table 92). In social class V a 
total of £4.9 million (95%CI £3.6-6.2 million) was spent on hospital admissions for 
cardiovascular disease. In social class I this figure was £1.8 million (£0.7-2.2 million). The 
cost of cardiovascular admissions per person again displayed a gradient with increasing 
cost with increasing deprivation. Similar results were observed when costs per 100 person 
years of follow up were calculated.  
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Table 91 Total cost, cost per person and cost per 100 person years of follow up of cardiovascular hospitalisations by Carstairs Morris index 
  N Total cost 95% CI 
Cost per  
person 95% CI 
Cost 
per 
100 
person 
years 95% CI 
CVD 1 990 1838840 1474637 2203043 1857 1490 2225 8331 6681 9982 
 3 2084 5864784 4508431 7221137 2814 2163 3465 12737 9792 15683 
 4 3347 9268959 7683509 10900000 2769 2296 3257 13924 11542 16374 
 5 5534 13700000 12200000 15200000 2476 2205 2747 19198 17096 21300 
 6&7 3389 10400000 8644849 12100000 3069 2551 3570 8865 7369 10314 
  15344 41072583 34511426 47624180 2677 2249 3104 12702 10673 14728 
            
CHD 1 990 287706 249306 326107 291 252 329 1304 1130 1478 
 3 2084 882182 799565 964800 423 384 463 1916 1737 2095 
 4 3347 1424624 1247787 1601461 426 373 478 2140 1874 2406 
 5 5534 3019709 2433039 3606379 546 440 652 4232 3409 5054 
 6&7 3389 1961437 1220061 2702813 579 360 798 1672 1040 2304 
  15344 7575659 5949758 9201559 494 388 600 2343 1840 2846 
            
MI 1 990 277182 236432 317932 280 239 321 1256 1071 1440 
 3 2084 793952 705877 882026 381 339 423 1724 1533 1916 
 4 3347 1377045 1120015 1634075 411 335 488 2069 1682 2455 
 5 5534 2695642 2041238 3350047 487 369 605 3777 2860 4694 
 6&7 3389 2101779 962366 3241193 620 284 956 1792 820 2763 
  15344 7245600 5065929 9425273 472 330 614 2241 1567 2915 
            
Stroke 1 990 1067839 640238 1495439 1079 647 1511 4838 2901 6776 
 3 2084 5131479 3279293 6983664 2462 1574 3351 11145 7122 15167 
 4 3347 7010453 4891650 9129256 2095 1462 2728 10531 7348 13714 
  207 
 5 5534 9323859 7537612 11100000 1685 1362 2006 13066 10562 15554 
 6&7 3389 7895208 5782386 10000000 2330 1706 2951 6730 4929 8524 
  15344 30428838 22131179 38708359 1983 1442 2523 9410 6844 11971 
            
HF 1 990 224401 170240 278561 227 172 281 1017 771 1262 
 3 2084 297537 249058 346015 143 120 166 646 541 751 
 4 3347 1142671 887325 1398016 341 265 418 1717 1333 2100 
 5 5534 1448120 1210626 1685613 262 219 305 2029 1696 2362 
 6&7 3389 9829343 882531 1083356 2900 260 320 8378 752 923 
  15344 12942072 3399779 4791562 843 222 312 4002 1051 1482 
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Table 92 Total cost, cost per person and cost per 100 person years of follow up of cardiovascular hospitalisations by social class 
  N Total cost 95% CI  
Cost per  
person 95% CI 
Cost per 
100 
person 
years 95% CI 
CVD I 545 1046991 674484 1419498 1921 1238 2605 8445 5440 11450 
 II 2,235 4734851 4282977 5186724 2119 1916 2321 18144 16413 19876 
 III-NM 2,804 6970454 5624946 8315962 2486 2006 2966 13929 11240 16618 
 III-M 4,299 10400000 8939809 11800000 2419 2080 2745 16535 14214 18761 
 IV 3,771 11300000 9575601 13000000 2997 2539 3447 14487 12276 16666 
 V 1,301 4905107 3574343 6235871 3770 2747 4793 5717 4166 7268 
  14955 39357403 32672160 45958055 2632 2185 3073 12485 10364 14579 
            
CHD I 545 190617 159877 221357 350 293 406 1538 1290 1785 
 II 2,235 985167 890892 1079442 441 399 483 3775 3414 4136 
 III-NM 2,804 1498997 760547 2237446 535 271 798 2995 1520 4471 
 III-M 4,299 2278342 1843735 2712948 530 429 631 3622 2931 4313 
 IV 3,771 1703256 1515021 1891492 452 402 502 2184 1942 2425 
 V 1,301 554753 490329 619178 426 377 476 647 571 722 
  14955 7211132 5660401 8761863 482 378 586 2288 1796 2779 
            
MI I 545 545 201511 161589 370 296 443 1625 1303 1947 
 II 2,235 2,235 846232 741216 379 332 426 3243 2840 3645 
 III-NM 2,804 2,804 1689665 555996 603 198 1007 3376 1111 5642 
 III-M 4,299 4,299 2260264 1610826 526 375 677 3594 2561 4626 
 IV 3,771 3,771 1579724 1308454 419 347 491 2025 1677 2373 
 V 1,301 1,301 526627 440763 405 339 471 614 514 714 
  14955 14955 7104023 4818844 475 322 628 2254 1529 2978 
            
            
  209 
Stroke I 545 708426 200142 1216711 1300 367 2232 5714 1614 9814 
 II 2,235 2681861 2189098 3174624 1200 979 1420 10277 8389 12165 
 III-NM 2,804 4584828 3090766 6078890 1635 1102 2168 9162 6176 12147 
 III-M 4,299 7392436 5517640 9267232 1720 1283 2156 11753 8773 14734 
 IV 3,771 9204139 6916172 11500000 2441 1834 3050 11800 8867 14743 
 V 1,301 4581412 2803893 6358932 3521 2155 4888 5340 3268 7411 
  14955 29153102 20717711 37596389 1949 1385 2514 9248 6572 11926 
            
HF I 545 156416 123162 189671 287 226 348 1262 993 1530 
 II 2,235 617753 518641 716865 276 232 321 2367 1987 2747 
 III-NM 2,804 641908 436262 847553 229 156 302 1283 872 1694 
 III-M 4,299 986445 860832 1112059 229 200 259 1568 1369 1768 
 IV 3,771 1077031 852644 1301417 286 226 345 1381 1093 1668 
 V 1,301 474052 349595 598509 364 269 460 553 407 698 
  14955 3953605 3141135 4766075 264 210 319 1254 996 1512 
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Population attributable fraction 
The population attributable fraction was calculated for the traditional risk factors for 
cardiovascular disease and also for socioeconomic deprivation (Table 93). The fraction of 
cardiovascular disease that was attributable to SED in this cohort was 13.7%. This was 
higher than serum cholesterol but lower than age, sex, smoking, diabetes and hypertension. 
For cardiovascular disease, CHD and MI the attributable risk of SED was generally similar 
to most of the other cardiovascular risk factors of smoking, serum cholesterol and 
hypertension. The attributable risk of SED in stroke and HF was similar to serum 
cholesterol. 
Table 93 Population attributable fraction for cardiovascular risk factors and Carstairs Morris 
index.  
 CVD CHD MI Stroke HF 
Age (55-64 vs. 45-54) 14.9 4.5 3.7 16.0 2.3 
Sex (Men vs. women) 16.2 8.3 7.3 5.7 1.7 
Smoking vs. non smoking 15.6 6.6 5.8 1.5 1.0 
Cholesterol (>5mmol vs. 
<5mmol) 13.4 5.2 4.4 2.2 1.1 
Diabetes vs. no diabetes 45.7 12.6 4.7 13.6 15.3 
Hypertension (>140mmHg vs. 
<140mmHg) 17.3 6.4 5.1 4.4 2.4 
Deprivation (most vs. least 
deprived) 13.7 5.4 4.3 2.8 1.0 
 
Calculation of the average population attributable fraction associated with SED was similar 
to that of smoking and hypertension following adjustment for the other factors in the table 
(Table 94). This risk was present for all cardiovascular event types.  
Table 94 Average population attributable fraction for cardiovascular risk factors and 
Carstairs Morris index 
 CVD CHD MI Stroke HF 
Age (55-64 vs. 45-54) 2.1 -0.3 0.3 16.0 8.9 
Sex (Men vs. women) 3.3 10.1 11.5 -8.5 6.4 
Smoking vs. non smoking 10.1 13.8 19.3 1.5 3.3 
Cholesterol (>5mmol vs. 
<5mmol) 13.6 23.9 28.0 2.2 16.5 
Diabetes vs. no diabetes 0.7 0.4 0.07 0.7 1.8 
Hypertension (>140mmHg vs. 
<140mmHg) 10.4 10.8 9.8 17.4 20.7 
Deprivation (most vs. least 
deprived) 7.8 13.0 10.2 22.9 4.3 
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The attributable fraction for SED measured by social class was similar to that of SED as 
measured by Carstairs Morris index (Table 95). A similar relationship to the other risk 
factors was also observed.  
Table 95 Population attributable fraction of cardiovascular risk factors and social class 
 CVD CHD MI Stroke HF 
Age (55-64 vs. 45-54) 14.9 4.5 3.7 16.0 2.3 
Sex (Men vs. women) 16.2 8.3 7.3 5.7 1.7 
Smoking vs. non smoking 15.6 6.6 5.8 1.5 1.0 
Cholesterol (>5mmol vs. 
<5mmol) 13.4 5.2 4.4 2.2 1.1 
Diabetes vs. no diabetes 45.7 12.6 4.7 13.6 15.3 
Hypertension (>140mmHg vs. 
<140mmHg) 17.3 6.4 5.1 4.4 2.4 
Deprivation (most vs. least 
deprived) 12.4 3.7 3.1 3.6 1.7 
 
When social class was used as the measure of SED the average attributable fraction was 
higher only for cholesterol and hypertension (Table 96).  
Table 96 Average population attributable fraction of cardiovascular risk factors and social 
class 
 CVD CHD MI Stroke HF 
Age (55-64 vs. 45-54) -0.7 -5.0 -3.8 14.7 1.5 
Sex (Men vs. women) 4.3 6.9 11.4 -7.6 1.2 
Smoking vs. non smoking 0.5 4.6 7.5 6.5 -7.6 
Cholesterol (>5mmol vs. 
<5mmol) 13.9 33.5 29.8 -7.5 21.3 
Diabetes vs. no diabetes 0.7 4.2 0.5 1.1 1.3 
Hypertension (>140mmHg 
vs. <140mmHg) 13.8 16.8 13.4 18.0 25.0 
Deprivation (most vs. least 
deprived) 11.4 7.3 10.8 13.2 24.7 
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Discussion 
In this chapter I report that greater socioeconomic deprivation is associated with a greater 
risk of death at all ages. Furthermore, this translates into a longer life expectancy amongst 
the least deprived. This risk persists after adjustment for traditional cardiovascular risk 
factors. The risk of a cardiovascular death is also higher in the most deprived and is only 
attenuated but not abolished by adjustment for cardiovascular risk factors.  
The most deprived also experience more hospital admissions for cardiovascular disease 
than the least deprived and tend to stay longer in hospital than the least deprived. Despite 
the shorter life span of the most deprived this increase in the number of hospital 
admissions led to a higher cost per person in the most deprived than the least deprived over 
the period of follow up.  
All cause and cardiovascular mortality 
Multiple previous studies have examined the relationship between socioeconomic 
deprivation and all cause mortality.7,16,35,51,248-251 In all studies the most deprived display 
consistently higher mortality rates than the least deprived irrespective of the method of 
defining socioeconomic deprivation. Cardiovascular mortality has also been examined by a 
number of authors.33,40,41,45,52,53,97,142,227,252 Not only is cardiovascular mortality higher in 
the most deprived but also coronary heart disease and stroke mortality. In this study I 
examined cardiovascular mortality and the results are congruent with other studies 
irrespective of the country examined or the measure of socioeconomic deprivation used. 
Few studies, however, have attempted to adjust the association between SED and 
cardiovascular mortality for traditional cardiovascular risk factors. In a study of 14 642 
Finnish men and women Harald et al142 only adjusted for smoking, hypertension and serum 
cholesterol. Strand et al40 failed to adjust for the presence of diabetes. One study from 
Western Australia did adjust for all of the “traditional” cardiovascular risk factors and 
found that the risk of cardiovascular mortality was non-significant (HR 1.18 (95% CI 0.78-
1.77)) in those with the least education compared to the most education, though follow up 
was relatively short (9 years).253 
Premature mortality 
As a consequence of the higher risk of all cause and cardiovascular mortality, the risk of 
death at predefined ages was performed. The association of SED with premature all cause 
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mortality has been reported before.42,249,254 The relationship is seen in both men and 
women.254 Similarly, reports of higher premature cardiovascular mortality have been 
published.41,42,252 However, these studies are based on routine data sources such as 
hospitalisation databases or routine death certificate data and have failed to adjust for the 
cardiovascular risk factors that were adjusted for in this study.  
Socioeconomic deprivation increases the risk of a number of diseases. This may occur 
through a number of pathways. Obvious pathways are through higher rates of smoking 
with in turn increase lung cancer rates. Increasing SED may work through other mediators 
such as poorer housing which may lead to increasing risk of respiratory disease. It is clear 
form these data that the risk of all cause and cardiovascular mortality is independent of 
traditional cardiovascular risk factors and therefore other pathways must mediate this 
relationship. Other suggestions have been explored such as work stress, psychosocial 
stress,255,256 heart rate variability195 and response to exercise195. Other hypotheses such as 
increased pathogen burden as a result of poorer environment have also been explored.180 
Whilst traditional risk factors do not appear to explain the entire relationship they are a 
large part of it.38,257 In this study, as in all others, adjustment for traditional cardiovascular 
risk factors attenuates, but does not completely eliminate, the relationship.  
Admissions 
The burden of cardiovascular disease according to socioeconomic status is less well 
studied. Although absolute numbers of admissions have not been measured by SED over a 
period of follow up, it can be extrapolated, from studies of disease incidence that use 
hospitalisations as a proxy, 68,73,122 that the deprived individuals in a society experience 
more admissions. I have found that despite surviving longer, the least deprived, experience 
less hospital admissions for cardiovascular causes. As a consequence, the costs accrued 
over the lifespan of the most deprived, were higher than the least deprived individuals. 
Neither of these observations have been reported in the literature. These data have 
important implications for health systems around the world and policy makers.  
This may at first sight be an intuitive observation. More deprived individuals tend to have 
poorer health, a worse risk factor profile, poorer health behaviours and more co-morbid 
disease. All of these factors would suggest that they are likely to experience more 
hospitalisations for cardiovascular disease. However, they also are more likely to die 32,49,97 
and to die at an earlier age42,252,254. This would appear to present less of an opportunity to 
accrue costs i.e. to spend less time at risk for a hospitalisation. However, as described in 
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this chapter the most deprived are still experiencing more hospitalisations despite this 
increased mortality. Therefore, not only do the most deprived individuals live shorter lives 
but the quality of that life (as denoted by more hospitalisations) is poorer.  
Length of stay 
The length of stay for hospital admissions for a range of cardiovascular diseases has not 
been examined in relation to SED in one cohort before. The more prolonged stays in the 
most deprived may reflect a number of factors. It may reflect more severe presentations in 
the most deprived versus the least deprived, with a consequently longer recuperation time. 
For example, in a study of patients admitted to hospital with stroke, the most deprived 
were more likely to need assistance with walking as a consequence of their stroke than the 
least deprived indicating that they had experienced a more severe stroke.115 In studies of 
myocardial infarction there is evidence that the severity of the myocardial infarct varies 
with socioeconomic deprivation.77 In addition, the increased prevalence of co-morbid 
diseases which would slow discharge rates in the most deprived e.g. dementia 84 may also 
explain why length of stay is higher in the most deprived.  
Another factor influencing the length of stay may also be the treatment received by 
individuals during a hospital stay. It has been described that the most deprived are less 
likely to receive certain pharmacological therapies230 and procedures such as coronary 
angioplasty79,231. Whilst most therapies are instituted for the benefit of secondary 
prevention it would appear that the lack of prescription of these therapies may serve as a 
marker for less aggressive treatment in hospital which in turn may be a cause of longer 
lengths of stay.  
Finally, SED is a complex construct of many factors. Not only does it capture material 
wealth, but it also may capture social support mechanisms, social isolation and 
environment.4 These factors may also lead to increased length of stay. An individual with 
more social support and better finances may be able to leave hospital earlier than someone 
without and recover better258. They may be more able to return home to a more amenable 
environment following the development of cardiovascular diseases such as stroke than 
someone who lives in a more deprived area and who therefore may need to be re-housed.  
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Cost of cardiovascular disease 
The cost to the NHS in terms of hospitalisations was estimated in these analyses and again 
despite living shorter lives the most deprived accrued the most costs over follow up. This is 
as a result of the number of admissions they suffered and the length of time spent in 
hospital per admission. This has important financial implications for the NHS and policy 
planners. Furthermore, deprivation not only costs society from the direct costs of 
healthcare but also in societal costs (time off work, unemployment, benefit payments) and 
therefore to understand the mechanism behind the drivers of increased costs, more and 
longer admissions, is crucial. As noted in the literature review, there is little information on 
the costs of cardiovascular care by SED.138 The findings of the present study would 
suggest that the cost of SED to the NHS is high and efforts to reduce these inequalities 
need to be made. 
Limitations 
The cause of death was determined using death certificate data. This raises concerns about 
the validity of the diagnosis of a cardiovascular death. However, studies in the UK259, 
Finland260 and USA261, and elsewhere would suggest that the validity of cardiovascular 
causes of death on death certificates are suitable for epidemiological research. These 
studies confirm that in older age groups the accuracy of a coronary cause of death is lower, 
though they disagree on the age at which the accuracy starts to fall, with a UK study 
259suggesting this is between 65-74 years and a study from the USA261 suggesting accuracy 
is lower after the age of 75 years. Other studies of stroke and certified deaths from stroke 
in the UK would suggest that the use of a death record indicating that stroke was the cause 
of death has good accuracy and predictive value for identifying a stroke.262  
The full burden of cardiovascular disease according to socioeconomic deprivation could 
not be calculated in this study. No data were available on what drug therapy each 
individual was prescribed or the primary care or outpatient care that they received. This 
area requires further research to help define and refine the full costs to a healthcare system 
of socioeconomic deprivation. 
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Summary  
In this chapter I have demonstrated that SED is associated with a higher risk of all cause 
mortality, cardiovascular mortality and premature mortality. This association is present 
after adjustment for cardiovascular risk factors. The most deprived also used more hospital 
resources over the course of follow up. This was due to a larger number of cardiovascular 
admissions and a longer length of stay in the most deprived groups. This translated into a 
larger total cost to the NHS during the course of follow up. Finally, I report that the 
population attributable fraction of SED in a number of cardiovascular disorders was similar 
to that of classical risk factors for cardiovascular disease. 
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Discussion  
Summary of findings 
The aim of these studies was to assess the association between socioeconomic deprivation 
and the risk of a number of forms of cardiovascular disease in a large cohort of men and 
women over a prolonged period of time, and to determine whether an association persisted 
following adjustment for known cardiovascular risk factors. In this cohort, SED was 
associated with a higher risk of an incident cardiovascular hospitalisation, death following 
an incident cardiovascular hospitalisation, cardiovascular and all-cause mortality, lifetime 
hospital burden and cost of hospitalisations. There was however, no association between 
SED and the risk of recurrent cardiovascular hospitalisations following adjustment for 
recognised cardiovascular risk factors.  
The relationship between socioeconomic deprivation and 
cardiovascular disease 
In these analyses I have shown that SED is associated with the risk of a hospitalisation for 
cardiovascular disease, any coronary heart disease, myocardial infarction, stroke and heart 
failure. Whilst at first sight these findings are in keeping with the literature presented in the 
first chapter of this thesis, these analyses are important additions to the literature as no 
prior study has been able to examine this relationship in both men and women or to 
examine all these forms of cardiovascular disease in one cohort. This is a major strength of 
these studies. Previous high quality longitudinal studies such as the Whitehall studies263 are 
limited by the inclusion of only men with a limited range of occupational experiences and 
therefore are not representative of the population. Also this study is the first to examine all 
forms of cardiovascular disease. Many studies have tried to find a mechanistic link 
between SED and cardiovascular disease.38,226,255,257 However these analyses would 
suggest that SED mediates a higher risk for cardiovascular disease through either one 
common factor to all forms of cardiovascular disease or through multiple factors that are 
differentially important in the pathogenesis of each different form of cardiovascular 
disease. William of Occam stated “Pluralitas non est ponenda sine necessitate; Plurality 
should not be posited without necessity”. Following Occam’s razor it should be expected 
that a simpler explanation of a common pathway mediating SED and CVD risk would 
seem the most likely. However, Chatton’s anti razor also may hold true in this setting in 
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that “If three things are not enough to verify an affirmative proposition about things, a 
fourth must be added, and so on” thus it may be that SED exerts its effect via different 
pathways. Much of current literature suggests that SED may exert its effect via different 
pathways.38,255,257  
Employing a classical biological model of disease, the differential distribution of risk 
factors in different socioeconomic groups has long been proposed as a potential 
mechanism. Multiple authors report that differential distribution of risk factors explain 
most, if not all, of the differential rates of cardiovascular disease.100,142,226,257 However, in 
these analyses the association between SED and each cardiovascular disease was still 
present after accounting for the different distribution of cardiovascular risk factors through 
the multivariable analyses. What is clear is that risk factors do tend to cluster in the most 
deprived. Understanding why this occurs and what may be done to change these unhealthy 
patterns is needed.  
Should socioeconomic deprivation be a cardiovascular 
risk factor? 
The variation in cardiovascular disease rates varies according to the distribution of the 
traditional risk factors of smoking, hypercholesterolaemia, hypertension and diabetes. 
However, the entire variation of CVD rates is not explained by these factors.38,71,264 
Socioeconomic factors seem to explain the remainder of this variation. This study, as well 
as others in the published literature, suggests that SED is indeed an independent risk factor 
even after adjustment for the above CVD risk factors. Kuller265 has set out criteria to 
determine if a factor should indeed be called a risk factor. These criteria for a new risk 
factor are  
1. It should be shown experimentally that it would increase the extent of atherosclerosis or 
its complications in suitable animal models.  
This is of course very difficult, if not impossible to do in this context. 
2. Persons with CVD would have either a higher risk (if the factor is directly correlated 
with coronary disease) or lower risk of disease (if inversely correlated with the level of the 
risk factor) than carefully matched controls.  
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Whilst this is not a case control study, prior case control studies have reported that SED is 
associated with a higher risk of CVD.266 
3. Distribution of risk factors should be correlated with the incidence, prevalence, and 
mortality of atherosclerotic disease within and between populations.  
This study has shown that SED is correlated with the incidence and mortality of CVD.  
4. People exposed to the factor would have a higher risk of coronary disease in 
longitudinal studies.  
Again these analyses of a longitudinal cohort clearly demonstrate that over a long period of 
time in both men and women the risk of CVD is higher in the most deprived.  
5. There should be a time-dose relation: the higher the dose the earlier the onset of the 
disease.  
A number of studies have reported that SED in early life is associated with the 
development of CVD in adulthood, suggesting that a prolonged exposure to deprivation 
leads to a greater risk of CVD in comparison to those who increase their social status 
through life.267-269   
6. The results of studies should be consistent from study to study, and ideally in different 
cultural settings.  
This study adds to the totality of the literature surrounding SED and CVD. It should be 
acknowledged that this cohort is limited in terms of its ethnic make up. However, other 
studies would suggest that the relationship between SED and CVD is present in different 
ethnic groups.102,145 
7. The relation between the risk factor and the disease should be independent of other 
known risk factors unless it enhances the predictive power of these risk factors.  
Investigation of this rule is a central part of this thesis. I have demonstrated that SED is a 
risk factor independent of the traditional risk factors for CVD. This relationship has been 
demonstrated in these studies for multiple forms of CVD i.e. coronary heart disease, stroke 
and heart failure.  
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8. Evidence should be available in either humans or a suitable animal model that 
modification of the risk factor would result in the reversal of the progression of 
atherosclerosis or clinical disease.  
This rule is difficult to prove in the context of SED and CVD. Not only is changing SED 
difficult but it is very difficult to determine the causal link with any subsequent decrease in 
CVD rates.  
9. The risk factors should make sense in relation to a biological model for cardiovascular 
disease. 
Studies have reported that SED affects levels of other physiological cardiovascular risk 
factors and health behaviours which confer cardiovascular risk.  
As can be seen these studies and others allow most of the above criteria to be filled by SED 
in relation to becoming a CVD risk factor. Kuller reported that few of the major risk 
factors met all of the above criteria for a relation with coronary disease. However, SED 
would appear to meet most of the above prerequisites for a new risk factor.  
Utilising socioeconomic deprivation as a risk factor 
Developed countries require risk factor screening that acknowledges the higher risk of the 
most deprived members of its society. Only through correct identification of these 
individuals will their higher risk be appreciated and interventions designed to lower their 
risk be accurately delivered. Brindle et al270 examined the Framingham risk score in the 
Renfrew Paisley cohort and determined how it performed in each socioeconomic group. 
Cardiovascular disease mortality was underestimated by 48% in the manual participants of 
the cohort (i.e. the most deprived) as compared to 31% in the non-manual classes, the least 
deprived. A similar finding was reported for the relationship between SED as measured by 
Carstairs Morris index and the ability of the Framingham risk score to predict events. This 
leads to the conclusion that current risk scores underestimate the risk of cardiovascular 
mortality in the most deprived individuals in society. It is not only in Scotland that this has 
been observed. In the USA, a study of the Atherosclerosis Risk in Communities study 
examined the model discrimination and calibration of the Framingham risk score with and 
without SED as measured by income and by education.271 In the most deprived the risk of 
coronary heart disease as estimated by the Framingham risk score was 3.7% as compared 
to 3.9% in the least deprived. The observed risks were 5.6% and 3.1% respectively again 
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demonstrating that this risk score underestimates risk in the most deprived. After addition 
of SED to the risk score the predicted risk was 3.1% in the least deprived and 5.2% in the 
most deprived, more closely matching the observed rates. These findings were also 
validated in the same study in another cohort, the National Health and Nutritional 
Examination Study.  
In recognition of these findings, the UK now has two risk scores that incorporate SED into 
the risk score. The ASSessing cardiovascular risk, using SIGN (ASSIGN) risk score was 
developed in the Scottish Heart Health Extended Cohort to allow better risk predication 
amongst individuals of all socioeconomic groups.272 In this study SED was measured using 
the Scottish Index of Multiple Deprivation (SIMD). This score incorporates multiple 
components from a number of social agencies. Small areas are assigned a score from 0.54 
(the least deprived) to 87.6 (the most deprived) and the population is then divided in to 
quintiles. ASSIGN classified more people with social deprivation and positive family 
history as high risk, anticipated more of their events, and abolished the gradient in 
cardiovascular event rates seen when risk was predicted solely using the Framingham 
score. In England and Wales a prospective cohort study in a large UK primary care 
population was used to develop a risk prediction model that included SED.273,274 In this 
study, version 14 of the QRESEARCH database, a large, validated electronic database 
representative of primary care and containing the health records of 10 million patients over 
a 17 year period from 529 general practices was used to develop and validate the score. In 
this risk score, SED was defined on the basis of the area based score, the Townsend score. 
An analysis of a risk score in acute coronary syndromes has also been tested with regards 
to its calibration according to SED and has been found to be useful in all groups 
irrespective of SED.275 Therefore, increasing awareness of this issue will hopefully lead to 
SED being taken into account in the development of future risk scores.  
Limitations of the studies 
The current studies are not without their limitations. A strength of this study is that two 
measures of SED were examined, social class and Carstairs Morris index. However, social 
class could not be assigned to every individual in the cohort and women were assigned the 
social class of their husband if they did not have an occupation. Using an area based 
measure of SED can lead to the “ecological fallacy”, i.e. that the relationship between SED 
and CVD is the same at an individual level and the area level measure in the Carstairs 
Morris index. The assumption that individual members of the area are correctly defined by 
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the average characteristics of the small area assigned may in fact be false. However, the 
Carstairs Morris index is based on small enough areas that the ecological fallacy is less of a 
concern and the index has been well validated.10,11  
There are limitations to the historical nature of this cohort. Whilst a mature cohort study is 
necessary to examine associations over a prolonged period, the long follow up does give 
rise to some problems. The cohort was examined at baseline only; follow up clinical 
measures were not available. The effect of changing risk factor profiles could not be 
assessed in these data therefore. Risk factors such as blood pressure and cholesterol change 
over time, often increasing with advancing age. However subjects in this cohort may have 
undergone lifestyle, behavioural and/or pharmacotherapeutic interventions aimed at 
modifying CVD risk factors over the course of follow up. There is evidence that the 
traditional cardiovascular risk factors have changed differentially by SED over time with 
those in the most deprived groups developing more unfavourable risk factor profiles.146 For 
example, a large proportion of participants were smokers at baseline. With only one 
assessment of smoking status, taken at baseline, I could not assess how many people quit 
during follow up. Nor could I assess the potential impact of a CVD hospitalisation on 
smoking. Studies would suggest that the impact of a CVD hospitalisation on risk factors, 
such as smoking through cessation rates, differs by SED, with the least deprived being 
more likely to quit.229 Other factors may be similarly affected differentially by SED such 
as cholesterol levels through differing rates of prescription of cholesterol lowering 
therapies.165 These are limitations of the studies. Similarly, no information was collected 
during follow up regarding the use of evidence based therapies that might alter 
cardiovascular risk.  Finally, whilst the long period of follow up is a major strength of 
these studies it is also a potential limitation. Regression dilution occurred as follow up 
progressed.225 Past the period of 25 years of follow up the hazard ratios associated with 
SED started to fall. This is not due to the lack of an effect but rather regression dilution. 
However, the impact of regression dilution affects all variables but it is unclear how it 
affects SED specifically. 
SED was also measured at only one time point in this study. The Carstairs Morris index 
applied was derived from the 1981 census. Therefore, the index may not have accurately 
captured the socioeconomic conditions of the cohort at recruitment. In addition by middle 
age, SED status is fairly well fixed it is not impossible that some movement in SED status 
occurred during follow up.276 A number of other possible mediators between SED and the 
risk of CVD have been described in the literature such as behaviour, stress, job control255, 
physiological variables such as heart rate recovery195 etc. These variables were not 
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recorded or measured in this cohort and the effect of these on the associations between 
SED and CVD seen in this cohort cannot be estimated. As noted above, the continued 
effect or “dose” of SED may have a role to play in the development of CVD over a 
lifetime. SED was measured at the point of midlife, between the ages of 45-64 in this 
cohort. It is unknown what the cumulative life course “dose” of SED was in this cohort as 
childhood SED status is unknown in this cohort. Therefore, a life course approach to SED 
could not be made in this particular cohort. Finally, a family history of premature 
cardiovascular disease is recognised as a major risk factor alongside, diabetes, 
hypertension, smoking and serum cholesterol. This was not recorded in the cohort. 
However, the Framingham risk score also did not include family history of CVD as a 
variable and therefore the results of these studies are still valid.  
Finally, it must be acknowledged that this cohort was restricted to the ages of 45-64 years 
at enrolment. Whilst the relationship between SED and CVD is certainly present in 
younger age groups41 (and studies would suggest that the relationship is stronger65), 
caution should be used in extrapolation of the results of this thesis to other age groups. 
How do we change the risk of the most deprived? 
Efforts at the level of the individual 
The above studies and results would suggest that SED is an important risk factor for 
cardiovascular disease, over and above the traditional risk factors. However, the exact 
mechanism by which this excess risk if conferred is open to speculation. What is becoming 
clearer from the literature is that SED exerts its effect through many pathways. Therefore, 
any intervention to change the risk of the most deprived needs to acknowledge this and try 
to change multiple possible pathways. Immediately it seems as if these interventions are 
out of the reach of individual health care professional. Altering SED seemingly relies on 
policy and government action to alter the disparities in society. Government level action is 
needed for example to change housing standards for the most deprived members of a 
society or help lower unemployment. The minimum wage is another area where policy 
change can have beneficial effects on inequities in a society or similarly banning unhealthy 
behaviour such as smoking will impact upon all parts of society. Other initiatives such as 
the introduction of health targets or reallocation of health care resources to more deprived 
areas are other examples of how policy may help to reduce the differences in CVD 
according to SED. Other factors are harder for the state to intervene in such as the 
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possibility that social support mediates part of the relationship between SED and CVD. 
However, through the improvement of communities and facilities this may lead to 
improvements in social structures and hence support mechanisms. However, more complex 
interventions will be needed to tackle the inequalities not only in cardiovascular health but 
health in general. I will return to these later.  
These are difficult and daunting tasks for the clinician or health care professional. 
However, multiple areas exist where an individual health care professional can make a 
difference to the risk of CVD associated with SED. The first issue is of identification of 
risk. The ASSIGN272 and QRISK273,274 scores attempt to do this by including SED in their 
CVD risk scores. This will ensure that high risk individuals are appropriately identified in 
primary care and evidence based therapies that are known to lower risk of CVD are 
appropriately prescribed. This in turn will help to reduce the inverse care law 24, where the 
most deprived in most need of health care are less likely to receive it.  
Change is also required early on in an individual’s life course to alter the risk of future 
disease, and as a health care professional engaging with young adults about poor life style 
choices around risk factors such as smoking is possible and beneficial. Indeed risk factor 
management may have one of the largest roles to play in reducing the differences in CVD 
rates in the deprived members of society.257 The INTERHEART studies indicated that the 
large proportion of attributable risk for myocardial infarction was explained by nine risk 
factors, smoking, diabetes, hypertension, abdominal obesity, exercise, alcohol, 
apoB/apoA1 lipoprotein ratio, and a psychosocial index that measured the presence of 
depression and stress at work and at home.67 These factors accounted for 90.5% of the 
attributable risk of myocardial infarction in the 12461 cases of myocardial infarction in the 
study. In a recent analysis of the INTERHEART study, the addition of education as a 
marker of SED increased this attributable risk to only 92.7%.68 This would suggest that 
most, if not all, inequalities in myocardial infarction rates could be eliminated if the nine 
modifiable risk factors could be improved. This does not mean that SED is not a risk factor 
or important risk factor for CVD but that the absolute inequalities may be explained by 
these risk factors, which explain the majority of cases in a population, even though they do 
not explain all of the association between SED and CVD. Thus, in absolute terms, 
treatment of known risk factors in a population such as smoking and high cholesterol will 
reduce SED differences in CVD rates. To further illustrate this point, take the following 
hypothetical example. If a population existed where all individuals smoked, were diabetic 
and had hypertension the relative differences in SED and CVD would be explained by the 
other factors such as cholesterol. However, whilst an intervention to reduce serum 
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cholesterol would reduce the relative inequalities in CVD it would not reduce the absolute 
burden of CVD which was driven by the ubiquity of the other major risk factors in this 
theoretical population. Therefore, health care professionals have the opportunity to reduce 
relative and absolute burdens of CVD in the population by adequately addressing the risk 
factor profile of patients at risk of CVD. A study of this theory was conducted in the 
Whitehall cohort.257 The authors reported that reducing the burden of classical 
cardiovascular risk factors, blood pressure, cholesterol, diabetes and smoking would 
reduce by 69%, if current best available practice or pharmacotherapies were applied. If risk 
factors could be removed the reduction would be 86%. Therefore, despite this some 
inequality in coronary heart disease mortality would remain. The underlying reasons for 
such persisting difference are of course the subject of much current research in this area as 
the classical cardiovascular risk factors do not explain the entire gradient.  
As noted the INTERHEART studies highlighted the important contribution of 
psychosocial factors to the risk of myocardial infarction. However, psychosocial factors 
may also explain part of the relationship between SED and CVD. Depression can be 
screened for using simple tools.277,278 Through the identification of such patients 
appropriate pharmacological therapy or non-pharmacological therapy such as cognitive 
behavioural therapy could be prescribed in an effort to reduce such psychosocial risks. The 
reduction of other psychosocial stressors such as financial or housing worries is more 
difficult and lends itself to a political approach to altering SED differentials in CVD risk.  
Finally, the use of multidisciplinary teams by health care professionals may also lead to 
improvements in health outcomes in all members of society. It is difficult for one health 
care professional to address all the determinants of health. The use of multidisciplinary 
teams maximises the chances of therapies being prescribed in appropriate doses, and, 
maximises the support an individual may receive in making hard lifestyle choices and 
alterations such as smoking cessation. Specialist knowledge on the complex societal and 
contextual effects of the causes of smoking153, such as that held by smoking cessation staff 
may help to improve the chances of an individual ceasing to smoke.  
Whilst most of these interventions are not targeting SED per se they do target the known 
modifiable risk factors for CVD that most health care professionals are comfortable 
dealing with. These interventions do however focus the health care professional to try and 
supply these treatments and services to the most deprived, and indeed all members of 
society, and try to ensure equitable access in an attempt to reduce social inequities and the 
burden of CVD overall in society.  
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Political efforts to reduce health inequalities  
Whilst the individual health care professional can make some efforts to improve the health 
of individuals and therefore society as a whole, it is perhaps clear that given 
socioeconomic differences in health and CVD are the function of complex causes, that 
society level intervention will be required to help reduce these inequalities. From this 
study, and others, it has been shown that SED not only acts at the level of the individual 
but also at the level of small areas of residence.  
Since devolution, a number of policy documents have focused on the issue of health 
inequalities in Scotland. The first, the 1999 White Paper, Towards A Healthier Scotland21, 
recognised that health improvement initiatives should include not only lifestyle choices 
and the major diseases but also include life circumstances i.e. housing, employment, 
education, welfare benefits, childcare and community care. All actions were designed to 
reduce health inequalities. Policies outlined in this document were associated with funding 
commitments and aimed to redress inequalities through a number of schemes. For 
example, interventions were aimed at families and young children to improve social 
support through after school care and education, childcare tax credits. Other interventions 
were aimed at housing such as improving the insulation in homes of low income families; 
the Warm Deal Initiative. Towards a Healthier Scotland was followed by subsequent 
policy documents. The 2003 White Paper, Partnership for Care279, Improving Health in 
Scotland: The Challenge22, 2003, and the 2005 Delivering for Health report280, all of which 
highlighted the need to reduce inequalities in health. 
In 2007, the Scottish Government set up a Ministerial Task Force on Health Inequalities. 
The report of the Task Force, Equally Well281, was published in 2008 and outlined a 
number of recommendations for dealing with the underlying causes of health inequalities. 
These recommendations fell under a number of headings: early years & young people; 
tackling poverty and increasing employment; physical environments and transport; harms 
to health and well being, alcohol, drugs and violence; health and wellbeing.  
Equally Well was followed in 2008 by the Equally Well Implementation Plan282 which 
sought to outline how the aims of the Equally Well report could be achieved via policy. A 
further publication listed the indicators to be used in assessing progress in tackling 
inequalities - Long-term monitoring of health inequalities: first report on headline 
indicators283. Finally, it was originally aimed that the Ministerial Task Force on Health 
Inequalities would be reconvened to review progress since the publication of Equally Well 
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in 2008. The Task Force is expected to report by the summer of 2010. The review will 
specifically consider whether any further actions are required to tackle the inequalities 
outlined in the three social policy frameworks - Equally Well, the Early Years Framework 
and Achieving Our Potential. This will consider the prevailing financial climate, new 
trends or concepts or evidence in health inequalities.  
The reduction of health inequalities plays a pivotal role in the Scottish Government’s 
overall purpose of sustainable economic growth. The Government has committed to 
increase healthy life expectancy and the proportion of income earned by the three lowest 
income deciles as a group by 2017. Inequality-related indicators also make up some of the 
forty-five national indicators being used to track progress towards the achievement of 
national outcomes.284 Examples include, decreasing the proportion of individuals living in 
poverty, increasing healthy life expectancy at birth in the most deprived areas, and 
reducing mortality from coronary heart disease among the under 75s in deprived areas.  
In parallel to these social model approaches to tackling inequalities, the health services in 
Scotland are being redeveloped according to proposals in a report on health care 
delivery.285 This shifted the focus of care onto preventative measures, in an attempt to 
prevent these inequalities in health from occurring. This has not been the only change in 
preventative healthcare in Scotland. NHS Health Scotland has as one of its aims to reduce 
health inequalities. In Glasgow the establishment of the Glasgow Centre for Population 
Health was intended to develop a better understanding of health in Glasgow and to 
evaluate the impact of strategies with the aim of enhancing health and in particular 
reducing inequalities.  
Future areas of research 
This study consolidates the current level of evidence that SED is indeed related to the risk 
of cardiovascular disease, but furthers it by confirming the relationship in a number of 
cardiovascular outcomes, over a prolonged period, independent of cardiovascular risk 
factors. Just as these analyses examined a gap in the current evidence, other gaps still 
remain and should be the focus of further research.  
As was noted above, the traditional cardiovascular risk factors only explain part of the 
association between SED and CVD. It is important to now try and elucidate the mechanism 
by which SED confers this extra risk. Authors have examined such issues as pathogen 
burden180, access to healthcare286, and the influence of peri-natal life162 to name but a few 
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examples. However, no one unifying hypothesis has yet been found. As noted above, no 
one explanation may be found, though further research may elucidate the many pathways 
by which SED ultimately leads to a higher cardiovascular risk.  
In recent years the rate of research in the field of genetic epidemiology has increased 
considerably. Some authors have examined focussed genetic differences in an attempt to 
explain differences in disease rates by SED.163 However, overall this field of research is 
underutilised in the realm of SED and health, although this approach will need careful 
consideration of the ethical issues.287  
Finally, one further major gap in our knowledge surrounding SED and CVD requires 
further investigation. In this thesis I was not able to examine the relationship between SED 
and other forms for cardiovascular disease such as atrial fibrillation and venous 
thromboembolism. These other cardiovascular disease have also been understudied with 
respect to SED differences in incidence, survival, treatment etc.288,289 Further research on 
these and less studied cardiovascular diseases is required.  
Conclusions 
The conclusions and outcomes of the analyses presented in this thesis can be summarised 
as follows: 
Socioeconomic deprivation is associated with higher rates of hospitalisation for 
cardiovascular disease in men and women irrespective of the measure of SED, either social 
class or the area based score of the Carstairs Morris index.  
The association between SED and hospitalisations persists after adjustment for the 
traditional cardiovascular risk factors of age, sex, smoking, systolic blood pressure and 
diabetes. 
The further adjustment for lung function as measured by FEV1, obesity as measured by 
BMI and cardiomegaly on a chest x-ray failed to explain or diminish this relationship. 
The association between SED and CVD is similar in coronary heart disease, myocardial 
infarction and stroke and all cause mortality.  
The effect of SED is long lasting and persists beyond 25 years of follow up. 
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SED is associated with higher mortality following an admission to hospital with 
cardiovascular disease again after adjustment for cardiovascular risk factors of age, sex, 
smoking, systolic blood pressure and diabetes and adjusting for the year of first developing 
cardiovascular disease.  
SED is not associated with the risk of a recurrent cardiovascular hospitalisation.  
The risk of all cause death is highest in the most deprived. Again this association persists 
after adjustment for cardiovascular risk factors.  
The most deprived stay longer in hospital than the least deprived for a number of 
cardiovascular disease types including myocardial infarction and stroke.  
The costs associated with cardiovascular disease admissions to hospital are higher in the 
most deprived despite their higher risk of dying during follow up. This is mediated by a 
higher number of admissions per person and longer in hospital stays in the most deprived.  
The population attributable risk associated with SED is comparable to that of other 
traditional cardiovascular risk factors.  
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Appendix 1 
Search strategy employed in the search of the literature.  
 
1. exp Occupations/ 
2. exp Income/ 
3. exp Employment/ 
4. exp Population characteristics/ 
5. exp Education/ 
6. exp Health Behavior/ 
7. exp Poverty/ 
8. exp Poverty Areas/ 
9. exp Socioeconomic Factors/ 
10. exp Social Class/ 
11. exp Social Conditions/ 
12. exp Unemployment/ 
13. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12  
14. (poverty or deprivation or deprived or ghettos or slums or disadvantaged or 
unemployed or unemployment).ti,ab. 
15. (socio?economic$ or socio?demographic or inequality or inequalities or (inner adj 
(city or cities)) or ((low or high) adj1 (income or wage or salary or salaries))).ti,ab. 
16. ((standard$1 adj2 living) or (blue adj collar) or (white adj collar) or ((working or 
middle) adj2 class$)).mp. [mp=title, original title, abstract, name of substance, mesh 
subject heading] 
17. (socio?economic$ or poverty or depriv$).ti. 
18. (poverty or deprivation or deprived or ghettos or slums or disadvantaged or 
unemployed or unemployment or (socio?economic$ or socio?demographic or 
inequality or inequalities or (inner adj (city or cities)) or ((low or high) adj1 (income or 
wage or salary or salaries))) or ((standard$1 adj2 living) or (blue adj collar) or (white 
adj collar) or ((working or middle) adj2 class$) or (social adj inclusion adj 
partnership))).ti. 
19. 14 or 15 or 16 or 17 or 18 
20. exp Heart Diseases/ 
21. *Cardiovascular Diseases/ 
22. exp Cardiovascular Diseases/ 
23. (cardiovascular or heart or coronary or cardiac or myocardial or stroke or 
cerebrovascular).ti. 
24. 20 or 21 or 22 or 23 
25. 13 and 24 
26. 19 and 24 
27. 25 or 26 
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Appendix 2 
This appendix gives some examples of the results of the full multivariable models from the 
analyses of cardiovascular hospitalisations. Only the results concerning the analysis of a 
first cardiovascular outcome are provided to demonstrate the validity of the other variables 
in the models The full results of the unadjusted model, the model adjusted for age, sex, 
diabetes, smoking, cholesterol and blood pressure as well as the models including 
bronchitis, body mass index, cardiomegaly on chest x-ray and adjusted FEV1 are included.  
Table 97 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
Deprivation Category 1          
Deprivation Category 3 1.10 0.08 1.31 0.191 0.95 1.27 
Deprivation Category 4 1.15 0.08 2.01 0.044 1.00 1.31 
Deprivation Category 5 1.22 0.08 3.1 0.002 1.08 1.39 
Deprivation Category 6 & 7 1.42 0.10 5.13 <0.001 1.24 1.62 
 
Table 98 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
Deprivation Category 1          
Deprivation Category 3 1.10 0.08 1.33 0.183 0.95 1.27 
Deprivation Category 4 1.16 0.08 2.15 0.032 1.01 1.33 
Deprivation Category 5 1.19 0.08 2.62 0.009 1.04 1.35 
Deprivation Category 6 & 7 1.39 0.09 4.79 <0.001 1.21 1.58 
Age (per year) 1.04 0.00 12.94 <0.001 1.03 1.04 
Sex (male vs. female) 1.49 0.05 12.25 <0.001 1.39 1.58 
Diabetes 2.19 0.24 7.17 <0.001 1.77 2.71 
Smoker 1.44 0.05 10.5 <0.001 1.34 1.54 
Cholesterol (per mmol/l) 1.07 0.02 4.58 <0.001 1.04 1.10 
Systolic blood pressure (per mmHg) 1.01 0.00 14.44 <0.001 1.01 1.01 
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Table 99 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
bronchitis, body mass index and adjusted FEV1.  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
Deprivation Category 1          
Deprivation Category 3 1.09 0.08 1.2 0.229 0.95 1.27 
Deprivation Category 4 1.12 0.08 1.61 0.107 0.98 1.28 
Deprivation Category 5 1.14 0.08 2 0.046 1.00 1.30 
Deprivation Category 6 & 7 1.30 0.09 3.81 <0.001 1.14 1.49 
Age (per year) 1.04 0.00 12.27 <0.001 1.03 1.04 
Sex (male vs. female) 1.51 0.05 12.29 <0.001 1.41 1.61 
Diabetes 2.20 0.25 7 <0.001 1.77 2.75 
Smoker 1.44 0.05 10.09 <0.001 1.34 1.54 
Cholesterol (per mmol/l) 1.07 0.02 4.75 <0.001 1.04 1.10 
Systolic blood pressure 
(per mmHg) 1.01 0.00 11.97 <0.001 1.01 1.01 
Bronchitis 1.35 0.12 3.44 0.001 1.14 1.61 
Body mass index (per 
kg/m2) 1.01 0.00 2.84 0.005 1.00 1.02 
Cardiomegaly 1.20 0.05 4.89 <0.001 1.12 1.29 
Adjusted FEV1 (per %)  1.00 0.00 -5.2 <0.001 0.99 1.00 
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Table 100 Full model for all CVD hospitalisations at 25 years with social class 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
 Social Class I          
Social Class II 1.22 0.11 2.17 0.03 1.02 1.46 
Social Class III-NM 1.19 0.11 1.88 0.06 0.99 1.42 
Social Class III-M 1.47 0.138 4.35 <0.001 1.23 1.74 
Social Class IV 1.29 0.11 2.88 0.004 1.09 1.54 
Social Class V 1.40 0.14 3.46 0.001 1.16 1.70 
 
 
Table 101 Full model for all CVD hospitalisations at 25 years with social class adjusted for 
age, sex, diabetes, smoking, cholesterol and systolic blood pressure 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
 Social Class I          
Social Class II 1.29 0.12 2.73 0.006 1.07 1.54 
Social Class 
III-NM 1.31 0.12 2.99 0.003 1.10 1.57 
Social Class 
III-M 1.37 0.12 3.55 <0.001 1.15 1.63 
Social Class 
IV 1.33 0.11 3.2 0.001 1.12 1.59 
Social Class V 1.44 0.14 3.69 <0.001 1.19 1.75 
Age (per year) 1.04 0.002 12.84 <0.001 1.03 1.04 
Sex (male vs. 
female) 1.48 0.05 11.56 <0.001 1.39 1.58 
Diabetes 2.17 0.24 6.93 <0.001 1.74 2.70 
Smoker 1.45 0.05 10.71 <0.001 1.36 1.56 
Cholesterol 
(per mmol/l) 1.07 0.01 4.86 <0.001 1.04 1.10 
Systolic blood 
pressure (per 
mmHg) 1.01 0.0006 13.96 <0.001 1.01 1.01 
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Table 102 Full model for all CVD hospitalisations at 25 years with social class adjusted for 
age, sex, diabetes, smoking, cholesterol and systolic blood pressure, bronchitis, body mass 
index and adjusted FEV1.  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
 Social Class I          
Social Class II 1.27 0.120866 2.53 0.011 1.06 1.53 
Social Class III-NM 1.31 0.122884 2.86 0.004 1.09 1.57 
Social Class III-M 1.32 0.11995 3.02 0.002 1.10 1.57 
Social Class IV 1.28 0.117988 2.63 0.009 1.06 1.53 
Social Class V 1.36 0.138722 2.97 0.003 1.11 1.66 
Age (per year) 1.04 0.003054 12.15 <0.001 1.03 1.04 
Sex (male vs. female) 1.51 0.053251 11.71 <0.001 1.41 1.62 
Diabetes 2.18 0.252124 6.75 <0.001 1.74 2.74 
Smoker 1.45 0.052863 10.18 <0.001 1.35 1.56 
Cholesterol (per mmol/l) 1.08 0.016114 5 <0.001 1.05 1.11 
Systolic blood pressure (per 
mmHg) 1.01 0.000679 11.64 <0.001 1.01 1.01 
Bronchitis 1.36 0.120321 3.5 <0.001 1.15 1.62 
Body mass index (per kg/m2) 1.01 0.004327 2.79 0.005 1.00 1.02 
Cardiomegaly 1.21 0.045828 4.95 <0.001 1.12 1.30 
Adjusted FEV1 (per %)  1.00 0.00073 -5.19 <0.001 0.99 1.00 
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Appendix 3 
This appendix gives some examples of the results of the full multivariable models from the 
analyses that examined the risk of a recurrent cardiovascular hospitalisation according to 
SED. Only the results concerning the analysis of a recurrent cardiovascular hospitalisations 
are provided to demonstrate the validity of the other variables in the models The full 
results of the unadjusted model, the model adjusted for age, sex, diabetes, smoking, 
cholesterol and blood pressure as well as the models including bronchitis, body mass 
index, cardiomegaly on chest x-ray and adjusted FEV1 are included.  
Table 103 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
Deprivation Category 1          
Deprivation Category 3 1.01 0.10 0.13 0.894 0.84 1.23 
Deprivation Category 4 1.07 0.10 0.72 0.471 0.89 1.28 
Deprivation Category 5 1.05 0.09 0.6 0.548 0.89 1.25 
Deprivation Category 6 
& 7 1.02 0.09 0.26 0.797 0.85 1.23 
 
 
Table 104 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
year of first CVD event 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
Deprivation Category 1          
Deprivation Category 3 0.99 0.10 -0.08 0.935 0.82 1.20 
Deprivation Category 4 1.05 0.10 0.51 0.608 0.87 1.26 
Deprivation Category 5 1.02 0.09 0.19 0.848 0.85 1.21 
Deprivation Category 6 & 7 0.99 0.09 -0.15 0.885 0.82 1.18 
Age (per year) 0.98 0.00 -4.68 <0.001 0.98 0.99 
Sex (male vs. female) 1.11 0.05 2.35 0.019 1.02 1.21 
Diabetes 1.13 0.17 0.76 0.445 0.83 1.52 
Smoker 1.08 0.05 1.64 0.101 0.99 1.18 
Cholesterol (per mmol/l) 1.09 0.02 4.5 <0.001 1.05 1.13 
Systolic blood pressure 
(per mmHg) 1.00 0.00 2.89 0.004 1.00 1.00 
Year of first CVD event 1.00 0.00 -0.11 0.915 0.99 1.01 
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Table 105 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
year of first CVD event, bronchitis, body mass index and adjusted FEV1.  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
Deprivation Category 1          
Deprivation Category 3 1.00 0.10 -0.03 0.973 0.82 1.21 
Deprivation Category 4 1.04 0.10 0.39 0.7 0.86 1.25 
Deprivation Category 5 0.99 0.09 -0.13 0.896 0.83 1.18 
Deprivation Category 6 & 
7 0.96 0.09 -0.41 0.684 0.80 1.16 
Age (per year) 0.98 0.00 -4.76 <0.001 0.97 0.99 
Sex (male vs. female) 1.17 0.07 2.8 0.005 1.05 1.31 
Diabetes 1.07 0.17 0.39 0.694 0.78 1.46 
Smoker 1.10 0.05 1.93 0.054 1.00 1.21 
Cholesterol (per mmol/l) 1.09 0.02 4.56 <0.001 1.05 1.14 
Systolic blood pressure 
(per mmHg) 1.00 0.00 2.06 0.04 1.00 1.00 
Year of first CVD event 1.00 0.00 0.5 0.616 0.99 1.01 
Bronchitis 1.04 0.13 0.31 0.756 0.81 1.33 
Body mass index (per 
kg/m2) 1.00 0.01 0.53 0.598 0.99 1.01 
Cardiomegaly 1.18 0.06 3.38 0.001 1.07 1.31 
Adjusted FEV1 (per %)  1.00 0.00 -0.71 0.48 1.00 1.00 
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Table 106 Model for all recurrent CVD hospitalisations at 25 years with social class  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
Social Class I          
Social Class II 0.94 0.11 -0.56 0.578 0.74 1.18 
Social Class III-
NM 0.90 0.11 -0.88 0.38 0.72 1.13 
Social Class III-M 0.91 0.10 -0.82 0.41 0.73 1.14 
Social Class IV 0.93 0.11 -0.65 0.518 0.74 1.16 
Social Class V 0.99 0.13 -0.05 0.957 0.77 1.27 
 
Table 107 Full model for all recurrent CVD hospitalisations at 25 years with social class 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, year of 
first CVD event 
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval 
  
Social Class I          
Social Class II 0.95 0.11 -0.41 0.681 0.75 1.20 
Social Class III-NM 0.93 0.11 -0.59 0.552 0.74 1.18 
Social Class III-M 0.90 0.10 -0.91 0.361 0.72 1.13 
Social Class IV 0.94 0.11 -0.49 0.624 0.75 1.19 
Social Class V 1.02 0.13 0.15 0.884 0.79 1.31 
Age (per year) 0.98 0.00 -4.81 <0.001 0.97 0.99 
Sex (male vs. female) 1.12 0.05 2.45 0.014 1.02 1.22 
Diabetes 1.15 0.18 0.92 0.358 0.85 1.57 
Smoker 1.09 0.05 1.74 0.083 0.99 1.19 
Cholesterol (per 
mmol/l) 1.09 0.02 4.3 <0.001 1.05 1.13 
Systolic blood 
pressure (per mmHg) 1.00 0.00 2.77 0.006 1.00 1.00 
Year of first CVD 
event 1.00 0.00 0.01 0.99 0.99 1.01 
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Table 108 Full model for all recurrent CVD hospitalisations at 25 years with social class 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, year of 
first CVD event, bronchitis, body mass index and adjusted FEV1..  
Variable 
Hazard 
Ratio SE z P 
95% 
Confidence 
Interval   
Social Class I          
Social Class II 0.94 0.12 -0.52 0.605 0.74 1.19 
Social Class III-NM 0.94 0.11 -0.55 0.579 0.74 1.19 
Social Class III-M 0.90 0.11 -0.86 0.391 0.72 1.14 
Social Class IV 0.94 0.11 -0.51 0.61 0.74 1.19 
Social Class V 1.00 0.13 0.01 0.989 0.77 1.30 
Age (per year) 0.98 0.00 -4.87 <0.001 0.97 0.99 
Sex (male vs. 
female) 1.18 0.07 2.89 0.004 1.06 1.33 
Diabetes 1.09 0.18 0.55 0.583 0.79 1.50 
Smoker 1.10 0.05 1.99 0.047 1.00 1.22 
Cholesterol (per 
mmol/l) 1.09 0.02 4.37 <0.001 1.05 1.14 
Systolic blood 
pressure (per mmHg) 1.00 0.00 1.87 0.062 1.00 1.00 
Year of first CVD 
event 1.00 0.00 0.61 0.539 0.99 1.01 
Bronchitis 1.01 0.13 0.11 0.91 0.79 1.30 
Body mass index 
(per kg/m2) 1.00 0.01 0.59 0.556 0.99 1.01 
Cardiomegaly 1.18 0.06 3.2 0.001 1.06 1.30 
Adjusted FEV1 (per 
%)  1.00 0.00 -0.75 0.454 1.00 1.00 
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